,Sentence,ESG BERT Topic 1,ESG BERT Topic 2,ESG BERT Topic 3,Mapped Criteria Topic 1,Mapped Criteria Topic 2,Mapped Criteria Topic 3
Line 1,"12020    SUSTAINABILITY   REPORT ENVIRONMENTAL SOCIAL GOVERNANCECOMPANY PROFILE Corporate Overview  .
","('Business_Model_Resilience', 0.3537760078907013)","('Human_Rights_And_Community_Relations', 0.15570253133773804)","('Management_Of_Legal_And_Regulatory_Framework', 0.10340037941932678)","('NON-ESG', 0.3537760078907013)","('NON-ESG', 0.15570253133773804)","('NON-ESG', 0.10340037941932678)"
Line 2,"Mission and Guiding Principles.
","('Human_Rights_And_Community_Relations', 0.48951178789138794)","('Director_Removal', 0.06701233237981796)","('Employee_Engagement_Inclusion_And_Diversity', 0.057919107377529144)","('NON-ESG', 0.48951178789138794)","('NON-ESG', 0.06701233237981796)","('NON-ESG', 0.057919107377529144)"
Line 3,"Our Sustainability Commitment  .
","('Business_Model_Resilience', 0.4109761416912079)","('Product_Design_And_Lifecycle_Management', 0.1241399496793747)","('Supply_Chain_Management', 0.09202111512422562)","('NON-ESG', 0.4109761416912079)","('NON-ESG', 0.1241399496793747)","('NON-ESG', 0.09202111512422562)"
Line 4,"COVID -19  .
","('Competitive_Behavior', 0.21452823281288147)","('GHG_Emissions', 0.17528600990772247)","('Management_Of_Legal_And_Regulatory_Framework', 0.13778139650821686)","('NON-ESG', 0.21452823281288147)","('NON-ESG', 0.17528600990772247)","('NON-ESG', 0.13778139650821686)"
Line 5,"ENVIRONMENTAL Environmental Risk Management Policy  .
","('Physical_Impacts_Of_Climate_Change', 0.344616562128067)","('Business_Model_Resilience', 0.14965203404426575)","('Ecological_Impacts', 0.10354471951723099)","('NON-ESG', 0.344616562128067)","('NON-ESG', 0.14965203404426575)","('NON-ESG', 0.10354471951723099)"
Line 6,"Compliance  .
","('Management_Of_Legal_And_Regulatory_Framework', 0.33099278807640076)","('Business_Ethics', 0.3158797323703766)","('Product_Quality_And_Safety', 0.03956470638513565)","('NON-ESG', 0.33099278807640076)","('NON-ESG', 0.3158797323703766)","('NON-ESG', 0.03956470638513565)"
Line 7,"Continuous Improvement  .
","('Access_And_Affordability', 0.5638823509216309)","('Product_Quality_And_Safety', 0.049652084708213806)","('Critical_Incident_Risk_Management', 0.036384642124176025)","(['Health Outcome Contribution'], 0.5638823509216309)","('NON-ESG', 0.049652084708213806)","('NON-ESG', 0.036384642124176025)"
Line 8,"4  Business Integration  .
","('Business_Model_Resilience', 0.4399975538253784)","('Supply_Chain_Management', 0.09949313849210739)","('Systemic_Risk_Management', 0.0876220166683197)","('NON-ESG', 0.4399975538253784)","('NON-ESG', 0.09949313849210739)","('NON-ESG', 0.0876220166683197)"
Line 9,"Environment & Climate Change  .
","('Physical_Impacts_Of_Climate_Change', 0.8866551518440247)","('GHG_Emissions', 0.031187424436211586)","('Business_Model_Resilience', 0.01379129197448492)","(['Climate Change'], 0.8866551518440247)","('NON-ESG', 0.031187424436211586)","('NON-ESG', 0.01379129197448492)"
Line 10,"Health & Safety .
","('Employee_Health_And_Safety', 0.9481860995292664)","('Critical_Incident_Risk_Management', 0.010584035888314247)","('Product_Quality_And_Safety', 0.008064085617661476)","(['Operational Eco-Efficiency'], 0.9481860995292664)","('NON-ESG', 0.010584035888314247)","('NON-ESG', 0.008064085617661476)"
Line 11,"Communication & Education  .
","('Access_And_Affordability', 0.3808101713657379)","('Employee_Engagement_Inclusion_And_Diversity', 0.15011413395404816)","('Human_Rights_And_Community_Relations', 0.14196304976940155)","('NON-ESG', 0.3808101713657379)","('NON-ESG', 0.15011413395404816)","('NON-ESG', 0.14196304976940155)"
Line 12,"Environmental Targets  .
","('Management_Of_Legal_And_Regulatory_Framework', 0.19171738624572754)","('Human_Rights_And_Community_Relations', 0.16429349780082703)","('Energy_Management', 0.11676210165023804)","('NON-ESG', 0.19171738624572754)","('NON-ESG', 0.16429349780082703)","('NON-ESG', 0.11676210165023804)"
Line 13,"SOCIAL Talent Management  .
","('Employee_Engagement_Inclusion_And_Diversity', 0.8685013651847839)","('Human_Rights_And_Community_Relations', 0.024880273267626762)","('Employee_Health_And_Safety', 0.013339848257601261)","(['Human Capital Development'], 0.8685013651847839)","('NON-ESG', 0.024880273267626762)","('NON-ESG', 0.013339848257601261)"
Line 14,"Performance Management  .
","('Employee_Engagement_Inclusion_And_Diversity', 0.23038016259670258)","('Business_Model_Resilience', 0.1343463808298111)","('Human_Rights_And_Community_Relations', 0.09833971410989761)","('NON-ESG', 0.23038016259670258)","('NON-ESG', 0.1343463808298111)","('NON-ESG', 0.09833971410989761)"
Line 15,"Culture Promises and Habits  .
","('Employee_Engagement_Inclusion_And_Diversity', 0.4839593172073364)","('Human_Rights_And_Community_Relations', 0.24293890595436096)","('Business_Model_Resilience', 0.029863562434911728)","('NON-ESG', 0.4839593172073364)","('NON-ESG', 0.24293890595436096)","('NON-ESG', 0.029863562434911728)"
Line 16,"Performance Coaching  .
","('Employee_Engagement_Inclusion_And_Diversity', 0.4454512596130371)","('Access_And_Affordability', 0.12361409515142441)","('Employee_Health_And_Safety', 0.05890355259180069)","('NON-ESG', 0.4454512596130371)","('NON-ESG', 0.12361409515142441)","('NON-ESG', 0.05890355259180069)"
Line 17,"Leadership Development  .
","('Employee_Engagement_Inclusion_And_Diversity', 0.7331907749176025)","('Human_Rights_And_Community_Relations', 0.04021519422531128)","('Business_Model_Resilience', 0.029435928910970688)","(['Human Capital Development'], 0.7331907749176025)","('NON-ESG', 0.04021519422531128)","('NON-ESG', 0.029435928910970688)"
Line 18,"New Hire Orientation  .
","('Employee_Engagement_Inclusion_And_Diversity', 0.8666483163833618)","('Employee_Health_And_Safety', 0.016410717740654945)","('Labor_Practices', 0.015441765077412128)","(['Human Capital Development'], 0.8666483163833618)","('NON-ESG', 0.016410717740654945)","('NON-ESG', 0.015441765077412128)"
Line 19,"Global Onboarding Checklist  .
","('Data_Security', 0.27699264883995056)","('Business_Model_Resilience', 0.14529624581336975)","('Customer_Privacy', 0.07879216969013214)","('NON-ESG', 0.27699264883995056)","('NON-ESG', 0.14529624581336975)","('NON-ESG', 0.07879216969013214)"
Line 20,"Bookboon  .
","('Product_Design_And_Lifecycle_Management', 0.0889042317867279)","('Management_Of_Legal_And_Regulatory_Framework', 0.07972660660743713)","('Business_Ethics', 0.07667915523052216)","('NON-ESG', 0.0889042317867279)","('NON-ESG', 0.07972660660743713)","('NON-ESG', 0.07667915523052216)"
Line 21,"Rational Programs  .
","('Competitive_Behavior', 0.5614688396453857)","('Business_Ethics', 0.05927529186010361)","('Management_Of_Legal_And_Regulatory_Framework', 0.03720037639141083)","(['Business Ethics'], 0.5614688396453857)","('NON-ESG', 0.05927529186010361)","('NON-ESG', 0.03720037639141083)"
Line 22,"Learning Management System  .
","('Employee_Engagement_Inclusion_And_Diversity', 0.31970787048339844)","('Access_And_Affordability', 0.11639735847711563)","('Human_Rights_And_Community_Relations', 0.06089390814304352)","('NON-ESG', 0.31970787048339844)","('NON-ESG', 0.11639735847711563)","('NON-ESG', 0.06089390814304352)"
Line 23,"Diversity, Equity & Inclusion .
","('Employee_Engagement_Inclusion_And_Diversity', 0.968018114566803)","('Human_Rights_And_Community_Relations', 0.0030056126415729523)","('Employee_Health_And_Safety', 0.0023357286117970943)","(['Human Capital Development'], 0.968018114566803)","('NON-ESG', 0.0030056126415729523)","('NON-ESG', 0.0023357286117970943)"
Line 24,"Employee Resource Group .
","('Employee_Engagement_Inclusion_And_Diversity', 0.626505434513092)","('Labor_Practices', 0.08776518702507019)","('Employee_Health_And_Safety', 0.07656023651361465)","(['Human Capital Development'], 0.626505434513092)","('NON-ESG', 0.08776518702507019)","('NON-ESG', 0.07656023651361465)"
Line 25,"Employee Engagement  .
","('Employee_Engagement_Inclusion_And_Diversity', 0.8201320171356201)","('Human_Rights_And_Community_Relations', 0.058625731617212296)","('Employee_Health_And_Safety', 0.017875349149107933)","(['Human Capital Development'], 0.8201320171356201)","('NON-ESG', 0.058625731617212296)","('NON-ESG', 0.017875349149107933)"
Line 26,"Health, Safety & Wellness .
","('Employee_Health_And_Safety', 0.5081234574317932)","('Product_Quality_And_Safety', 0.12358412146568298)","('Employee_Engagement_Inclusion_And_Diversity', 0.0755922943353653)","(['Operational Eco-Efficiency'], 0.5081234574317932)","('NON-ESG', 0.12358412146568298)","('NON-ESG', 0.0755922943353653)"
Line 27,"Work/Life Balance  .
","('Employee_Health_And_Safety', 0.2189292311668396)","('Employee_Engagement_Inclusion_And_Diversity', 0.1915334016084671)","('Human_Rights_And_Community_Relations', 0.08840931206941605)","('NON-ESG', 0.2189292311668396)","('NON-ESG', 0.1915334016084671)","('NON-ESG', 0.08840931206941605)"
Line 28,"Pay Equity  .
","('Competitive_Behavior', 0.3743288815021515)","('Systemic_Risk_Management', 0.1275489628314972)","('Labor_Practices', 0.08634098619222641)","('NON-ESG', 0.3743288815021515)","('NON-ESG', 0.1275489628314972)","('NON-ESG', 0.08634098619222641)"
Line 29,"Benefits  .
","('Employee_Health_And_Safety', 0.19872890412807465)","('Product_Quality_And_Safety', 0.09219290316104889)","('Employee_Engagement_Inclusion_And_Diversity', 0.08178827911615372)","('NON-ESG', 0.19872890412807465)","('NON-ESG', 0.09219290316104889)","('NON-ESG', 0.08178827911615372)"
Line 30,"Collective Bargaining  .
","('Labor_Practices', 0.9667952656745911)","('Director_Removal', 0.003116433508694172)","('Supply_Chain_Management', 0.0022363176103681326)","(['Labor Practice Indicators'], 0.9667952656745911)","('NON-ESG', 0.003116433508694172)","('NON-ESG', 0.0022363176103681326)"
Line 31,"Discrimination Policy  .
","('Employee_Engagement_Inclusion_And_Diversity', 0.8701813220977783)","('Labor_Practices', 0.02498435415327549)","('Business_Ethics', 0.013659968972206116)","(['Human Capital Development'], 0.8701813220977783)","('NON-ESG', 0.02498435415327549)","('NON-ESG', 0.013659968972206116)"
Line 32,"Product Quality  .
","('Product_Design_And_Lifecycle_Management', 0.8102402091026306)","('Product_Quality_And_Safety', 0.07090743631124496)","('Selling_Practices_And_Product_Labeling', 0.02475384622812271)","(['Product Stewardship'], 0.8102402091026306)","('NON-ESG', 0.07090743631124496)","('NON-ESG', 0.02475384622812271)"
Line 33,"Supplier Code of Conduct .
","('Supply_Chain_Management', 0.9079453349113464)","('Labor_Practices', 0.01491320226341486)","('Waste_And_Hazardous_Materials_Management', 0.0069217015989124775)","(['Supply Chain Management'], 0.9079453349113464)","('NON-ESG', 0.01491320226341486)","('NON-ESG', 0.0069217015989124775)"
Line 34,"Supplier Social Responsibility Audits  .
","('Supply_Chain_Management', 0.7892562747001648)","('Human_Rights_And_Community_Relations', 0.042162586003541946)","('Business_Model_Resilience', 0.019030138850212097)","(['Supply Chain Management'], 0.7892562747001648)","('NON-ESG', 0.042162586003541946)","('NON-ESG', 0.019030138850212097)"
Line 35,"11Supplier Diligence  .
","('Business_Ethics', 0.3848152756690979)","('Competitive_Behavior', 0.23978595435619354)","('Management_Of_Legal_And_Regulatory_Framework', 0.1319257766008377)","('NON-ESG', 0.3848152756690979)","('NON-ESG', 0.23978595435619354)","('NON-ESG', 0.1319257766008377)"
Line 36,"Supplier Quality Audits  .
","('Supply_Chain_Management', 0.9183954000473022)","('Labor_Practices', 0.008262102492153645)","('Waste_And_Hazardous_Materials_Management', 0.005336126312613487)","(['Supply Chain Management'], 0.9183954000473022)","('NON-ESG', 0.008262102492153645)","('NON-ESG', 0.005336126312613487)"
Line 37,"Supplier Diversity Policy  .
","('Employee_Engagement_Inclusion_And_Diversity', 0.9125421047210693)","('Labor_Practices', 0.014323527924716473)","('Supply_Chain_Management', 0.007563414052128792)","(['Human Capital Development'], 0.9125421047210693)","('NON-ESG', 0.014323527924716473)","('NON-ESG', 0.007563414052128792)"
Line 38,"Management of Risks Associated   with Use of Critical Materials  .
","('Supply_Chain_Management', 0.616769552230835)","('Waste_And_Hazardous_Materials_Management', 0.144697368144989)","('Product_Design_And_Lifecycle_Management', 0.02271188423037529)","(['Supply Chain Management'], 0.616769552230835)","('NON-ESG', 0.144697368144989)","('NON-ESG', 0.02271188423037529)"
Line 39,"Animal Testing Policy  .
","('Management_Of_Legal_And_Regulatory_Framework', 0.24547246098518372)","('Product_Quality_And_Safety', 0.11540549248456955)","('Business_Ethics', 0.07773681730031967)","('NON-ESG', 0.24547246098518372)","('NON-ESG', 0.11540549248456955)","('NON-ESG', 0.07773681730031967)"
Line 40,"Critical Trial Program  .
","('Competitive_Behavior', 0.4567439556121826)","('Customer_Welfare', 0.0667017474770546)","('Management_Of_Legal_And_Regulatory_Framework', 0.06447973847389221)","('NON-ESG', 0.4567439556121826)","('NON-ESG', 0.0667017474770546)","('NON-ESG', 0.06447973847389221)"
Line 41,"Critical Trial Transparency  .
","('Business_Ethics', 0.9566879272460938)","('Management_Of_Legal_And_Regulatory_Framework', 0.0056413100101053715)","('Systemic_Risk_Management', 0.004635737743228674)","(['Business Ethics'], 0.9566879272460938)","('NON-ESG', 0.0056413100101053715)","('NON-ESG', 0.004635737743228674)"
Line 42,"Grants, Donations and Funding .
","('Management_Of_Legal_And_Regulatory_Framework', 0.8462825417518616)","('Human_Rights_And_Community_Relations', 0.02091269940137863)","('GHG_Emissions', 0.01848936639726162)","(['Corporate Governance'], 0.8462825417518616)","('NON-ESG', 0.02091269940137863)","('NON-ESG', 0.01848936639726162)"
Line 43,"Zimmer Biomet Foundation  .
","('Management_Of_Legal_And_Regulatory_Framework', 0.11502531170845032)","('Customer_Welfare', 0.08520302921533585)","('Business_Ethics', 0.07380014657974243)","('NON-ESG', 0.11502531170845032)","('NON-ESG', 0.08520302921533585)","('NON-ESG', 0.07380014657974243)"
Line 44,"americares  .
","('Management_Of_Legal_And_Regulatory_Framework', 0.14159290492534637)","('Waste_And_Hazardous_Materials_Management', 0.07383165508508682)","('Director_Removal', 0.06760254502296448)","('NON-ESG', 0.14159290492534637)","('NON-ESG', 0.07383165508508682)","('NON-ESG', 0.06760254502296448)"
Line 45,"Faith In Practice  .
","('Human_Rights_And_Community_Relations', 0.2176467776298523)","('Employee_Engagement_Inclusion_And_Diversity', 0.16819171607494354)","('Business_Ethics', 0.0882268100976944)","('NON-ESG', 0.2176467776298523)","('NON-ESG', 0.16819171607494354)","('NON-ESG', 0.0882268100976944)"
Line 46,"Access to Healthcare .
","('Access_And_Affordability', 0.8997789025306702)","('Human_Rights_And_Community_Relations', 0.011929549276828766)","('Product_Quality_And_Safety', 0.009183968417346478)","(['Health Outcome Contribution'], 0.8997789025306702)","('NON-ESG', 0.011929549276828766)","('NON-ESG', 0.009183968417346478)"
Line 47,"Movement is Life  .
","('Business_Model_Resilience', 0.14139433205127716)","('Employee_Engagement_Inclusion_And_Diversity', 0.12489205598831177)","('Product_Design_And_Lifecycle_Management', 0.07734066992998123)","('NON-ESG', 0.14139433205127716)","('NON-ESG', 0.12489205598831177)","('NON-ESG', 0.07734066992998123)"
Line 48,"Patient Privacy and Data Security .
","('Data_Security', 0.8134377598762512)","('Customer_Privacy', 0.1101667582988739)","('Director_Removal', 0.006691740360110998)","(['Information Security/Cybersecurity & System Availability'], 0.8134377598762512)","('NON-ESG', 0.1101667582988739)","('NON-ESG', 0.006691740360110998)"
Line 49,"Privacy  .
","('Customer_Privacy', 0.6171815991401672)","('Data_Security', 0.19023634493350983)","('Labor_Practices', 0.018333427608013153)","(['Privacy Protection'], 0.6171815991401672)","('NON-ESG', 0.19023634493350983)","('NON-ESG', 0.018333427608013153)"
Line 50,"Data Security .
","('Data_Security', 0.9359430074691772)","('Customer_Privacy', 0.01165156438946724)","('Waste_And_Hazardous_Materials_Management', 0.004777421243488789)","(['Information Security/Cybersecurity & System Availability'], 0.9359430074691772)","('NON-ESG', 0.01165156438946724)","('NON-ESG', 0.004777421243488789)"
Line 51,"Data Usage  .
","('Customer_Privacy', 0.7940269708633423)","('Data_Security', 0.09321184456348419)","('Business_Model_Resilience', 0.010781035758554935)","(['Privacy Protection'], 0.7940269708633423)","('NON-ESG', 0.09321184456348419)","('NON-ESG', 0.010781035758554935)"
Line 52,"Ownership  .
","('Competitive_Behavior', 0.1631014049053192)","('Employee_Engagement_Inclusion_And_Diversity', 0.08115348219871521)","('Access_And_Affordability', 0.0576949343085289)","('NON-ESG', 0.1631014049053192)","('NON-ESG', 0.08115348219871521)","('NON-ESG', 0.0576949343085289)"
Line 53,"Cybersecurity  .
","('Data_Security', 0.6627269983291626)","('Business_Model_Resilience', 0.06883599609136581)","('Systemic_Risk_Management', 0.044365253299474716)","(['Information Security/Cybersecurity & System Availability'], 0.6627269983291626)","('NON-ESG', 0.06883599609136581)","('NON-ESG', 0.044365253299474716)"
Line 54,"GOVERNANCE Corporate Governance  .
","('Competitive_Behavior', 0.2616554796695709)","('Management_Of_Legal_And_Regulatory_Framework', 0.25847506523132324)","('Business_Ethics', 0.13982699811458588)","('NON-ESG', 0.2616554796695709)","('NON-ESG', 0.25847506523132324)","('NON-ESG', 0.13982699811458588)"
Line 55,"Audit Committee  .
","('Management_Of_Legal_And_Regulatory_Framework', 0.607505738735199)","('Business_Ethics', 0.10126495361328125)","('Director_Removal', 0.0715600997209549)","(['Corporate Governance'], 0.607505738735199)","('NON-ESG', 0.10126495361328125)","('NON-ESG', 0.0715600997209549)"
Line 56,"Compensation and Management   Development Committee .
","('Management_Of_Legal_And_Regulatory_Framework', 0.28426414728164673)","('Human_Rights_And_Community_Relations', 0.11506842821836472)","('Employee_Engagement_Inclusion_And_Diversity', 0.11158256977796555)","('NON-ESG', 0.28426414728164673)","('NON-ESG', 0.11506842821836472)","('NON-ESG', 0.11158256977796555)"
Line 57,"Corporate Governance Committee  .
","('Management_Of_Legal_And_Regulatory_Framework', 0.27872565388679504)","('Director_Removal', 0.18936648964881897)","('Business_Model_Resilience', 0.09834719449281693)","('NON-ESG', 0.27872565388679504)","('NON-ESG', 0.18936648964881897)","('NON-ESG', 0.09834719449281693)"
Line 58,"Quality, Regulatory and Technology Committee  .
","('Management_Of_Legal_And_Regulatory_Framework', 0.9464092254638672)","('Business_Ethics', 0.006604354828596115)","('Competitive_Behavior', 0.004103845451027155)","(['Corporate Governance'], 0.9464092254638672)","('NON-ESG', 0.006604354828596115)","('NON-ESG', 0.004103845451027155)"
Line 59,"Executive Compensation  .
","('Labor_Practices', 0.5361263751983643)","('Employee_Engagement_Inclusion_And_Diversity', 0.0988193154335022)","('Director_Removal', 0.08516910672187805)","(['Labor Practice Indicators'], 0.5361263751983643)","('NON-ESG', 0.0988193154335022)","('NON-ESG', 0.08516910672187805)"
Line 60,"Ethical Business Conduct  .
","('Business_Ethics', 0.931149423122406)","('Competitive_Behavior', 0.0060986909084022045)","('Customer_Privacy', 0.005235627759248018)","(['Business Ethics'], 0.931149423122406)","('NON-ESG', 0.0060986909084022045)","('NON-ESG', 0.005235627759248018)"
Line 61,"Counter Corruption  .
","('Business_Ethics', 0.9587657451629639)","('Competitive_Behavior', 0.004806371405720711)","('Data_Security', 0.004077887628227472)","(['Business Ethics'], 0.9587657451629639)","('NON-ESG', 0.004806371405720711)","('NON-ESG', 0.004077887628227472)"
Line 62,"Whistleblower Program .
","('Business_Ethics', 0.5784887671470642)","('Data_Security', 0.25695866346359253)","('Customer_Privacy', 0.02175302430987358)","(['Business Ethics'], 0.5784887671470642)","('NON-ESG', 0.25695866346359253)","('NON-ESG', 0.02175302430987358)"
Line 63,"Ethical Marketing  .
","('Business_Ethics', 0.4063655734062195)","('Competitive_Behavior', 0.09250180423259735)","('Customer_Privacy', 0.06600655615329742)","('NON-ESG', 0.4063655734062195)","('NON-ESG', 0.09250180423259735)","('NON-ESG', 0.06600655615329742)"
Line 64,"Zimmer Biomet’s Statement of Engagement   on Public Policy Issues .
","('Management_Of_Legal_And_Regulatory_Framework', 0.6172706484794617)","('Human_Rights_And_Community_Relations', 0.1364983469247818)","('Physical_Impacts_Of_Climate_Change', 0.0409114845097065)","(['Corporate Governance'], 0.6172706484794617)","('NON-ESG', 0.1364983469247818)","('NON-ESG', 0.0409114845097065)"
Line 65,"How Zimmer Biomet Engages .
","('Competitive_Behavior', 0.31615492701530457)","('Customer_Welfare', 0.11331457644701004)","('Systemic_Risk_Management', 0.0730728805065155)","('NON-ESG', 0.31615492701530457)","('NON-ESG', 0.11331457644701004)","('NON-ESG', 0.0730728805065155)"
Line 66,"Industry Groups and Trade Associations  .
","('Management_Of_Legal_And_Regulatory_Framework', 0.53676837682724)","('Labor_Practices', 0.10666337609291077)","('Competitive_Behavior', 0.06482360512018204)","(['Corporate Governance'], 0.53676837682724)","('NON-ESG', 0.10666337609291077)","('NON-ESG', 0.06482360512018204)"
Line 67,"Political Contributions  .
","('Management_Of_Legal_And_Regulatory_Framework', 0.4382394552230835)","('Labor_Practices', 0.09067396819591522)","('Director_Removal', 0.06963133066892624)","('NON-ESG', 0.4382394552230835)","('NON-ESG', 0.09067396819591522)","('NON-ESG', 0.06963133066892624)"
Line 68,"2020 Sustainability Accounting Standards   Board Index  .
","('Management_Of_Legal_And_Regulatory_Framework', 0.36799734830856323)","('Systemic_Risk_Management', 0.1093265563249588)","('Business_Model_Resilience', 0.08599883317947388)","('NON-ESG', 0.36799734830856323)","('NON-ESG', 0.1093265563249588)","('NON-ESG', 0.08599883317947388)"
Line 69,"25Table of Contents1Corporate Overview Zimmer Biomet is a global medical technology leader with  a comprehensive portfolio designed to maximize mobility  and improve health.
","('Product_Design_And_Lifecycle_Management', 0.23570884764194489)","('Customer_Welfare', 0.168511763215065)","('Access_And_Affordability', 0.08917686343193054)","('NON-ESG', 0.23570884764194489)","('NON-ESG', 0.168511763215065)","('NON-ESG', 0.08917686343193054)"
Line 70,"We seamlessly transform the patient  experience through our innovative products and suite of  integrated digital and robotic technologies that leverage  data, analytics and artificial intelligence.
","('Product_Design_And_Lifecycle_Management', 0.8525310754776001)","('Energy_Management', 0.01989142782986164)","('Customer_Welfare', 0.01744171977043152)","(['Product Stewardship'], 0.8525310754776001)","('NON-ESG', 0.01989142782986164)","('NON-ESG', 0.01744171977043152)"
Line 71,"With more than 90 years of trusted leadership and  proven expertise, Zimmer Biomet is positioned to deliver  the highest quality solutions to patients and providers.
","('Business_Model_Resilience', 0.20989234745502472)","('Product_Design_And_Lifecycle_Management', 0.16883236169815063)","('Access_And_Affordability', 0.0965544804930687)","('NON-ESG', 0.20989234745502472)","('NON-ESG', 0.16883236169815063)","('NON-ESG', 0.0965544804930687)"
Line 72,"Our legacy continues to come to life today through our  progressive culture of evolution and innovation.
","('Business_Model_Resilience', 0.24686592817306519)","('Product_Design_And_Lifecycle_Management', 0.22281892597675323)","('Employee_Engagement_Inclusion_And_Diversity', 0.14761027693748474)","('NON-ESG', 0.24686592817306519)","('NON-ESG', 0.22281892597675323)","('NON-ESG', 0.14761027693748474)"
Line 73,"For more information about our product portfolio, our  operations in more than 25 countries and sales in more  than 100 countries, or about joining our team, visit   www.zimmerbiomet.com  or follow Zimmer Biomet   on Twitter at www.twitter.com/zimmerbiomet.Our Mission   Alleviate pain and improve the quality of life for people  around the world.
","('Product_Design_And_Lifecycle_Management', 0.8397092223167419)","('Selling_Practices_And_Product_Labeling', 0.03664509579539299)","('Customer_Welfare', 0.03275372087955475)","(['Product Stewardship'], 0.8397092223167419)","('NON-ESG', 0.03664509579539299)","('NON-ESG', 0.03275372087955475)"
Line 74,"Guiding Principles    • Respect the contributions and perspectives   of all Team Members.
","('Human_Rights_And_Community_Relations', 0.7055792808532715)","('Director_Removal', 0.04395436495542526)","('Employee_Engagement_Inclusion_And_Diversity', 0.0349479503929615)","(['Community Relations'], 0.7055792808532715)","('NON-ESG', 0.04395436495542526)","('NON-ESG', 0.0349479503929615)"
Line 75,"• Commit to the highest standards of patient safety,  quality and integrity.
","('Product_Quality_And_Safety', 0.43872156739234924)","('Employee_Health_And_Safety', 0.3937290608882904)","('Access_And_Affordability', 0.015717677772045135)","('NON-ESG', 0.43872156739234924)","('NON-ESG', 0.3937290608882904)","('NON-ESG', 0.015717677772045135)"
Line 76,"• Focus our resources in areas where we will   make a difference.
","('Human_Rights_And_Community_Relations', 0.7056883573532104)","('Business_Model_Resilience', 0.05552332475781441)","('Employee_Engagement_Inclusion_And_Diversity', 0.04483994096517563)","(['Community Relations'], 0.7056883573532104)","('NON-ESG', 0.05552332475781441)","('NON-ESG', 0.04483994096517563)"
Line 77,"• Ensure the Company’s return is equivalent   to the value we provide our customers and patients.
","('Business_Model_Resilience', 0.361364483833313)","('Competitive_Behavior', 0.18816028535366058)","('Product_Design_And_Lifecycle_Management', 0.0631050318479538)","('NON-ESG', 0.361364483833313)","('NON-ESG', 0.18816028535366058)","('NON-ESG', 0.0631050318479538)"
Line 78,"• Give back to our communities and people in need.
","('Human_Rights_And_Community_Relations', 0.8428218960762024)","('Access_And_Affordability', 0.06927510350942612)","('Critical_Incident_Risk_Management', 0.010347303934395313)","(['Community Relations'], 0.8428218960762024)","('NON-ESG', 0.06927510350942612)","('NON-ESG', 0.010347303934395313)"
Line 79,"Our Sustainability Commitment   Zimmer Biomet is committed to being a good corporate  citizen.
","('Business_Model_Resilience', 0.45846205949783325)","('Product_Design_And_Lifecycle_Management', 0.11397736519575119)","('Supply_Chain_Management', 0.08021610975265503)","('NON-ESG', 0.45846205949783325)","('NON-ESG', 0.11397736519575119)","('NON-ESG', 0.08021610975265503)"
Line 80,"Our global team is dedicated to sustainable  practices across the entire spectrum of the environmental,  social and governance platform.
","('Human_Rights_And_Community_Relations', 0.6427996158599854)","('Management_Of_Legal_And_Regulatory_Framework', 0.07355409860610962)","('Business_Model_Resilience', 0.05703587830066681)","(['Community Relations'], 0.6427996158599854)","('NON-ESG', 0.07355409860610962)","('NON-ESG', 0.05703587830066681)"
Line 81,"COMPANY PROFILE2COMPANY AWARDSCOVID-The COVID-19 pandemic has affected Zimmer Biomet’s  financial results, but there has been no significant impact  on our overall operations, manufacturing or strategy.
","('Systemic_Risk_Management', 0.4626583158969879)","('Business_Model_Resilience', 0.3661503791809082)","('Supply_Chain_Management', 0.0362020842730999)","('NON-ESG', 0.4626583158969879)","('NON-ESG', 0.3661503791809082)","('NON-ESG', 0.0362020842730999)"
Line 82,"Additionally, the pandemic has not impacted the quality,  safety and efficacy of our products.
","('Product_Quality_And_Safety', 0.6179763674736023)","('Product_Design_And_Lifecycle_Management', 0.18260136246681213)","('Selling_Practices_And_Product_Labeling', 0.06486094743013382)","(['Product Quality & Recall Management'], 0.6179763674736023)","('NON-ESG', 0.18260136246681213)","('NON-ESG', 0.06486094743013382)"
Line 83,"Prior to COVID-19, Zimmer Biomet developed  comprehensive crisis response plans and initiated  contingency drills – including for pandemic events – across  our operations.
","('Critical_Incident_Risk_Management', 0.5580675005912781)","('Physical_Impacts_Of_Climate_Change', 0.28210705518722534)","('Systemic_Risk_Management', 0.030484069138765335)","(['Risk & Crisis Management'], 0.5580675005912781)","('NON-ESG', 0.28210705518722534)","('NON-ESG', 0.030484069138765335)"
Line 84,"This exercise helped prepare the Company  and create enhanced disaster recovery plans that have  been a significant benefit throughout our response to  COVID-19.
","('Critical_Incident_Risk_Management', 0.9725516438484192)","('Employee_Health_And_Safety', 0.004561958834528923)","('Air_Quality', 0.0026146431919187307)","(['Risk & Crisis Management'], 0.9725516438484192)","('NON-ESG', 0.004561958834528923)","('NON-ESG', 0.0026146431919187307)"
Line 85,"Accordingly, we were able to promptly secure  our global supply chain in early 2020, as COVID-19 reached  pandemic proportions, and continued operations without  compromising product quality and safety.
","('Product_Design_And_Lifecycle_Management', 0.4368729889392853)","('Product_Quality_And_Safety', 0.4217439889907837)","('Selling_Practices_And_Product_Labeling', 0.015549767762422562)","('NON-ESG', 0.4368729889392853)","('NON-ESG', 0.4217439889907837)","('NON-ESG', 0.015549767762422562)"
Line 86,"Our China manufacturing facilities quickly recovered  from the initial outbreak of COVID-19 and resumed full  operations sooner than initially expected.
","('Supply_Chain_Management', 0.21148686110973358)","('Product_Design_And_Lifecycle_Management', 0.16801618039608002)","('Systemic_Risk_Management', 0.13515353202819824)","('NON-ESG', 0.21148686110973358)","('NON-ESG', 0.16801618039608002)","('NON-ESG', 0.13515353202819824)"
Line 87,"Zimmer Biomet promptly secured the transportation of raw and finished  goods materials, as well as personal protective equipment  inside and outside of the Asia Pacific (APAC) region.
","('Product_Design_And_Lifecycle_Management', 0.4525192975997925)","('Employee_Health_And_Safety', 0.19218844175338745)","('Waste_And_Hazardous_Materials_Management', 0.07676458358764648)","('NON-ESG', 0.4525192975997925)","('NON-ESG', 0.19218844175338745)","('NON-ESG', 0.07676458358764648)"
Line 88,"All of our manufacturing sites and distribution centers  outside of APAC implemented enhanced safety protocols  and established regional health contacts prior to the  pandemic spreading across all regions.
","('Product_Quality_And_Safety', 0.43960556387901306)","('Employee_Health_And_Safety', 0.3772403597831726)","('Selling_Practices_And_Product_Labeling', 0.019418219104409218)","('NON-ESG', 0.43960556387901306)","('NON-ESG', 0.3772403597831726)","('NON-ESG', 0.019418219104409218)"
Line 89,"Our enhanced  safety protocols were openly shared with our suppliers  to ensure as secure a supply chain as possible.
","('Supply_Chain_Management', 0.5119631886482239)","('Product_Quality_And_Safety', 0.11983733624219894)","('Employee_Health_And_Safety', 0.11186274886131287)","(['Supply Chain Management'], 0.5119631886482239)","('NON-ESG', 0.11983733624219894)","('NON-ESG', 0.11186274886131287)"
Line 90,"Zimmer  Biomet personnel not directly connected to manufacturing  operations, and the supply chain shifted to work from  home arrangements as an added safety measure to secure  the supply chain and reduce risk of infection for all team  members.
","('Supply_Chain_Management', 0.9295170903205872)","('Labor_Practices', 0.007060011383146048)","('Employee_Health_And_Safety', 0.006177152972668409)","(['Supply Chain Management'], 0.9295170903205872)","('NON-ESG', 0.007060011383146048)","('NON-ESG', 0.006177152972668409)"
Line 91,"A measured approach to balance manufacturing and cash  flow proved successful and since that time, our service  levels have been running at or above industry norms.4Environmental Risk Management Policy Consistent with Zimmer Biomet’s Mission, Code of Business  Conduct and Ethics and the Environmental, Health, Safety,  and Sustainability (EHSS) Vision, we are committed to our  policy of conducting business in a safe and environmentally  sustainable manner that promotes the health of our  employees, customers, community and the environment  and that meets global EHSS requirements.
","('Employee_Health_And_Safety', 0.39332860708236694)","('Product_Quality_And_Safety', 0.13550832867622375)","('Business_Ethics', 0.09332722425460815)","('NON-ESG', 0.39332860708236694)","('NON-ESG', 0.13550832867622375)","('NON-ESG', 0.09332722425460815)"
Line 92,"A measured approach to balance manufacturing and cash  flow proved successful and since that time, our service  levels have been running at or above industry norms.4Environmental Risk Management Policy Consistent with Zimmer Biomet’s Mission, Code of Business  Conduct and Ethics and the Environmental, Health, Safety,  and Sustainability (EHSS) Vision, we are committed to our  policy of conducting business in a safe and environmentally  sustainable manner that promotes the health of our  employees, customers, community and the environment  and that meets global EHSS requirements.
","('Human_Rights_And_Community_Relations', 0.7788113355636597)","('Ecological_Impacts', 0.08117586374282837)","('GHG_Emissions', 0.018483048304915428)","(['Community Relations'], 0.7788113355636597)","('NON-ESG', 0.08117586374282837)","('NON-ESG', 0.018483048304915428)"
Line 93,"The purpose of  our Environmental Risk Management Policy is to implement  the principles of the EHSS programs.
","('Management_Of_Legal_And_Regulatory_Framework', 0.2660711705684662)","('Physical_Impacts_Of_Climate_Change', 0.1651289016008377)","('Business_Model_Resilience', 0.16105018556118011)","('NON-ESG', 0.2660711705684662)","('NON-ESG', 0.1651289016008377)","('NON-ESG', 0.16105018556118011)"
Line 94,"Corporate and  regional standards exist to support these principles.
","('Management_Of_Legal_And_Regulatory_Framework', 0.485254168510437)","('Business_Ethics', 0.16159981489181519)","('Product_Quality_And_Safety', 0.09716372191905975)","('NON-ESG', 0.485254168510437)","('NON-ESG', 0.16159981489181519)","('NON-ESG', 0.09716372191905975)"
Line 95,"This policy applies to all Zimmer Biomet locations  throughout the world.
","('Management_Of_Legal_And_Regulatory_Framework', 0.1473236083984375)","('Customer_Welfare', 0.1287301778793335)","('Competitive_Behavior', 0.06781715899705887)","('NON-ESG', 0.1473236083984375)","('NON-ESG', 0.1287301778793335)","('NON-ESG', 0.06781715899705887)"
Line 96,"It provides uniform guidance for the  Zimmer Biomet EHSS teams to manage and monitor risk  within the global manufacturing and distribution processes.
","('Systemic_Risk_Management', 0.9130842089653015)","('Supply_Chain_Management', 0.021575404331088066)","('Business_Ethics', 0.009242958389222622)","(['Risk & Crisis Management'], 0.9130842089653015)","('NON-ESG', 0.021575404331088066)","('NON-ESG', 0.009242958389222622)"
Line 97,"As part of our EHSS Management System, Zimmer Biomet  commits to: Compliance Zimmer Biomet complies with all applicable EHSS  laws, regulations, Company EHSS Standards and other  requirements to which the organization subscribes related  to all EHSS subject matter and risks.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8468527793884277)","('Business_Ethics', 0.023443331941962242)","('Product_Quality_And_Safety', 0.023142483085393906)","(['Corporate Governance'], 0.8468527793884277)","('NON-ESG', 0.023443331941962242)","('NON-ESG', 0.023142483085393906)"
Line 98,"Zimmer Biomet  conducts audits and implements best practices to ensure  compliance with these requirements.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7870067358016968)","('Business_Ethics', 0.12199617922306061)","('Product_Quality_And_Safety', 0.013072241097688675)","(['Corporate Governance'], 0.7870067358016968)","('NON-ESG', 0.12199617922306061)","('NON-ESG', 0.013072241097688675)"
Line 99,"Continuous Improvement Zimmer Biomet establishes EHSS goals, objectives and  targets across our global business and strives to continually  improve our performance and publicly report on our  progress.
","('Business_Model_Resilience', 0.5261688828468323)","('Human_Rights_And_Community_Relations', 0.10469867289066315)","('Management_Of_Legal_And_Regulatory_Framework', 0.05039086565375328)","(['Codes of Business Conduct'], 0.5261688828468323)","('NON-ESG', 0.10469867289066315)","('NON-ESG', 0.05039086565375328)"
Line 100,"The Zimmer Biomet EHSS Standards establish  controls and promote a positive EHSS culture.Business Integration   Zimmer Biomet integrates EHSS principles into business  decisions to proactively ensure the health and safety of  our employees and communities while also promoting  environmentally sustainable practices.
","('Employee_Health_And_Safety', 0.5541240572929382)","('Human_Rights_And_Community_Relations', 0.2720184326171875)","('Product_Quality_And_Safety', 0.026172619313001633)","(['Operational Eco-Efficiency'], 0.5541240572929382)","('NON-ESG', 0.2720184326171875)","('NON-ESG', 0.026172619313001633)"
Line 101,"Specifically,  we require that an EHSS evaluation be integrated into  product design, manufacturing and distribution business  processes and services that will reduce EHSS risks, improve  performance throughout our operations, products and  packaging across their lifecycle, and promote pollution  prevention.
","('Product_Design_And_Lifecycle_Management', 0.9537015557289124)","('Product_Quality_And_Safety', 0.008230462670326233)","('Selling_Practices_And_Product_Labeling', 0.00523685896769166)","(['Product Stewardship'], 0.9537015557289124)","('NON-ESG', 0.008230462670326233)","('NON-ESG', 0.00523685896769166)"
Line 102,"Environment & Climate Change Zimmer Biomet minimizes waste and emissions, reuses  and recycles materials, promotes renewable energy use,  reduces greenhouse gas emissions, and conserves energy  and water wherever feasible, to minimize our impact on the  environment.
","('GHG_Emissions', 0.7420006990432739)","('Physical_Impacts_Of_Climate_Change', 0.07004372775554657)","('Energy_Management', 0.029312947764992714)","(['Climate Change'], 0.7420006990432739)","('NON-ESG', 0.07004372775554657)","('NON-ESG', 0.029312947764992714)"
Line 103,"Health & Safety Zimmer Biomet EHSS establishes health and safety  standards that promote a safe and healthy workplace by  striving continuously to reduce hazards and risks to prevent  workplace injuries and illnesses.
","('Employee_Health_And_Safety', 0.9846857786178589)","('Employee_Engagement_Inclusion_And_Diversity', 0.0017652623355388641)","('Critical_Incident_Risk_Management', 0.0015374310314655304)","(['Operational Eco-Efficiency'], 0.9846857786178589)","('NON-ESG', 0.0017652623355388641)","('NON-ESG', 0.0015374310314655304)"
Line 104,"Communication & Education Zimmer Biomet EHSS communicates this policy to  employees, customers, shareholders, suppliers, community  and other stakeholders.
","('Supply_Chain_Management', 0.4347403943538666)","('Human_Rights_And_Community_Relations', 0.13196821510791779)","('Access_And_Affordability', 0.05071331560611725)","('NON-ESG', 0.4347403943538666)","('NON-ESG', 0.13196821510791779)","('NON-ESG', 0.05071331560611725)"
Line 105,"Zimmer Biomet EHSS Standards,  Procedures and other resources enable employees to  implement this policy and share best practices throughout  the Company in order to promote continuous improvement  and enhance environmental, health and safety performance.
","('Employee_Health_And_Safety', 0.7755520939826965)","('Product_Quality_And_Safety', 0.12869419157505035)","('Business_Ethics', 0.008434629999101162)","(['Operational Eco-Efficiency'], 0.7755520939826965)","('NON-ESG', 0.12869419157505035)","('NON-ESG', 0.008434629999101162)"
Line 106,"ENVIRONMENTAL5Environmental Targets We believe the environmental issues facing the world warrant an urgent and immediate response.
","('Physical_Impacts_Of_Climate_Change', 0.34172552824020386)","('Human_Rights_And_Community_Relations', 0.25389888882637024)","('Ecological_Impacts', 0.0628914162516594)","('NON-ESG', 0.34172552824020386)","('NON-ESG', 0.25389888882637024)","('NON-ESG', 0.0628914162516594)"
Line 107,"Since 2015, Zimmer Biomet has  achieved each of our environmental targets, including reductions in greenhouse gas (GHG) emissions, landfill waste and water  usage.
","('GHG_Emissions', 0.9683787226676941)","('Ecological_Impacts', 0.004797444213181734)","('Management_Of_Legal_And_Regulatory_Framework', 0.002660545986145735)","(['Climate Change'], 0.9683787226676941)","('NON-ESG', 0.004797444213181734)","('NON-ESG', 0.002660545986145735)"
Line 108,"Zimmer Biomet has outfitted all major manufacturing and distribution sites globally with LED lighting.
","('Energy_Management', 0.49847039580345154)","('Product_Design_And_Lifecycle_Management', 0.33645856380462646)","('Supply_Chain_Management', 0.0212593674659729)","('NON-ESG', 0.49847039580345154)","('NON-ESG', 0.33645856380462646)","('NON-ESG', 0.0212593674659729)"
Line 109,"In addition, we  actively participate in the Carbon Disclosure Project (CDP), with a 2020 ranking of B.
","('GHG_Emissions', 0.3678847849369049)","('Management_Of_Legal_And_Regulatory_Framework', 0.2496495395898819)","('Ecological_Impacts', 0.10461067408323288)","('NON-ESG', 0.3678847849369049)","('NON-ESG', 0.2496495395898819)","('NON-ESG', 0.10461067408323288)"
Line 110,"In 2020, Zimmer Biomet publicly committed  to setting a science-based target for GHG emissions.
","('GHG_Emissions', 0.9666028618812561)","('Air_Quality', 0.003839201061055064)","('Ecological_Impacts', 0.003515603020787239)","(['Climate Change'], 0.9666028618812561)","('NON-ESG', 0.003839201061055064)","('NON-ESG', 0.003515603020787239)"
Line 111,"In setting our science-based targets, we are focusing on Scope 1, 2 and 3  emissions.
","('GHG_Emissions', 0.9192416667938232)","('Management_Of_Legal_And_Regulatory_Framework', 0.012577898800373077)","('Air_Quality', 0.012218602001667023)","(['Climate Change'], 0.9192416667938232)","('NON-ESG', 0.012577898800373077)","('NON-ESG', 0.012218602001667023)"
Line 112,"Furthermore, in 2020, construction commenced on a large-scale solar farm for which Zimmer Biomet negotiated a  Virtual Power Purchase Agreement (VPPA), which will offset our North American electrical load.
","('Energy_Management', 0.9621716737747192)","('Management_Of_Legal_And_Regulatory_Framework', 0.010103127919137478)","('GHG_Emissions', 0.0032770787365734577)","(['Operational Eco-Efficiency'], 0.9621716737747192)","('NON-ESG', 0.010103127919137478)","('NON-ESG', 0.0032770787365734577)"
Line 113,"We continue to pursue renewable  energies in other regions throughout the world in order to advance our commitment to becoming a recognized leader within the  environmental space.
","('Management_Of_Legal_And_Regulatory_Framework', 0.2926073968410492)","('Energy_Management', 0.23212923109531403)","('GHG_Emissions', 0.07358970493078232)","('NON-ESG', 0.2926073968410492)","('NON-ESG', 0.23212923109531403)","('NON-ESG', 0.07358970493078232)"
Line 114,"Additionally, we are proud that eight of our major manufacturing sites are zero waste to landfill, and we  continue to increase recycling as we reduce our landfill waste.
","('Waste_And_Hazardous_Materials_Management', 0.9841534495353699)","('Water_And_Wastewater_Management', 0.001556366914883256)","('Data_Security', 0.0011776454048231244)","(['Operational Eco-Efficiency'], 0.9841534495353699)","('NON-ESG', 0.001556366914883256)","('NON-ESG', 0.0011776454048231244)"
Line 115,"Since 201 1, Zimmer Biomet has been a corporate sponsor of  ACRES Land Trust, Indiana’s oldest and largest membership- based nonprofit land conservation organization.
","('Ecological_Impacts', 0.9435259699821472)","('Water_And_Wastewater_Management', 0.01022441778331995)","('Human_Rights_And_Community_Relations', 0.005990447476506233)","(['Natural Capital'], 0.9435259699821472)","('NON-ESG', 0.01022441778331995)","('NON-ESG', 0.005990447476506233)"
Line 116,"ACRES  protects more than 6,700 acres of forests, wetlands,  grasslands and unique geological features in more than 100  nature preserves, many of which are open to the public.
","('Ecological_Impacts', 0.9770987629890442)","('GHG_Emissions', 0.00228160060942173)","('Waste_And_Hazardous_Materials_Management', 0.0018610847182571888)","(['Natural Capital'], 0.9770987629890442)","('NON-ESG', 0.00228160060942173)","('NON-ESG', 0.0018610847182571888)"
Line 117,"6One of Zimmer Biomet’s core strategic pillars is our  dedication to being a ‘Best and Preferred Place to Work’  and we advance that priority with an integrated and multi- faceted approach.
","('Business_Model_Resilience', 0.6975616216659546)","('Product_Design_And_Lifecycle_Management', 0.047343749552965164)","('Systemic_Risk_Management', 0.031237179413437843)","(['Codes of Business Conduct'], 0.6975616216659546)","('NON-ESG', 0.047343749552965164)","('NON-ESG', 0.031237179413437843)"
Line 118,"Below are just some of the highlights of  our 2020 achievements in this area.
","('Human_Rights_And_Community_Relations', 0.2394610196352005)","('Business_Model_Resilience', 0.1539909541606903)","('Management_Of_Legal_And_Regulatory_Framework', 0.13690173625946045)","('NON-ESG', 0.2394610196352005)","('NON-ESG', 0.1539909541606903)","('NON-ESG', 0.13690173625946045)"
Line 119,"Talent Management Zimmer Biomet supports a fair and competitive work  environment and is dedicated to attracting and retaining  the best talent.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9529032111167908)","('Competitive_Behavior', 0.004088918212801218)","('Employee_Health_And_Safety', 0.0039013547357171774)","(['Human Capital Development'], 0.9529032111167908)","('NON-ESG', 0.004088918212801218)","('NON-ESG', 0.0039013547357171774)"
Line 120,"We hire, compensate and promote based  on qualifications, experience and skills.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9412375092506409)","('Labor_Practices', 0.008320705965161324)","('Employee_Health_And_Safety', 0.006334721110761166)","(['Human Capital Development'], 0.9412375092506409)","('NON-ESG', 0.008320705965161324)","('NON-ESG', 0.006334721110761166)"
Line 121,"We offer all team  members globally a performance-based annual bonus  opportunity that is tied to defined financial metrics.
","('Employee_Engagement_Inclusion_And_Diversity', 0.4763399064540863)","('Labor_Practices', 0.12664204835891724)","('Employee_Health_And_Safety', 0.05596188083291054)","('NON-ESG', 0.4763399064540863)","('NON-ESG', 0.12664204835891724)","('NON-ESG', 0.05596188083291054)"
Line 122,"Zimmer Biomet is committed to helping our team members  achieve their full potential.
","('Employee_Engagement_Inclusion_And_Diversity', 0.18590788543224335)","('Business_Model_Resilience', 0.15998362004756927)","('Human_Rights_And_Community_Relations', 0.13183991611003876)","('NON-ESG', 0.18590788543224335)","('NON-ESG', 0.15998362004756927)","('NON-ESG', 0.13183991611003876)"
Line 123,"As such, we conduct annual  talent reviews as part of our talent management processes.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9470822811126709)","('Employee_Health_And_Safety', 0.004578222520649433)","('Customer_Privacy', 0.0037960754707455635)","(['Human Capital Development'], 0.9470822811126709)","('NON-ESG', 0.004578222520649433)","('NON-ESG', 0.0037960754707455635)"
Line 124,"One component of talent management is to identify critical  roles that are aligned to our strategic pillar priorities.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9343180060386658)","('Business_Model_Resilience', 0.00683048740029335)","('Employee_Health_And_Safety', 0.005733623635023832)","(['Human Capital Development'], 0.9343180060386658)","('NON-ESG', 0.00683048740029335)","('NON-ESG', 0.005733623635023832)"
Line 125,"Given  the high importance of these positions, we incorporate  a clearly defined process to assess talent and ensure  meaningful individual development plans are in place and  activated.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8655608296394348)","('Human_Rights_And_Community_Relations', 0.014623656868934631)","('Employee_Health_And_Safety', 0.013111761771142483)","(['Human Capital Development'], 0.8655608296394348)","('NON-ESG', 0.014623656868934631)","('NON-ESG', 0.013111761771142483)"
Line 126,"Performance Management In 2020, we implemented a new approach to continuous  performance management – Performance Connections  – which focuses on individual priority setting (>95%  completion rate), mid-year career development  conversations and ongoing check-ins that include  a mechanism to request and receive feedback from  managers, direct reports and colleagues.
","('Employee_Engagement_Inclusion_And_Diversity', 0.21625177562236786)","('Business_Model_Resilience', 0.1875028759241104)","('Human_Rights_And_Community_Relations', 0.10123930126428604)","('NON-ESG', 0.21625177562236786)","('NON-ESG', 0.1875028759241104)","('NON-ESG', 0.10123930126428604)"
Line 127,"Frequent check- ins are vital to driving a culture of accountability, and to  fostering a culture of engagement and connectivity, which  is even more critical now given the rise in remote work  arrangements.
","('Human_Rights_And_Community_Relations', 0.5101601481437683)","('Business_Ethics', 0.07806825637817383)","('Management_Of_Legal_And_Regulatory_Framework', 0.07770182192325592)","(['Community Relations'], 0.5101601481437683)","('NON-ESG', 0.07806825637817383)","('NON-ESG', 0.07770182192325592)"
Line 128,"Culture Promises and Habits Aligned with our Culture Promises and Habits, we  developed and deployed the Zimmer Biomet Leadership  360 Assessment as a tool for sharing insights into critical  leadership characteristics and attributes, which are  important to bringing the Zimmer Biomet Culture Promises  and Habits to life.
","('Employee_Engagement_Inclusion_And_Diversity', 0.6065334677696228)","('Human_Rights_And_Community_Relations', 0.09198325127363205)","('Business_Model_Resilience', 0.0429166741669178)","(['Human Capital Development'], 0.6065334677696228)","('NON-ESG', 0.09198325127363205)","('NON-ESG', 0.0429166741669178)"
Line 129,"Leaders complete a self-assessment and  solicit feedback from multiple stakeholders, including their  manager, direct reports and peers.
","('Management_Of_Legal_And_Regulatory_Framework', 0.2266913205385208)","('Business_Ethics', 0.13984514772891998)","('Human_Rights_And_Community_Relations', 0.0979161262512207)","('NON-ESG', 0.2266913205385208)","('NON-ESG', 0.13984514772891998)","('NON-ESG', 0.0979161262512207)"
Line 130,"The insights from the  360-degree assessment process help inform development  planning and reinforce behaviors that align with our Culture  Promises.
","('Human_Rights_And_Community_Relations', 0.31796807050704956)","('Employee_Engagement_Inclusion_And_Diversity', 0.3075854182243347)","('Access_And_Affordability', 0.06361914426088333)","('NON-ESG', 0.31796807050704956)","('NON-ESG', 0.3075854182243347)","('NON-ESG', 0.06361914426088333)"
Line 131,"SOCIAL7Performance Coaching We implemented a train-the-trainer program with  customized training content for our HR leaders across the  APAC region to teach them how to be more effective coaches.
","('Employee_Engagement_Inclusion_And_Diversity', 0.449594646692276)","('Access_And_Affordability', 0.17368067800998688)","('Employee_Health_And_Safety', 0.038725558668375015)","('NON-ESG', 0.449594646692276)","('NON-ESG', 0.17368067800998688)","('NON-ESG', 0.038725558668375015)"
Line 132,"Virtual instructor-led sessions for people managers were  cascaded in Japan, Australia, India, Singapore and Malaysia.
","('Employee_Engagement_Inclusion_And_Diversity', 0.49624741077423096)","('Employee_Health_And_Safety', 0.0907023474574089)","('Customer_Welfare', 0.040532924234867096)","('NON-ESG', 0.49624741077423096)","('NON-ESG', 0.0907023474574089)","('NON-ESG', 0.040532924234867096)"
Line 133,"Leadership Development We established iGrow, a regional leadership development  program that takes high potential emerging leaders  through team projects, learning and development activities,  networking and team-building.
","('Employee_Engagement_Inclusion_And_Diversity', 0.6399559378623962)","('Human_Rights_And_Community_Relations', 0.06948573887348175)","('Business_Model_Resilience', 0.04828082397580147)","(['Human Capital Development'], 0.6399559378623962)","('NON-ESG', 0.06948573887348175)","('NON-ESG', 0.04828082397580147)"
Line 134,"In 2020, the group consisted  of 21 team members from 15 functions across 12 countries.
","('Employee_Engagement_Inclusion_And_Diversity', 0.27752694487571716)","('Human_Rights_And_Community_Relations', 0.13367077708244324)","('Director_Removal', 0.09310133010149002)","('NON-ESG', 0.27752694487571716)","('NON-ESG', 0.13367077708244324)","('NON-ESG', 0.09310133010149002)"
Line 135,"The program offered participants an accelerated learning  experience to fast-track their journey to future leadership  positions and saw 43 percent of the cohort promoted  during or shortly after program completion.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8381488919258118)","('Business_Model_Resilience', 0.026409458369016647)","('Human_Rights_And_Community_Relations', 0.01811322383582592)","(['Human Capital Development'], 0.8381488919258118)","('NON-ESG', 0.026409458369016647)","('NON-ESG', 0.01811322383582592)"
Line 136,"New Hire Orientation In 2020, we initiated our bi-weekly New Hire Orientation  (NHO) program, with a focus on grounding new team  members in the Company’s history, products, and  medical device/orthopedics industry.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8140702247619629)","('Employee_Health_And_Safety', 0.062208354473114014)","('Labor_Practices', 0.018361063674092293)","(['Human Capital Development'], 0.8140702247619629)","('NON-ESG', 0.062208354473114014)","('NON-ESG', 0.018361063674092293)"
Line 137,"NHO helps new  team members transition efficiently and effectively into  the organization and prepares them to make meaningful  contributions to the Company’s success.
","('Business_Model_Resilience', 0.2982426881790161)","('Employee_Engagement_Inclusion_And_Diversity', 0.1806488335132599)","('Director_Removal', 0.11590205878019333)","('NON-ESG', 0.2982426881790161)","('NON-ESG', 0.1806488335132599)","('NON-ESG', 0.11590205878019333)"
Line 138,"Global Onboarding Checklist We developed and implemented a global, standard  onboarding checklist intended to help guide new team  members through more tactical and role-based steps that will  help them quickly become oriented to the organization, as well  as their team and position.
","('Employee_Engagement_Inclusion_And_Diversity', 0.2538953721523285)","('Business_Model_Resilience', 0.23049502074718475)","('Director_Removal', 0.11204607039690018)","('NON-ESG', 0.2538953721523285)","('NON-ESG', 0.23049502074718475)","('NON-ESG', 0.11204607039690018)"
Line 139,"Broken down into 30-60-90 day  sections, the checklist is designed to provide the new team  member with relevant information that will help them navigate  the organization and get off to the best start possible.
","('Business_Model_Resilience', 0.12173669785261154)","('Customer_Privacy', 0.09615293890237808)","('Data_Security', 0.08727584034204483)","('NON-ESG', 0.12173669785261154)","('NON-ESG', 0.09615293890237808)","('NON-ESG', 0.08727584034204483)"
Line 140,"Bookboon Zimmer Biomet continued to offer our team members  access to a free eLibrary, consisting of more than 650  business eBooks and audio books available in a number  of different languages and with topics ranging from sales  and leadership skills to technical skills like PowerPoint and  Excel.
","('Employee_Engagement_Inclusion_And_Diversity', 0.28830358386039734)","('Product_Design_And_Lifecycle_Management', 0.10876532644033432)","('Product_Quality_And_Safety', 0.08132293820381165)","('NON-ESG', 0.28830358386039734)","('NON-ESG', 0.10876532644033432)","('NON-ESG', 0.08132293820381165)"
Line 141,"These resources are intended to meet team members  “where they are” by developing skills quickly through  varied, curated micro-learning content.Rotational Programs In 2020, we continued our focus on early career development  through two rotational programs.
","('Employee_Engagement_Inclusion_And_Diversity', 0.7709829807281494)","('Access_And_Affordability', 0.04730621352791786)","('Employee_Health_And_Safety', 0.021864669397473335)","(['Human Capital Development'], 0.7709829807281494)","('NON-ESG', 0.04730621352791786)","('NON-ESG', 0.021864669397473335)"
Line 142,"Both the Finance and  Quality corporate functions hire new college graduates,  typically from our co-op and intern population, into their  two-year programs, designed to accelerate individuals’  careers through rotational assignments.
","('Employee_Engagement_Inclusion_And_Diversity', 0.925187885761261)","('Labor_Practices', 0.00626946659758687)","('Customer_Welfare', 0.005687194876372814)","(['Human Capital Development'], 0.925187885761261)","('NON-ESG', 0.00626946659758687)","('NON-ESG', 0.005687194876372814)"
Line 143,"Learning Management System In 2020, Zimmer Biomet completed a significant update  to our global Learning Management System (LMS), which  improved the learner interface and team members’  ability to locate and access on-demand courses, as well  as streamlined administrator processes for assigning  and maintaining training assignments.
","('Access_And_Affordability', 0.33911776542663574)","('Employee_Engagement_Inclusion_And_Diversity', 0.2020627111196518)","('Customer_Welfare', 0.0502488911151886)","('NON-ESG', 0.33911776542663574)","('NON-ESG', 0.2020627111196518)","('NON-ESG', 0.0502488911151886)"
Line 144,"The Company  also reviewed training plans and implemented processes  that help ensure the right training is assigned to the right  people, eliminating the assignment of unnecessary courses  for many team members across the organization.
","('Employee_Engagement_Inclusion_And_Diversity', 0.3295310139656067)","('Employee_Health_And_Safety', 0.24273069202899933)","('Access_And_Affordability', 0.0866226851940155)","('NON-ESG', 0.3295310139656067)","('NON-ESG', 0.24273069202899933)","('NON-ESG', 0.0866226851940155)"
Line 145,"Diversity, Equity & Inclusion Zimmer Biomet remains committed to creating, supporting  and celebrating diverse and equal workplaces and  communities.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9747903347015381)","('Human_Rights_And_Community_Relations', 0.002327508293092251)","('Employee_Health_And_Safety', 0.0021158279851078987)","(['Human Capital Development'], 0.9747903347015381)","('NON-ESG', 0.002327508293092251)","('NON-ESG', 0.0021158279851078987)"
Line 146,"We continue to foster and embrace diversity  and inclusion within our team and our communities, and  commit our voices and our resources to community groups,  business platforms and other organizations united to  driving meaningful change and sustained improvement.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9715942740440369)","('Human_Rights_And_Community_Relations', 0.003346809186041355)","('Employee_Health_And_Safety', 0.002091627102345228)","(['Human Capital Development'], 0.9715942740440369)","('NON-ESG', 0.003346809186041355)","('NON-ESG', 0.002091627102345228)"
Line 147,"8Zimmer Biomet believes that representation matters.
","('Competitive_Behavior', 0.5816431045532227)","('Business_Ethics', 0.1114361509680748)","('Management_Of_Legal_And_Regulatory_Framework', 0.0694512352347374)","(['Business Ethics'], 0.5816431045532227)","('NON-ESG', 0.1114361509680748)","('NON-ESG', 0.0694512352347374)"
Line 148,"As of  December 31, 2020, women made up 36.1 percent of our  total employee population, and 23.2 percent of positions  at Director level and above.
","('Employee_Engagement_Inclusion_And_Diversity', 0.5751619935035706)","('Labor_Practices', 0.25909993052482605)","('Director_Removal', 0.029176373034715652)","(['Human Capital Development'], 0.5751619935035706)","('NON-ESG', 0.25909993052482605)","('NON-ESG', 0.029176373034715652)"
Line 149,"People of Color (POC) made  up 24.5 percent of our total employee population in the  U.S., and comprised 13.9 percent of positions at Director  level and above.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9711794257164001)","('Labor_Practices', 0.002702506026253104)","('Employee_Health_And_Safety', 0.0022363695316016674)","(['Human Capital Development'], 0.9711794257164001)","('NON-ESG', 0.002702506026253104)","('NON-ESG', 0.0022363695316016674)"
Line 150,"We are currently working to establish  2026 representation goals for women and POC at all levels  of the organization, guided by internal data and external  benchmarking.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9499471187591553)","('Competitive_Behavior', 0.0063459849916398525)","('Labor_Practices', 0.005232921801507473)","(['Human Capital Development'], 0.9499471187591553)","('NON-ESG', 0.0063459849916398525)","('NON-ESG', 0.005232921801507473)"
Line 151,"Core to Zimmer Biomet’s values is our commitment to  stand together against hatred, discrimination and injustice,  and we advance these values through our actions and  investments.
","('Employee_Engagement_Inclusion_And_Diversity', 0.28631195425987244)","('Business_Ethics', 0.20567111670970917)","('Human_Rights_And_Community_Relations', 0.1788514405488968)","('NON-ESG', 0.28631195425987244)","('NON-ESG', 0.20567111670970917)","('NON-ESG', 0.1788514405488968)"
Line 152,"With this in mind, we have committed to the  following initiatives to drive and accelerate change both  within our own organization and around the globe.
","('Human_Rights_And_Community_Relations', 0.3926534056663513)","('Business_Model_Resilience', 0.1674405038356781)","('Physical_Impacts_Of_Climate_Change', 0.09319738298654556)","('NON-ESG', 0.3926534056663513)","('NON-ESG', 0.1674405038356781)","('NON-ESG', 0.09319738298654556)"
Line 153,"We have  shared these commitments publicly and are tracking our  progress against them:    • Engage our more than 20,000 global team members in  cultural awareness and inclusion programming.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9277627468109131)","('Human_Rights_And_Community_Relations', 0.0163735244423151)","('Access_And_Affordability', 0.0075308047235012054)","(['Human Capital Development'], 0.9277627468109131)","('NON-ESG', 0.0163735244423151)","('NON-ESG', 0.0075308047235012054)"
Line 154,"• Invest $1 million and provide executive sponsorship to  support ongoing programs and elevate the impact of  our employee resource groups (ERGs).
","('Employee_Engagement_Inclusion_And_Diversity', 0.5954489707946777)","('Access_And_Affordability', 0.12114640325307846)","('Employee_Health_And_Safety', 0.06308185309171677)","(['Human Capital Development'], 0.5954489707946777)","('NON-ESG', 0.12114640325307846)","('NON-ESG', 0.06308185309171677)"
Line 155,"• Commit at least $5 million over five years through the  Zimmer Biomet Foundation to nonprofit organizations  dedicated to combating racism and supporting  diversity, equality and justice.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9692761301994324)","('Human_Rights_And_Community_Relations', 0.002905214438214898)","('Employee_Health_And_Safety', 0.002615458332002163)","(['Human Capital Development'], 0.9692761301994324)","('NON-ESG', 0.002905214438214898)","('NON-ESG', 0.002615458332002163)"
Line 156,"The Zimmer Biomet  Foundation is an independent, nonprofit organization  established in 2018 to address the needs of our global  community.
","('Access_And_Affordability', 0.40406888723373413)","('Human_Rights_And_Community_Relations', 0.31800025701522827)","('Employee_Engagement_Inclusion_And_Diversity', 0.04351223260164261)","('NON-ESG', 0.40406888723373413)","('NON-ESG', 0.31800025701522827)","('NON-ESG', 0.04351223260164261)"
Line 157,"• Match, through the Zimmer Biomet Foundation,  employee financial contributions to non-profit  organizations, including those dedicated to combating  racism and supporting diversity, equality and justice.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9731394648551941)","('Human_Rights_And_Community_Relations', 0.0023193492088466883)","('Employee_Health_And_Safety', 0.0022660375107079744)","(['Human Capital Development'], 0.9731394648551941)","('NON-ESG', 0.0023193492088466883)","('NON-ESG', 0.0022660375107079744)"
Line 158,"• Expand our student and early career internship  programs to attract and develop more Black leaders.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9334979057312012)","('Access_And_Affordability', 0.0071347979828715324)","('Employee_Health_And_Safety', 0.00593434926122427)","(['Human Capital Development'], 0.9334979057312012)","('NON-ESG', 0.0071347979828715324)","('NON-ESG', 0.00593434926122427)"
Line 159,"• Continue our financial support of Movement is Life, a  multidisciplinary coalition seeking to eliminate racial,  ethnic and gender disparities in muscle and joint  health.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9760103821754456)","('Human_Rights_And_Community_Relations', 0.0016760737635195255)","('Employee_Health_And_Safety', 0.001640807488001883)","(['Human Capital Development'], 0.9760103821754456)","('NON-ESG', 0.0016760737635195255)","('NON-ESG', 0.001640807488001883)"
Line 160,"Employee Resource Groups (ERGs) Zimmer Biomet’s team members reflect the global  communities in which we live and work.
","('Human_Rights_And_Community_Relations', 0.3425942063331604)","('Employee_Engagement_Inclusion_And_Diversity', 0.3263954818248749)","('Employee_Health_And_Safety', 0.11378250271081924)","('NON-ESG', 0.3425942063331604)","('NON-ESG', 0.3263954818248749)","('NON-ESG', 0.11378250271081924)"
Line 161,"ERGs are trusted  groups of team members who create a space of belonging for  all team members and drive innovative business solutions  in support of the Zimmer Biomet Mission and diversity,  equity and inclusion strategy.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9719113707542419)","('Human_Rights_And_Community_Relations', 0.0026912344619631767)","('Employee_Health_And_Safety', 0.002140691038221121)","(['Human Capital Development'], 0.9719113707542419)","('NON-ESG', 0.0026912344619631767)","('NON-ESG', 0.002140691038221121)"
Line 162,"Zimmer Biomet’s continued  investment in our ERGs has resulted in the elevation to  global scale.
","('Business_Model_Resilience', 0.5582332611083984)","('Systemic_Risk_Management', 0.14711177349090576)","('Supply_Chain_Management', 0.03605808690190315)","(['Codes of Business Conduct'], 0.5582332611083984)","('NON-ESG', 0.14711177349090576)","('NON-ESG', 0.03605808690190315)"
Line 163,"The global ERG program relaunched in March  2021 with strong participation from team members across the globe and with keynote speakers including our Chief  Executive Officer, Chief Operating Officer and Chief Human  Resources Officer, as well as our newly confirmed ERG  leaders.
","('Business_Model_Resilience', 0.6158846020698547)","('Director_Removal', 0.0575249120593071)","('Employee_Engagement_Inclusion_And_Diversity', 0.054161686450242996)","(['Codes of Business Conduct'], 0.6158846020698547)","('NON-ESG', 0.0575249120593071)","('NON-ESG', 0.054161686450242996)"
Line 164,"The new ERG strategy, aligned to drive business  results and team member engagement, was released  during the relaunch.
","('Business_Model_Resilience', 0.7309181690216064)","('Director_Removal', 0.03976736590266228)","('Employee_Engagement_Inclusion_And_Diversity', 0.032280392944812775)","(['Codes of Business Conduct'], 0.7309181690216064)","('NON-ESG', 0.03976736590266228)","('NON-ESG', 0.032280392944812775)"
Line 165,"With a focused strategy and leaders  who believe deeply in the work, we will move forward in  the journey together to make Zimmer Biomet a Best and  Preferred Place to Work.
","('Business_Model_Resilience', 0.39883604645729065)","('Human_Rights_And_Community_Relations', 0.12192270904779434)","('Employee_Engagement_Inclusion_And_Diversity', 0.11605094373226166)","('NON-ESG', 0.39883604645729065)","('NON-ESG', 0.12192270904779434)","('NON-ESG', 0.11605094373226166)"
Line 166,"Employee Engagement We greatly value our team members’ input and, to that  end, we conduct comprehensive employee engagement  surveys that ultimately inform our actions towards  improving our team member experience and engagement.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9109728932380676)","('Employee_Health_And_Safety', 0.018764114007353783)","('Human_Rights_And_Community_Relations', 0.011260207742452621)","(['Human Capital Development'], 0.9109728932380676)","('NON-ESG', 0.018764114007353783)","('NON-ESG', 0.011260207742452621)"
Line 167,"The surveys attempt to assess five drivers of engagement,  including purpose, culture, leadership, personal growth  and belonging.
","('Employee_Engagement_Inclusion_And_Diversity', 0.7752336263656616)","('Human_Rights_And_Community_Relations', 0.07324442267417908)","('Customer_Privacy', 0.020610906183719635)","(['Human Capital Development'], 0.7752336263656616)","('NON-ESG', 0.07324442267417908)","('NON-ESG', 0.020610906183719635)"
Line 168,"The results of surveys and commensurate  action plans are shared with our Board of Directors and with  all global team members.
","('Director_Removal', 0.6611074805259705)","('Management_Of_Legal_And_Regulatory_Framework', 0.050327591598033905)","('Business_Model_Resilience', 0.04424609988927841)","(['Anti-Crime Policy & Measures'], 0.6611074805259705)","('NON-ESG', 0.050327591598033905)","('NON-ESG', 0.04424609988927841)"
Line 169,"We believe it is critically important to keep our team  members engaged through frequent and transparent  communication.
","('Business_Ethics', 0.6103562712669373)","('Director_Removal', 0.05892006680369377)","('Human_Rights_And_Community_Relations', 0.05439514294266701)","(['Business Ethics'], 0.6103562712669373)","('NON-ESG', 0.05892006680369377)","('NON-ESG', 0.05439514294266701)"
Line 170,"This is accomplished through town  hall meetings, video and written messages, news and  recognition on our intranet site, and various other channels.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3987427353858948)","('Customer_Privacy', 0.11823072284460068)","('Director_Removal', 0.04945720359683037)","('NON-ESG', 0.3987427353858948)","('NON-ESG', 0.11823072284460068)","('NON-ESG', 0.04945720359683037)"
Line 171,"To stay connected throughout the COVID-19 pandemic,  our Chief Executive Officer kept team members informed  of our priorities, financial results, management response  and employee health and safety through frequent video  messages and written communications.
","('Employee_Health_And_Safety', 0.9728161096572876)","('Critical_Incident_Risk_Management', 0.009204896166920662)","('Employee_Engagement_Inclusion_And_Diversity', 0.0017544503789395094)","(['Operational Eco-Efficiency'], 0.9728161096572876)","('NON-ESG', 0.009204896166920662)","('NON-ESG', 0.0017544503789395094)"
Line 172,"Health, Safety & Wellness The physical and mental health, financial well-being  and work/life balance of our team members is vital to  accomplishing our Mission and achieving our goals.
","('Employee_Health_And_Safety', 0.9130895733833313)","('Employee_Engagement_Inclusion_And_Diversity', 0.019563773646950722)","('Product_Design_And_Lifecycle_Management', 0.008639880456030369)","(['Operational Eco-Efficiency'], 0.9130895733833313)","('NON-ESG', 0.019563773646950722)","('NON-ESG', 0.008639880456030369)"
Line 173,"We  sponsor wellness programs designed to enhance physical,  financial and mental well-being, and encourage participation  in these programs through regular communications,  educational sessions and other incentives.
","('Access_And_Affordability', 0.47358760237693787)","('Employee_Health_And_Safety', 0.24402768909931183)","('Employee_Engagement_Inclusion_And_Diversity', 0.05467771366238594)","('NON-ESG', 0.47358760237693787)","('NON-ESG', 0.24402768909931183)","('NON-ESG', 0.05467771366238594)"
Line 174,"We are also acutely focused on the health and safety of our  team members in the workplace.
","('Employee_Health_And_Safety', 0.9821028709411621)","('Employee_Engagement_Inclusion_And_Diversity', 0.0019511544378474355)","('Critical_Incident_Risk_Management', 0.0017814112361520529)","(['Operational Eco-Efficiency'], 0.9821028709411621)","('NON-ESG', 0.0019511544378474355)","('NON-ESG', 0.0017814112361520529)"
Line 175,"Our environmental, health  and safety team constantly monitors various metrics to  ensure we are providing the safest environment in which to  work.
","('Employee_Health_And_Safety', 0.9714034795761108)","('Critical_Incident_Risk_Management', 0.007959093898534775)","('Employee_Engagement_Inclusion_And_Diversity', 0.0018800058169290423)","(['Operational Eco-Efficiency'], 0.9714034795761108)","('NON-ESG', 0.007959093898534775)","('NON-ESG', 0.0018800058169290423)"
Line 176,"In 2020, our Total Recordable Incident Rate was 0.27  and our Lost Time Incident Rate was 0.1 1.9Work/Life Balance Zimmer Biomet recognizes that a healthy balance in work  and life is vital.
","('Employee_Health_And_Safety', 0.9409993886947632)","('Critical_Incident_Risk_Management', 0.03230413421988487)","('Air_Quality', 0.0020336646120995283)","(['Operational Eco-Efficiency'], 0.9409993886947632)","('NON-ESG', 0.03230413421988487)","('NON-ESG', 0.0020336646120995283)"
Line 177,"Our full-time team members receive paid  holidays and paid time off that is based on length of service.
","('Labor_Practices', 0.9412243366241455)","('Employee_Health_And_Safety', 0.006892934441566467)","('Director_Removal', 0.006649945862591267)","(['Labor Practice Indicators'], 0.9412243366241455)","('NON-ESG', 0.006892934441566467)","('NON-ESG', 0.006649945862591267)"
Line 178,"When life events occur, such as the birth or adoption of a  child or the loss of a loved one, team members receive paid  time off to focus on their families.
","('Access_And_Affordability', 0.2381141185760498)","('Employee_Health_And_Safety', 0.21252252161502838)","('Employee_Engagement_Inclusion_And_Diversity', 0.18561150133609772)","('NON-ESG', 0.2381141185760498)","('NON-ESG', 0.21252252161502838)","('NON-ESG', 0.18561150133609772)"
Line 179,"We have also rolled out a Virtual Workplace Program that  enables designated part-time and full-time team members  to effectively work remotely.
","('Labor_Practices', 0.4566292464733124)","('Employee_Engagement_Inclusion_And_Diversity', 0.20592907071113586)","('Employee_Health_And_Safety', 0.08031167834997177)","('NON-ESG', 0.4566292464733124)","('NON-ESG', 0.20592907071113586)","('NON-ESG', 0.08031167834997177)"
Line 180,"Team members must be  in a position designated by the Company as eligible for  virtual work.
","('Employee_Engagement_Inclusion_And_Diversity', 0.3637250065803528)","('Employee_Health_And_Safety', 0.1315261572599411)","('Director_Removal', 0.10428519546985626)","('NON-ESG', 0.3637250065803528)","('NON-ESG', 0.1315261572599411)","('NON-ESG', 0.10428519546985626)"
Line 181,"In making that determination, the Company  considered the requirements of the role, the cost of  supporting the virtual work arrangement, nature of the  work, required technology support and other relevant  factors.
","('Management_Of_Legal_And_Regulatory_Framework', 0.24933524429798126)","('Labor_Practices', 0.22143325209617615)","('Employee_Health_And_Safety', 0.11970177292823792)","('NON-ESG', 0.24933524429798126)","('NON-ESG', 0.22143325209617615)","('NON-ESG', 0.11970177292823792)"
Line 182,"Team members must be in good standing, meaning  they have demonstrated satisfactory performance, in order  to be eligible for a virtual work arrangement.
","('Employee_Health_And_Safety', 0.5450749397277832)","('Labor_Practices', 0.1717180609703064)","('Human_Rights_And_Community_Relations', 0.04537639021873474)","(['Operational Eco-Efficiency'], 0.5450749397277832)","('NON-ESG', 0.1717180609703064)","('NON-ESG', 0.04537639021873474)"
Line 183,"Pay Equity We are committed to our pay equity process, with annual  pay equity reviews conducted since 2016, following  the merger of Zimmer and Biomet.
","('Competitive_Behavior', 0.31653568148612976)","('Systemic_Risk_Management', 0.1622885912656784)","('Management_Of_Legal_And_Regulatory_Framework', 0.11810082197189331)","('NON-ESG', 0.31653568148612976)","('NON-ESG', 0.1622885912656784)","('NON-ESG', 0.11810082197189331)"
Line 184,"Our comprehensive  pay equity review covers pay, promotions and new hire  practices.
","('Labor_Practices', 0.9652177691459656)","('Employee_Engagement_Inclusion_And_Diversity', 0.004876270890235901)","('Director_Removal', 0.003831258276477456)","(['Labor Practice Indicators'], 0.9652177691459656)","('NON-ESG', 0.004876270890235901)","('NON-ESG', 0.003831258276477456)"
Line 185,"This includes various types of pay, such as base  salary, bonus, long-term incentives and new hire sign-on  awards (cash or equity).
","('Labor_Practices', 0.9662687182426453)","('Employee_Engagement_Inclusion_And_Diversity', 0.004439817275851965)","('Director_Removal', 0.002976522780954838)","(['Labor Practice Indicators'], 0.9662687182426453)","('NON-ESG', 0.004439817275851965)","('NON-ESG', 0.002976522780954838)"
Line 186,"Prior to 2019, the pay equity review was focused on gender  differences, with any identified pay issue also being  reviewed for ethnicity against similarly situated positions.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9435591697692871)","('Labor_Practices', 0.017575232312083244)","('Customer_Privacy', 0.0032263610046356916)","(['Human Capital Development'], 0.9435591697692871)","('NON-ESG', 0.017575232312083244)","('NON-ESG', 0.0032263610046356916)"
Line 187,"Starting in 2019, we further enhanced our analysis to review  pay differences by gender, age, ethnicity and location.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9715908765792847)","('Customer_Privacy', 0.0024081275332719088)","('Labor_Practices', 0.0020569723565131426)","(['Human Capital Development'], 0.9715908765792847)","('NON-ESG', 0.0024081275332719088)","('NON-ESG', 0.0020569723565131426)"
Line 188,"Each  year we assess our analysis capabilities to identify areas of  opportunity.
","('Employee_Engagement_Inclusion_And_Diversity', 0.6190569400787354)","('Business_Model_Resilience', 0.08029966801404953)","('Human_Rights_And_Community_Relations', 0.05839354172348976)","(['Human Capital Development'], 0.6190569400787354)","('NON-ESG', 0.08029966801404953)","('NON-ESG', 0.05839354172348976)"
Line 189,"Human Resources coordinates the Company’s process to  address any issues identified from the pay equity analysis.
","('Employee_Engagement_Inclusion_And_Diversity', 0.16711097955703735)","('Systemic_Risk_Management', 0.16620004177093506)","('Labor_Practices', 0.10828601568937302)","('NON-ESG', 0.16711097955703735)","('NON-ESG', 0.16620004177093506)","('NON-ESG', 0.10828601568937302)"
Line 190,"Individuals identified in the annual pay equity review  continue to have their annual progress monitored in order  to ensure that any pay issues are resolved.Benefits We review our benefits each plan year considering both  our team member population as well as market benefit  practices to ensure we are competitive in our offerings.
","('Labor_Practices', 0.596228301525116)","('Competitive_Behavior', 0.11704371869564056)","('Business_Ethics', 0.0636792778968811)","(['Labor Practice Indicators'], 0.596228301525116)","('NON-ESG', 0.11704371869564056)","('NON-ESG', 0.0636792778968811)"
Line 191,"Over the last six years, we have focused on key areas for  women, family and individual health:  • For women’s health, we continue to offer key  preventative services and for mothers, we provide  opportunities to help support and transition back to  the workforce.
","('Access_And_Affordability', 0.5210739374160767)","('Employee_Health_And_Safety', 0.20351579785346985)","('Human_Rights_And_Community_Relations', 0.06753987073898315)","(['Health Outcome Contribution'], 0.5210739374160767)","('NON-ESG', 0.20351579785346985)","('NON-ESG', 0.06753987073898315)"
Line 192,"• Team members and their families are assisted through  many stages of life for a family.
","('Access_And_Affordability', 0.5781264305114746)","('Human_Rights_And_Community_Relations', 0.1397349238395691)","('Employee_Health_And_Safety', 0.07681772112846375)","(['Health Outcome Contribution'], 0.5781264305114746)","('NON-ESG', 0.1397349238395691)","('NON-ESG', 0.07681772112846375)"
Line 193,"In 2019, we increased  Infertility benefits and the number of Parental Leave  days while continuing to provide child care discounts  at multiple day care facilities.
","('Access_And_Affordability', 0.7025898694992065)","('Employee_Health_And_Safety', 0.04988512396812439)","('Employee_Engagement_Inclusion_And_Diversity', 0.04166527837514877)","(['Health Outcome Contribution'], 0.7025898694992065)","('NON-ESG', 0.04988512396812439)","('NON-ESG', 0.04166527837514877)"
Line 194,"• We understand our team members have individualized  needs and we offer programs to support them such as  employee assistance programs (EAP) counseling, as  well as benefits such as transgender surgery/medical  benefits which started in January 2017 .
","('Employee_Engagement_Inclusion_And_Diversity', 0.8777498602867126)","('Employee_Health_And_Safety', 0.030537011101841927)","('Access_And_Affordability', 0.019069122150540352)","(['Human Capital Development'], 0.8777498602867126)","('NON-ESG', 0.030537011101841927)","('NON-ESG', 0.019069122150540352)"
Line 195,"• We continue to assess the above key areas annually  and adjust offerings as needed to support our team  members.
","('Employee_Engagement_Inclusion_And_Diversity', 0.18215131759643555)","('Business_Model_Resilience', 0.1705687791109085)","('Access_And_Affordability', 0.09228672087192535)","('NON-ESG', 0.18215131759643555)","('NON-ESG', 0.1705687791109085)","('NON-ESG', 0.09228672087192535)"
Line 196,"Collective Bargaining Zimmer Biomet has more than 20,000 active team members  globally, approximately 200 of which are affiliated with a  U.S. collective bargaining agreement.
","('Labor_Practices', 0.9716988205909729)","('Director_Removal', 0.002598932944238186)","('Supply_Chain_Management', 0.002132902853190899)","(['Labor Practice Indicators'], 0.9716988205909729)","('NON-ESG', 0.002598932944238186)","('NON-ESG', 0.002132902853190899)"
Line 197,"Discrimination Policy Zimmer Biomet is an equal opportunity employer and is fully  committed to a policy of treating all of our team members  and job applicants equally.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9134399890899658)","('Labor_Practices', 0.022678717970848083)","('Employee_Health_And_Safety', 0.007839763537049294)","(['Human Capital Development'], 0.9134399890899658)","('NON-ESG', 0.022678717970848083)","('NON-ESG', 0.007839763537049294)"
Line 198,"We take all reasonable steps to employ, train and promote  team members on the basis of their experience, abilities and  qualifications without regard to race, color, ethnic origin,  nationality, national origin, religion or belief, sex, sexual  orientation, gender reassignment, age, marital or civil  partnership status or disability.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9734650254249573)","('Employee_Health_And_Safety', 0.0025475563015788794)","('Customer_Privacy', 0.0019828593358397484)","(['Human Capital Development'], 0.9734650254249573)","('NON-ESG', 0.0025475563015788794)","('NON-ESG', 0.0019828593358397484)"
Line 199,"The Company also takes all reasonable steps to provide a  work environment in which all team members are treated  with respect and dignity and that is free of harassment  based upon an employee’s race, color, ethnic origin,  nationality, national origin, religion or belief, sex, sexual  orientation, gender reassignment, age, marital or civil  partnership status or disability.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9692009687423706)","('Employee_Health_And_Safety', 0.004740446340292692)","('Human_Rights_And_Community_Relations', 0.0024964334443211555)","(['Human Capital Development'], 0.9692009687423706)","('NON-ESG', 0.004740446340292692)","('NON-ESG', 0.0024964334443211555)"
Line 200,"Zimmer Biomet does not condone any form of harassment,  whether engaged in by team members or by outside third  parties who do business with the Company.
","('Business_Ethics', 0.27564334869384766)","('Employee_Health_And_Safety', 0.192285418510437)","('Employee_Engagement_Inclusion_And_Diversity', 0.11784615367650986)","('NON-ESG', 0.27564334869384766)","('NON-ESG', 0.192285418510437)","('NON-ESG', 0.11784615367650986)"
Line 201,"10Product Quality  Zimmer Biomet is committed to best-in-class product  quality and the robustness of our Quality Management  System.
","('Product_Design_And_Lifecycle_Management', 0.925807535648346)","('Product_Quality_And_Safety', 0.025223542004823685)","('Customer_Welfare', 0.004273716825991869)","(['Product Stewardship'], 0.925807535648346)","('NON-ESG', 0.025223542004823685)","('NON-ESG', 0.004273716825991869)"
Line 202,"Every site has a stringent internal quality audit  program.
","('Business_Ethics', 0.8289087414741516)","('Systemic_Risk_Management', 0.03516944497823715)","('Management_Of_Legal_And_Regulatory_Framework', 0.02675619348883629)","(['Business Ethics'], 0.8289087414741516)","('NON-ESG', 0.03516944497823715)","('NON-ESG', 0.02675619348883629)"
Line 203,"In addition, we have an independent corporate  quality audit program and are frequently audited by  external regulatory bodies such as the U.S. Food and Drug  Administration (FDA) and other competent authorities  around the world.
","('Management_Of_Legal_And_Regulatory_Framework', 0.805309534072876)","('Business_Ethics', 0.06793070584535599)","('Product_Quality_And_Safety', 0.030810270458459854)","(['Corporate Governance'], 0.805309534072876)","('NON-ESG', 0.06793070584535599)","('NON-ESG', 0.030810270458459854)"
Line 204,"Corporate audit and external audit results  are closely monitored and reported at regular management  review meetings, and the Company maintains a detailed set  of key performance indicators in the quality area.
","('Management_Of_Legal_And_Regulatory_Framework', 0.33186018466949463)","('Business_Ethics', 0.231587216258049)","('Systemic_Risk_Management', 0.19609369337558746)","('NON-ESG', 0.33186018466949463)","('NON-ESG', 0.231587216258049)","('NON-ESG', 0.19609369337558746)"
Line 205,"In addition,  the Quality, Regulatory and Technology Committee of  the Board of Directors receives a comprehensive quality  presentation at each quarterly meeting.
","('Director_Removal', 0.6936649084091187)","('Management_Of_Legal_And_Regulatory_Framework', 0.09263178706169128)","('Business_Ethics', 0.030570661649107933)","(['Anti-Crime Policy & Measures'], 0.6936649084091187)","('NON-ESG', 0.09263178706169128)","('NON-ESG', 0.030570661649107933)"
Line 206,"We have multiple manufacturing sites proactively  participating in the Medical Device Innovation Consortium  and the FDA Case for Quality Voluntary Improvement  program.
","('Product_Quality_And_Safety', 0.26629701256752014)","('Product_Design_And_Lifecycle_Management', 0.1328088492155075)","('Competitive_Behavior', 0.09624823927879333)","('NON-ESG', 0.26629701256752014)","('NON-ESG', 0.1328088492155075)","('NON-ESG', 0.09624823927879333)"
Line 207,"For more information on this program, visit  https:/ /www.fda.gov/medical-devices/quality-and- compliance-medical-devices/case-quality Furthermore, we have a stringent supply chain monitoring  program inclusive of quality, delivery and cost measures.
","('Supply_Chain_Management', 0.9354798793792725)","('Product_Design_And_Lifecycle_Management', 0.009247055277228355)","('Labor_Practices', 0.004408181644976139)","(['Supply Chain Management'], 0.9354798793792725)","('NON-ESG', 0.009247055277228355)","('NON-ESG', 0.004408181644976139)"
Line 208,"In recent years, Zimmer Biomet has made substantial  progress on quality system enhancements and remediation  across our network.
","('Critical_Incident_Risk_Management', 0.30724793672561646)","('Employee_Health_And_Safety', 0.2606605291366577)","('Water_And_Wastewater_Management', 0.06849730759859085)","('NON-ESG', 0.30724793672561646)","('NON-ESG', 0.2606605291366577)","('NON-ESG', 0.06849730759859085)"
Line 209,"As of June 2021, the Company has only  one pending FDA Warning Letter, which pertains to our  Warsaw, Indiana North Campus facility.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5769780278205872)","('Product_Quality_And_Safety', 0.0828041359782219)","('Competitive_Behavior', 0.07245468348264694)","(['Corporate Governance'], 0.5769780278205872)","('NON-ESG', 0.0828041359782219)","('NON-ESG', 0.07245468348264694)"
Line 210,"The 2012 Ponce,  Puerto Rico FDA Warning Letter was successfully cleared  in 2020 after multiple positive follow-up FDA inspections.
","('Management_Of_Legal_And_Regulatory_Framework', 0.862974226474762)","('Product_Quality_And_Safety', 0.028654340654611588)","('Business_Ethics', 0.013265665620565414)","(['Corporate Governance'], 0.862974226474762)","('NON-ESG', 0.028654340654611588)","('NON-ESG', 0.013265665620565414)"
Line 211,"While the Warning Letter at the Warsaw North facility  remains active, following an FDA re-inspection in 2020, the  FDA classified the site as Voluntary Action Indicated, or VAI.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7894867658615112)","('Product_Quality_And_Safety', 0.04224320873618126)","('GHG_Emissions', 0.02201925218105316)","(['Corporate Governance'], 0.7894867658615112)","('NON-ESG', 0.04224320873618126)","('NON-ESG', 0.02201925218105316)"
Line 212,"We have made significant investments in Quality  Management System remediation and upgrades over the  past four years.
","('Critical_Incident_Risk_Management', 0.13223393261432648)","('Product_Quality_And_Safety', 0.11735448241233826)","('Physical_Impacts_Of_Climate_Change', 0.09556527435779572)","('NON-ESG', 0.13223393261432648)","('NON-ESG', 0.11735448241233826)","('NON-ESG', 0.09556527435779572)"
Line 213,"While these enhancements continue, we are  very encouraged that these efforts have already resulted in  a 60 percent reduction in FDA product recalls during that  time.
","('Product_Quality_And_Safety', 0.5427974462509155)","('Selling_Practices_And_Product_Labeling', 0.15803520381450653)","('Product_Design_And_Lifecycle_Management', 0.09283101558685303)","(['Product Quality & Recall Management'], 0.5427974462509155)","('NON-ESG', 0.15803520381450653)","('NON-ESG', 0.09283101558685303)"
Line 214,"YearClass 1  RecallsClass 2  RecallsClass 3  RecallsForms  ReceivedWarning  Letters  Received 2016 1 40 1 3 2017 1 62 0 7 2018 1 48 0 3 2019 1 24 0 3 2020 0 21 0 1 0We are advancing automation in manufacturing, quality  systems and inspection and measurement methods such as  Manufacturing Execution System (MES), Design Controls  and Risk Management Software (The Vault), and InfinityQS.
","('Business_Ethics', 0.2548871338367462)","('Product_Quality_And_Safety', 0.2087903767824173)","('Critical_Incident_Risk_Management', 0.11241457611322403)","('NON-ESG', 0.2548871338367462)","('NON-ESG', 0.2087903767824173)","('NON-ESG', 0.11241457611322403)"
Line 215,"We have rolled out the Quality Begins With Me  program  across the entire Zimmer Biomet network.
","('Systemic_Risk_Management', 0.1435651332139969)","('Competitive_Behavior', 0.10257519781589508)","('Management_Of_Legal_And_Regulatory_Framework', 0.10154031962156296)","('NON-ESG', 0.1435651332139969)","('NON-ESG', 0.10257519781589508)","('NON-ESG', 0.10154031962156296)"
Line 216,"This is a  structured culture enhancement program with a mission to  promote a blame free culture of driving proper behaviors,  empowering team members to promote operational  excellence and creating a singular binding focus on quality  and compliance improvements.
","('Business_Ethics', 0.680621325969696)","('Management_Of_Legal_And_Regulatory_Framework', 0.07088341563940048)","('Product_Quality_And_Safety', 0.05673004686832428)","(['Business Ethics'], 0.680621325969696)","('NON-ESG', 0.07088341563940048)","('NON-ESG', 0.05673004686832428)"
Line 217,"The program is intended to  drive flawless execution to achieve doing things right the  first time and every time.
","('Product_Design_And_Lifecycle_Management', 0.2113475650548935)","('Business_Model_Resilience', 0.16502001881599426)","('Business_Ethics', 0.08659247308969498)","('NON-ESG', 0.2113475650548935)","('NON-ESG', 0.16502001881599426)","('NON-ESG', 0.08659247308969498)"
Line 218,"We implemented Class A and Operational Excellence  initiatives across all of our manufacturing sites to drive  a continuous improvement culture and manufacturing  and supply chain excellence.
","('Supply_Chain_Management', 0.9436563849449158)","('Product_Design_And_Lifecycle_Management', 0.005859317723661661)","('Employee_Health_And_Safety', 0.004425068385899067)","(['Supply Chain Management'], 0.9436563849449158)","('NON-ESG', 0.005859317723661661)","('NON-ESG', 0.004425068385899067)"
Line 219,"As evidence of this effort,  Oliver Wight has certified Class A in our Ireland sites and  we have moved to self-implementation and certification  in the remaining facilities.
","('Product_Quality_And_Safety', 0.3460950553417206)","('Management_Of_Legal_And_Regulatory_Framework', 0.2251153588294983)","('Access_And_Affordability', 0.06009640917181969)","('NON-ESG', 0.3460950553417206)","('NON-ESG', 0.2251153588294983)","('NON-ESG', 0.06009640917181969)"
Line 220,"For more information, visit  https:/ /www.oliverwight-americas.com/services/class-a- standard-for-business-excellence/ We have implemented Green Belt and Black Belt employee  certification programs aimed at teaching and utilizing  essential LEAN tools to drive waste reduction through  continuous improvement, as well as to drive out variation  by applying Define, Measure, Analyze, Improve and Control  (DMAIC) problem-solving methodology and to make data- driven decisions through proven quality tools and statistical  methods.
","('Waste_And_Hazardous_Materials_Management', 0.9420987963676453)","('Water_And_Wastewater_Management', 0.00951972883194685)","('Employee_Health_And_Safety', 0.00618825014680624)","(['Operational Eco-Efficiency'], 0.9420987963676453)","('NON-ESG', 0.00951972883194685)","('NON-ESG', 0.00618825014680624)"
Line 221,"For more information, visit  https:/ /www.oliverwight-americas.com/services/class-a- standard-for-business-excellence/ We have implemented Green Belt and Black Belt employee  certification programs aimed at teaching and utilizing  essential LEAN tools to drive waste reduction through  continuous improvement, as well as to drive out variation  by applying Define, Measure, Analyze, Improve and Control  (DMAIC) problem-solving methodology and to make data- driven decisions through proven quality tools and statistical  methods.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4049004316329956)","('Competitive_Behavior', 0.15219779312610626)","('Business_Ethics', 0.08330564200878143)","('NON-ESG', 0.4049004316329956)","('NON-ESG', 0.15219779312610626)","('NON-ESG', 0.08330564200878143)"
Line 222,"We are also working toward compliance and certification  with the European Union Medical Device Regulation  standards by 2024.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9263814091682434)","('Product_Quality_And_Safety', 0.016633300110697746)","('Competitive_Behavior', 0.004487266298383474)","(['Corporate Governance'], 0.9263814091682434)","('NON-ESG', 0.016633300110697746)","('NON-ESG', 0.004487266298383474)"
Line 223,"Supplier Code of Conduct  Zimmer Biomet strives to achieve and maintain the highest  possible standards of corporate integrity and ethical  behavior.
","('Business_Ethics', 0.9467474818229675)","('Labor_Practices', 0.0049333092756569386)","('Product_Quality_And_Safety', 0.003837191266939044)","(['Business Ethics'], 0.9467474818229675)","('NON-ESG', 0.0049333092756569386)","('NON-ESG', 0.003837191266939044)"
Line 224,"We expect that our suppliers will conduct their  business not only in a lawful manner but also in compliance  with the same high standards of integrity and ethics.
","('Business_Ethics', 0.9703561663627625)","('Management_Of_Legal_And_Regulatory_Framework', 0.0023688008077442646)","('Product_Quality_And_Safety', 0.0022112715523689985)","(['Business Ethics'], 0.9703561663627625)","('NON-ESG', 0.0023688008077442646)","('NON-ESG', 0.0022112715523689985)"
Line 225,"In  order to establish guidelines for such standards, Zimmer  Biomet has instituted a Code of Supplier Conduct, available  at https:/ /www.zimmerbiomet.com/content/dam/zimmer- biomet/sourcing/Zimmer-Biomet-Supplier-Code-of- Conduct.pdf 11At a minimum, suppliers must conduct business in  accordance with all applicable country, state and local  laws and regulations covering the jurisdictions in which  they operate, including, without limitation, laws relating  to employment, human rights, the environment, health  and safety and trade.
","('Supply_Chain_Management', 0.8889763355255127)","('Labor_Practices', 0.0184700395911932)","('Human_Rights_And_Community_Relations', 0.014560292474925518)","(['Supply Chain Management'], 0.8889763355255127)","('NON-ESG', 0.0184700395911932)","('NON-ESG', 0.014560292474925518)"
Line 226,"In  order to establish guidelines for such standards, Zimmer  Biomet has instituted a Code of Supplier Conduct, available  at https:/ /www.zimmerbiomet.com/content/dam/zimmer- biomet/sourcing/Zimmer-Biomet-Supplier-Code-of- Conduct.pdf 11At a minimum, suppliers must conduct business in  accordance with all applicable country, state and local  laws and regulations covering the jurisdictions in which  they operate, including, without limitation, laws relating  to employment, human rights, the environment, health  and safety and trade.
","('Employee_Health_And_Safety', 0.7804384231567383)","('Product_Quality_And_Safety', 0.10128413140773773)","('Waste_And_Hazardous_Materials_Management', 0.011682023294270039)","(['Operational Eco-Efficiency'], 0.7804384231567383)","('NON-ESG', 0.10128413140773773)","('NON-ESG', 0.011682023294270039)"
Line 227,"Each supplier is to comply with  the commercial best practices of the supplier’s industry.
","('Supply_Chain_Management', 0.9304715991020203)","('Product_Design_And_Lifecycle_Management', 0.007563911844044924)","('Labor_Practices', 0.006466931197792292)","(['Supply Chain Management'], 0.9304715991020203)","('NON-ESG', 0.007563911844044924)","('NON-ESG', 0.006466931197792292)"
Line 228,"Zimmer Biomet reserves the right to decline to deal with  suppliers who do not comply with the law or our standards.
","('Supply_Chain_Management', 0.49635887145996094)","('Management_Of_Legal_And_Regulatory_Framework', 0.12022987753152847)","('Product_Quality_And_Safety', 0.07418406009674072)","('NON-ESG', 0.49635887145996094)","('NON-ESG', 0.12022987753152847)","('NON-ESG', 0.07418406009674072)"
Line 229,"Zimmer Biomet also has taken steps to ensure that slavery  and human trafficking is not taking place in our supply  chains or any parts of our business operations through  the UK Modern Slavery Act of 2015 and the California  Transparency in Supply Chains Act of 2010.
","('Business_Ethics', 0.354386568069458)","('Labor_Practices', 0.15883125364780426)","('Supply_Chain_Management', 0.12079617381095886)","('NON-ESG', 0.354386568069458)","('NON-ESG', 0.15883125364780426)","('NON-ESG', 0.12079617381095886)"
Line 230,"https:/ /www.zimmerbiomet.com/content/dam/zimmer- biomet/homepage/CA%20Transparency%20and%UK%20MSA%20Statement.pdf Supplier Social Responsibility Audits Zimmer Biomet conducts social responsibility audits with all  new suppliers in high risk regions and on existing suppliers  every three years.
","('Supply_Chain_Management', 0.9122152924537659)","('Systemic_Risk_Management', 0.011305826716125011)","('Business_Model_Resilience', 0.008277678862214088)","(['Supply Chain Management'], 0.9122152924537659)","('NON-ESG', 0.011305826716125011)","('NON-ESG', 0.008277678862214088)"
Line 231,"Forty-seven suppliers were audited in  2019 with no major findings.
","('Supply_Chain_Management', 0.8499428629875183)","('Systemic_Risk_Management', 0.025088801980018616)","('Labor_Practices', 0.01035451702773571)","(['Supply Chain Management'], 0.8499428629875183)","('NON-ESG', 0.025088801980018616)","('NON-ESG', 0.01035451702773571)"
Line 232,"Social Responsibility audits  are planned every three years; the next round of audits will  occur in 2022.
","('Human_Rights_And_Community_Relations', 0.3559659719467163)","('Management_Of_Legal_And_Regulatory_Framework', 0.19983740150928497)","('Business_Model_Resilience', 0.0626976490020752)","('NON-ESG', 0.3559659719467163)","('NON-ESG', 0.19983740150928497)","('NON-ESG', 0.0626976490020752)"
Line 233,"Supplier Diligence For all new proposed international suppliers, due diligence  investigations are conducted by the Zimmer Biomet  Compliance team to make sure the third party is not on any  watch lists.
","('Supply_Chain_Management', 0.9016655683517456)","('Labor_Practices', 0.015688588842749596)","('Systemic_Risk_Management', 0.008915046229958534)","(['Supply Chain Management'], 0.9016655683517456)","('NON-ESG', 0.015688588842749596)","('NON-ESG', 0.008915046229958534)"
Line 234,"This global due diligence review starts at the  front end of the request process.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8712778091430664)","('Business_Ethics', 0.022366898134350777)","('Human_Rights_And_Community_Relations', 0.011008254252374172)","(['Corporate Governance'], 0.8712778091430664)","('NON-ESG', 0.022366898134350777)","('NON-ESG', 0.011008254252374172)"
Line 235,"Ongoing due diligence is  conducted annually for existing suppliers.
","('Supply_Chain_Management', 0.8508136868476868)","('GHG_Emissions', 0.01530162338167429)","('Management_Of_Legal_And_Regulatory_Framework', 0.012607133947312832)","(['Supply Chain Management'], 0.8508136868476868)","('NON-ESG', 0.01530162338167429)","('NON-ESG', 0.012607133947312832)"
Line 236,"Supplier Quality Audits New and existing supplier audit plans are established based  on the applicable Quality Management System (QMS)  requirement for the product/service the supplier provides.
","('Supply_Chain_Management', 0.6137323975563049)","('Product_Design_And_Lifecycle_Management', 0.1998867392539978)","('Product_Quality_And_Safety', 0.036305706948041916)","(['Supply Chain Management'], 0.6137323975563049)","('NON-ESG', 0.1998867392539978)","('NON-ESG', 0.036305706948041916)"
Line 237,"The applicable QMS requirements are focused on FDA  and International Organization for Standardization (ISO)  standards.
","('Management_Of_Legal_And_Regulatory_Framework', 0.44628721475601196)","('Product_Quality_And_Safety', 0.2118382751941681)","('Competitive_Behavior', 0.03755159676074982)","('NON-ESG', 0.44628721475601196)","('NON-ESG', 0.2118382751941681)","('NON-ESG', 0.03755159676074982)"
Line 238,"These standards include FDA 21 CFR 820 and  ISO 13485.
","('Management_Of_Legal_And_Regulatory_Framework', 0.45296868681907654)","('Product_Quality_And_Safety', 0.27772772312164307)","('Competitive_Behavior', 0.03094753623008728)","('NON-ESG', 0.45296868681907654)","('NON-ESG', 0.27772772312164307)","('NON-ESG', 0.03094753623008728)"
Line 239,"Zimmer Biomet has three global procedures detailing the  process:  (i) the Supplier Questionnaire is used to collect a  variety of information on the supplier, including an overview  of the supplier’s quality system; (ii) the Supplier Qualification  Report determines which audit plan will be followed and the risk classification; and (iii) the Supplier Audit Plan details the  information found during the audit and the attendees.
","('Supply_Chain_Management', 0.9358479380607605)","('Labor_Practices', 0.008652792312204838)","('Systemic_Risk_Management', 0.004980055615305901)","(['Supply Chain Management'], 0.9358479380607605)","('NON-ESG', 0.008652792312204838)","('NON-ESG', 0.004980055615305901)"
Line 240,"All  information gathered from the auditing process is stored  in a global system and accessible to all Zimmer Biomet  businesses.
","('Data_Security', 0.20712688565254211)","('Business_Ethics', 0.19773565232753754)","('Management_Of_Legal_And_Regulatory_Framework', 0.1954316794872284)","('NON-ESG', 0.20712688565254211)","('NON-ESG', 0.19773565232753754)","('NON-ESG', 0.1954316794872284)"
Line 241,"Supplier Diversity Policy We believe that a diverse supply chain strengthens our  ability to carry out our Mission and improve the communities  in which we live and work.
","('Supply_Chain_Management', 0.687598466873169)","('Employee_Engagement_Inclusion_And_Diversity', 0.08887789398431778)","('Labor_Practices', 0.05097063258290291)","(['Supply Chain Management'], 0.687598466873169)","('NON-ESG', 0.08887789398431778)","('NON-ESG', 0.05097063258290291)"
Line 242,"Zimmer Biomet’s Supplier  Diversity Policy in the United States and Puerto Rico assists  in establishing and maintaining business relationships with  suppliers that are either certified in diverse categories by  the Small Business Administration or self-certified where  applicable.
","('Supply_Chain_Management', 0.6340504288673401)","('Employee_Engagement_Inclusion_And_Diversity', 0.1103438287973404)","('Labor_Practices', 0.039504196494817734)","(['Supply Chain Management'], 0.6340504288673401)","('NON-ESG', 0.1103438287973404)","('NON-ESG', 0.039504196494817734)"
Line 243,"We assign a Small Business Liaison Officer (SBLO) as an  administrator for the Supplier Diversity Program.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9014104604721069)","('Access_And_Affordability', 0.009517813101410866)","('Labor_Practices', 0.00919308327138424)","(['Human Capital Development'], 0.9014104604721069)","('NON-ESG', 0.009517813101410866)","('NON-ESG', 0.00919308327138424)"
Line 244,"The SBLO  assures that reports documenting procurement levels,  broken down by supplier classification, are prepared as  requested by government agencies and contract groups.
","('Supply_Chain_Management', 0.9399700164794922)","('Labor_Practices', 0.00696942675858736)","('Product_Design_And_Lifecycle_Management', 0.0050484840758144855)","(['Supply Chain Management'], 0.9399700164794922)","('NON-ESG', 0.00696942675858736)","('NON-ESG', 0.0050484840758144855)"
Line 245,"Annual Summary Subcontract Reports and Year End  Supplementary Small Disadvantaged Business (SDB)  Reports are submitted according to existing Small Business  Administration and U.S. Government mandates.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9509187936782837)","('Director_Removal', 0.00400929432362318)","('Access_And_Affordability', 0.003962958697229624)","(['Corporate Governance'], 0.9509187936782837)","('NON-ESG', 0.00400929432362318)","('NON-ESG', 0.003962958697229624)"
Line 246,"Zimmer Biomet’s diversity reporting obligations to the  U.S. Federal Government include spending in the United  States and Puerto Rico in the following six diverse supplier  categories annually: 1.
","('Supply_Chain_Management', 0.9173977375030518)","('Product_Design_And_Lifecycle_Management', 0.010566717945039272)","('Customer_Welfare', 0.00622051116079092)","(['Supply Chain Management'], 0.9173977375030518)","('NON-ESG', 0.010566717945039272)","('NON-ESG', 0.00622051116079092)"
Line 247,"Historically Underutilized Business Zone Small  Business (HUBZone)  2.
","('Business_Model_Resilience', 0.27937445044517517)","('Systemic_Risk_Management', 0.26250702142715454)","('Supply_Chain_Management', 0.11633702367544174)","('NON-ESG', 0.27937445044517517)","('NON-ESG', 0.26250702142715454)","('NON-ESG', 0.11633702367544174)"
Line 248,"Service-Disabled Veteran-Owned Small Business  (SDVOSB)  3.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8647586107254028)","('Employee_Health_And_Safety', 0.029805142432451248)","('Labor_Practices', 0.014402681961655617)","(['Human Capital Development'], 0.8647586107254028)","('NON-ESG', 0.029805142432451248)","('NON-ESG', 0.014402681961655617)"
Line 249,"Small Business (SB)  4.
","('Systemic_Risk_Management', 0.43569236993789673)","('Business_Model_Resilience', 0.1649651974439621)","('Competitive_Behavior', 0.06785938143730164)","('NON-ESG', 0.43569236993789673)","('NON-ESG', 0.1649651974439621)","('NON-ESG', 0.06785938143730164)"
Line 250,"Small Disadvantaged Business (SDB)  5.
","('Human_Rights_And_Community_Relations', 0.24315908551216125)","('Access_And_Affordability', 0.22182758152484894)","('Employee_Engagement_Inclusion_And_Diversity', 0.1828286051750183)","('NON-ESG', 0.24315908551216125)","('NON-ESG', 0.22182758152484894)","('NON-ESG', 0.1828286051750183)"
Line 251,"Veteran-Owned Small Business (VOSB)  6.
","('Supply_Chain_Management', 0.22179405391216278)","('Business_Model_Resilience', 0.1294419765472412)","('Systemic_Risk_Management', 0.12202490121126175)","('NON-ESG', 0.22179405391216278)","('NON-ESG', 0.1294419765472412)","('NON-ESG', 0.12202490121126175)"
Line 252,"Women-Owned Small Business (WOSB) Management of Risks Associated   with Use of Critical Materials   Zimmer Biomet has a Global Supply Risk Management  process.
","('Supply_Chain_Management', 0.9021927714347839)","('Waste_And_Hazardous_Materials_Management', 0.018238626420497894)","('Product_Design_And_Lifecycle_Management', 0.011478432454168797)","(['Supply Chain Management'], 0.9021927714347839)","('NON-ESG', 0.018238626420497894)","('NON-ESG', 0.011478432454168797)"
Line 253,"We have established a systematic approach to: • Ensure continuity of supply for goods and services • Proactively manage (identify, assess, mitigate and  monitor) potential supply risks which may result in  product delays and/or revenue impact to the business • Ensure that a global process is being utilized across the  Zimmer Biomet Global Sourcing Organization A key component in risk monitoring is the financial  impacts that might occur in raw material scarcity and/or  physical disruptions of Zimmer Biomet’s own operations  or in the operations of our supply chain.
","('Supply_Chain_Management', 0.9279863834381104)","('Product_Design_And_Lifecycle_Management', 0.016075920313596725)","('Systemic_Risk_Management', 0.004711179994046688)","(['Supply Chain Management'], 0.9279863834381104)","('NON-ESG', 0.016075920313596725)","('NON-ESG', 0.004711179994046688)"
Line 254,"We have established a systematic approach to: • Ensure continuity of supply for goods and services • Proactively manage (identify, assess, mitigate and  monitor) potential supply risks which may result in  product delays and/or revenue impact to the business • Ensure that a global process is being utilized across the  Zimmer Biomet Global Sourcing Organization A key component in risk monitoring is the financial  impacts that might occur in raw material scarcity and/or  physical disruptions of Zimmer Biomet’s own operations  or in the operations of our supply chain.
","('Supply_Chain_Management', 0.9450456500053406)","('Physical_Impacts_Of_Climate_Change', 0.004532756749540567)","('Labor_Practices', 0.004503190983086824)","(['Supply Chain Management'], 0.9450456500053406)","('NON-ESG', 0.004532756749540567)","('NON-ESG', 0.004503190983086824)"
Line 255,"To mitigate these  risks, Zimmer Biomet utilizes a third party to rank our top  suppliers against 73 financial ratios on a scale of 1-100 to  understand the overall financial health of these suppliers.
","('Supply_Chain_Management', 0.9477246999740601)","('Systemic_Risk_Management', 0.004337019752711058)","('Physical_Impacts_Of_Climate_Change', 0.0041792187839746475)","(['Supply Chain Management'], 0.9477246999740601)","('NON-ESG', 0.004337019752711058)","('NON-ESG', 0.0041792187839746475)"
Line 256,"It is considered to have substantive strategic impact on  Zimmer Biomet’s business if suppliers score below a 20  in this rating.
","('Supply_Chain_Management', 0.846778929233551)","('Product_Design_And_Lifecycle_Management', 0.038610298186540604)","('Business_Model_Resilience', 0.03486322984099388)","(['Supply Chain Management'], 0.846778929233551)","('NON-ESG', 0.038610298186540604)","('NON-ESG', 0.03486322984099388)"
Line 257,"Through a third-party vendor, the Company  obtains international private company financial statements  and has a greater than 85 percent success rate (and above  90 percent in certain markets) to measure the core health  of a supplier out to 36 months, and predicating probability  of default over 12 to 18 months via a quantitative model to  generate a rating.Animal Testing Policy Zimmer Biomet’s utilization of animal testing is consistent  with animal welfare acts around the world.
","('Product_Quality_And_Safety', 0.16328518092632294)","('Selling_Practices_And_Product_Labeling', 0.10871748626232147)","('Access_And_Affordability', 0.08449029922485352)","('NON-ESG', 0.16328518092632294)","('NON-ESG', 0.10871748626232147)","('NON-ESG', 0.08449029922485352)"
Line 258,"We utilize  animal testing when required to demonstrate biological  safety for our products that cannot be demonstrated by  laboratory benchtop tests or when required to demonstrate  compliance with medical device regulations.
","('Product_Quality_And_Safety', 0.9011781811714172)","('Selling_Practices_And_Product_Labeling', 0.015467138960957527)","('Customer_Welfare', 0.008716057986021042)","(['Product Quality & Recall Management'], 0.9011781811714172)","('NON-ESG', 0.015467138960957527)","('NON-ESG', 0.008716057986021042)"
Line 259,"The  laboratories that Zimmer Biomet engages for animal testing  typically have American Association for Accreditation of  Laboratory Animal Care (AAALAC) certification or have  their own animal research committee (i.e., an independent  review committee) to ensure compliance with national  animal welfare acts.
","('Management_Of_Legal_And_Regulatory_Framework', 0.12763682007789612)","('Product_Quality_And_Safety', 0.11731372028589249)","('Ecological_Impacts', 0.09155674278736115)","('NON-ESG', 0.12763682007789612)","('NON-ESG', 0.11731372028589249)","('NON-ESG', 0.09155674278736115)"
Line 260,"Zimmer Biomet does not perform  animal testing directly; the work is contracted to labs.
","('GHG_Emissions', 0.2456415593624115)","('Selling_Practices_And_Product_Labeling', 0.10364258289337158)","('Customer_Welfare', 0.09513991326093674)","('NON-ESG', 0.2456415593624115)","('NON-ESG', 0.10364258289337158)","('NON-ESG', 0.09513991326093674)"
Line 261,"Clinical Trial Program Zimmer Biomet operates a robust global clinical research  program that strives to collect meaningful clinical evidence  to support our vast portfolio of products that ultimately  help alleviate pain and improve the quality of life for people  around the world.
","('Product_Design_And_Lifecycle_Management', 0.29403698444366455)","('Customer_Welfare', 0.2775045335292816)","('Product_Quality_And_Safety', 0.09958266466856003)","('NON-ESG', 0.29403698444366455)","('NON-ESG', 0.2775045335292816)","('NON-ESG', 0.09958266466856003)"
Line 262,"Our clinical research programs support  the safety and effectiveness of our products, services  and technologies in a compliant and transparent manner.
","('Product_Quality_And_Safety', 0.8356585502624512)","('Selling_Practices_And_Product_Labeling', 0.04441295936703682)","('Product_Design_And_Lifecycle_Management', 0.025246495380997658)","(['Product Quality & Recall Management'], 0.8356585502624512)","('NON-ESG', 0.04441295936703682)","('NON-ESG', 0.025246495380997658)"
Line 263,"Zimmer Biomet supported clinical trials are conducted across many different programs, including sponsored multi- center global clinical trials, as well as Company supported  smaller investigator initiated clinical trials.
","('Competitive_Behavior', 0.16021133959293365)","('Customer_Welfare', 0.14445418119430542)","('Access_And_Affordability', 0.1369563341140747)","('NON-ESG', 0.16021133959293365)","('NON-ESG', 0.14445418119430542)","('NON-ESG', 0.1369563341140747)"
Line 264,"Zimmer Biomet conducts studies all over the world that are  managed by our global Clinical Affairs teams.
","('Access_And_Affordability', 0.15512050688266754)","('Customer_Welfare', 0.1359376758337021)","('Competitive_Behavior', 0.08763335645198822)","('NON-ESG', 0.15512050688266754)","('NON-ESG', 0.1359376758337021)","('NON-ESG', 0.08763335645198822)"
Line 265,"These teams  manage our regulated and post-market studies and are  located in key locations across the globe.
","('Competitive_Behavior', 0.41234079003334045)","('Management_Of_Legal_And_Regulatory_Framework', 0.26347750425338745)","('Systemic_Risk_Management', 0.13082246482372284)","('NON-ESG', 0.41234079003334045)","('NON-ESG', 0.26347750425338745)","('NON-ESG', 0.13082246482372284)"
Line 266,"In all instances,  these programs and teams adhere to Zimmer Biomet  policies and procedures that incorporate the standards set  forth in the International Conference on Harmonization, the  Declaration of Helsinki, Good Clinical Practice guidelines  and the AdvaMed Code of Ethics.
","('Business_Ethics', 0.6519699096679688)","('Management_Of_Legal_And_Regulatory_Framework', 0.20503975450992584)","('Product_Quality_And_Safety', 0.03569578006863594)","(['Business Ethics'], 0.6519699096679688)","('NON-ESG', 0.20503975450992584)","('NON-ESG', 0.03569578006863594)"
Line 267,"To protect the rights, safety and well-being of clinical trial  participants, Zimmer Biomet has an overarching global  procedure for Conducting Clinical Research Involving  Human Subjects, GBL12000.
","('Product_Quality_And_Safety', 0.5727592706680298)","('Customer_Welfare', 0.09894680231809616)","('Selling_Practices_And_Product_Labeling', 0.07409654557704926)","(['Product Quality & Recall Management'], 0.5727592706680298)","('NON-ESG', 0.09894680231809616)","('NON-ESG', 0.07409654557704926)"
Line 268,"This procedure also ensures  that the clinical research from our clinical trials is qualified  and reliable and can be used by worldwide regulatory  authorities.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5996262431144714)","('Competitive_Behavior', 0.10063914209604263)","('Access_And_Affordability', 0.056084491312503815)","(['Corporate Governance'], 0.5996262431144714)","('NON-ESG', 0.10063914209604263)","('NON-ESG', 0.056084491312503815)"
Line 269,"As part of our procedures, clinical trials are  reviewed and approved by several cross-functional internal  committees, including a Clinical Investigation Review  Committee and a Clinical Research Review Committee.
","('Management_Of_Legal_And_Regulatory_Framework', 0.18274681270122528)","('Competitive_Behavior', 0.12748228013515472)","('Access_And_Affordability', 0.10724551975727081)","('NON-ESG', 0.18274681270122528)","('NON-ESG', 0.12748228013515472)","('NON-ESG', 0.10724551975727081)"
Line 270,"Clinical trials are only approved if they are scientifically  sound, meet a well-defined business need and are within fair market value calculations.
","('Competitive_Behavior', 0.18523983657360077)","('Customer_Welfare', 0.15714888274669647)","('Management_Of_Legal_And_Regulatory_Framework', 0.09030180424451828)","('NON-ESG', 0.18523983657360077)","('NON-ESG', 0.15714888274669647)","('NON-ESG', 0.09030180424451828)"
Line 271,"Clinical trial support can range  from monetary funding, providing in-kind product, or even  the loaning of specialized instrumentation and equipment.
","('Customer_Welfare', 0.1412992626428604)","('Competitive_Behavior', 0.13834546506404877)","('Access_And_Affordability', 0.12610061466693878)","('NON-ESG', 0.1412992626428604)","('NON-ESG', 0.13834546506404877)","('NON-ESG', 0.12610061466693878)"
Line 272,"In addition to the internal Zimmer Biomet review and  approval processes, all clinical studies are required to be  reviewed and approved by an Institutional Review Board  or Ethics Committee that is independent of both Zimmer  Biomet and the participating investigational centers.
","('Management_Of_Legal_And_Regulatory_Framework', 0.47407498955726624)","('Competitive_Behavior', 0.08313442766666412)","('Access_And_Affordability', 0.06714966148138046)","('NON-ESG', 0.47407498955726624)","('NON-ESG', 0.08313442766666412)","('NON-ESG', 0.06714966148138046)"
Line 273,"Clinical Trial Transparency Zimmer Biomet supports clinical research to foster  advances in clinical knowledge and furthering medical  device development related to our products and  programs.
","('Customer_Welfare', 0.2756030857563019)","('Product_Design_And_Lifecycle_Management', 0.16061411798000336)","('Competitive_Behavior', 0.10762885212898254)","('NON-ESG', 0.2756030857563019)","('NON-ESG', 0.16061411798000336)","('NON-ESG', 0.10762885212898254)"
Line 274,"As such, clinical trial transparency is required  to appropriately contribute to and comply with the  International Committee of Medical Journal Editors (ICMJE)  initiative and Food and Drug Administration Amendments  Act (FDAAA) requirements by utilizing ClinicalTrials.gov to  register our active clinical studies and study results once  they are available.
","('Business_Ethics', 0.9285711646080017)","('Management_Of_Legal_And_Regulatory_Framework', 0.010191668756306171)","('Systemic_Risk_Management', 0.00912115816026926)","(['Business Ethics'], 0.9285711646080017)","('NON-ESG', 0.010191668756306171)","('NON-ESG', 0.00912115816026926)"
Line 275,"All study results are posted, regardless  of whether the trial is deemed successful or failed to meet  the primary end point.
","('Competitive_Behavior', 0.28149956464767456)","('Management_Of_Legal_And_Regulatory_Framework', 0.22404806315898895)","('Access_And_Affordability', 0.06410011649131775)","('NON-ESG', 0.28149956464767456)","('NON-ESG', 0.22404806315898895)","('NON-ESG', 0.06410011649131775)"
Line 276,"A sample listing of Zimmer Biomet  clinical trials can be found at ClinicalTrials.gov .14Grants, Donations and Funding Zimmer Biomet Foundation As an independent, philanthropic and non-profit  organization, the Zimmer Biomet Foundation (ZBF)  improves the quality of life for our communities by providing  resources to help:  build healthy communities; advance  STEM education; provide disaster relief; and address  healthcare disparities while advancing diversity, equity and  inclusion.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8280780911445618)","('Human_Rights_And_Community_Relations', 0.04514240846037865)","('Access_And_Affordability', 0.03618183359503746)","(['Human Capital Development'], 0.8280780911445618)","('NON-ESG', 0.04514240846037865)","('NON-ESG', 0.03618183359503746)"
Line 277,"In 2020, the ZBF established the Team Member Relief  Fund to help support Zimmer Biomet team members  facing financial hardships due to personal or catastrophic  tragedies.
","('Employee_Health_And_Safety', 0.2517642676830292)","('Critical_Incident_Risk_Management', 0.153799906373024)","('Systemic_Risk_Management', 0.1431654393672943)","('NON-ESG', 0.2517642676830292)","('NON-ESG', 0.153799906373024)","('NON-ESG', 0.1431654393672943)"
Line 278,"One example of the ZBF’s contributions to global  pandemic relief was a $50,000 grant to Direct Relief, a  humanitarian aid organization active in all 50 states and  more than 80 countries focused on improving the health  and lives of people affected by poverty and emergencies.
","('Critical_Incident_Risk_Management', 0.9303204417228699)","('Access_And_Affordability', 0.009683087468147278)","('Employee_Health_And_Safety', 0.009470575489103794)","(['Risk & Crisis Management'], 0.9303204417228699)","('NON-ESG', 0.009683087468147278)","('NON-ESG', 0.009470575489103794)"
Line 279,"As part of its 2020 COVID-19 response efforts, Direct Relief  provided much needed support to numerous countries  in the APAC, Europe, Middle East and Africa (EMEA), and  Americas regions, including delivering personal protective  equipment, surgical masks and intensive care unit  medication kits.
","('Employee_Health_And_Safety', 0.8574792742729187)","('Critical_Incident_Risk_Management', 0.049631375819444656)","('Product_Design_And_Lifecycle_Management', 0.011479959823191166)","(['Operational Eco-Efficiency'], 0.8574792742729187)","('NON-ESG', 0.049631375819444656)","('NON-ESG', 0.011479959823191166)"
Line 280,"The ZBF also launched a program to match team member  donations to approved non-profit organizations with a  dollar-for-dollar match.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7281245589256287)","('Human_Rights_And_Community_Relations', 0.03305007889866829)","('Labor_Practices', 0.02256334014236927)","(['Corporate Governance'], 0.7281245589256287)","('NON-ESG', 0.03305007889866829)","('NON-ESG', 0.02256334014236927)"
Line 281,"Zimmer Biomet proudly supports team members  volunteering in their communities and abroad by offering  resources to match team members with volunteer  opportunities and work policies that allow them to take the  time to support their community.
","('Human_Rights_And_Community_Relations', 0.2882128357887268)","('Employee_Health_And_Safety', 0.28189390897750854)","('Access_And_Affordability', 0.11961682140827179)","('NON-ESG', 0.2882128357887268)","('NON-ESG', 0.28189390897750854)","('NON-ESG', 0.11961682140827179)"
Line 282,"In 2020, the ZBF announced a $2 million partnership with  the National Association for the Advancement of Colored  People (NAACP) to focus on expanding medical access  for people of color by establishing a health-related Black  Opportunity Index.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9603250026702881)","('Access_And_Affordability', 0.004855804610997438)","('Employee_Health_And_Safety', 0.004057698883116245)","(['Human Capital Development'], 0.9603250026702881)","('NON-ESG', 0.004855804610997438)","('NON-ESG', 0.004057698883116245)"
Line 283,"Numerous organizations received support from the ZBF  throughout 2020.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5960532426834106)","('Competitive_Behavior', 0.07866612076759338)","('Business_Ethics', 0.041376423090696335)","(['Corporate Governance'], 0.5960532426834106)","('NON-ESG', 0.07866612076759338)","('NON-ESG', 0.041376423090696335)"
Line 284,"Zimmer Biomet continued to fund the  ZBF with a large contribution in 2020, allowing ZBF to  continue charitable work globally.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4606958031654358)","('Access_And_Affordability', 0.16357958316802979)","('Human_Rights_And_Community_Relations', 0.05064544826745987)","('NON-ESG', 0.4606958031654358)","('NON-ESG', 0.16357958316802979)","('NON-ESG', 0.05064544826745987)"
Line 285,"The ZBF provided donations and funding to various  organizations to support community and global projects in  2020, including:American   Red Crossredcross.org Americares americares.org Arthritis  Foundationarthritis.org Beaman Home thebeamanhome.com Big Brothers   Big Sistersbbbs.org Cardinal  Servicescardinalservices.org Combined  Community  Servicescombinedcommunityservices.org Direct Relief directrelief.org/ Kosciusko  Community  YMCAkcymca.org Lilly Center  for Lakes &  Streamslakes.grace.edu United Way unitedway.org Warsaw  Community  Schoolswarsaw.k12.in.us In addition, Zimmer Biomet donated orthopedic products  to support more than 10 philanthropic medical mission  trips in 2020 to help patients in need around the globe.
","('Human_Rights_And_Community_Relations', 0.3445762097835541)","('Access_And_Affordability', 0.32071396708488464)","('Management_Of_Legal_And_Regulatory_Framework', 0.07244043052196503)","('NON-ESG', 0.3445762097835541)","('NON-ESG', 0.32071396708488464)","('NON-ESG', 0.07244043052196503)"
Line 286,"The ZBF provided donations and funding to various  organizations to support community and global projects in  2020, including:American   Red Crossredcross.org Americares americares.org Arthritis  Foundationarthritis.org Beaman Home thebeamanhome.com Big Brothers   Big Sistersbbbs.org Cardinal  Servicescardinalservices.org Combined  Community  Servicescombinedcommunityservices.org Direct Relief directrelief.org/ Kosciusko  Community  YMCAkcymca.org Lilly Center  for Lakes &  Streamslakes.grace.edu United Way unitedway.org Warsaw  Community  Schoolswarsaw.k12.in.us In addition, Zimmer Biomet donated orthopedic products  to support more than 10 philanthropic medical mission  trips in 2020 to help patients in need around the globe.
","('Access_And_Affordability', 0.7944192290306091)","('Employee_Health_And_Safety', 0.03268243744969368)","('Critical_Incident_Risk_Management', 0.024028221145272255)","(['Health Outcome Contribution'], 0.7944192290306091)","('NON-ESG', 0.03268243744969368)","('NON-ESG', 0.024028221145272255)"
Line 287,"Due  to the pandemic, several planned medical mission trips  were postponed and rescheduled for future dates.
","('Critical_Incident_Risk_Management', 0.23613996803760529)","('Physical_Impacts_Of_Climate_Change', 0.1560465395450592)","('Employee_Health_And_Safety', 0.09415604174137115)","('NON-ESG', 0.23613996803760529)","('NON-ESG', 0.1560465395450592)","('NON-ESG', 0.09415604174137115)"
Line 288,"Zimmer  Biomet continued to partner with Faith in Practice by  donating a replenishment of implant inventory necessary  to continually perform charitable surgeries in Guatemala.
","('Access_And_Affordability', 0.2812079191207886)","('Management_Of_Legal_And_Regulatory_Framework', 0.26612693071365356)","('Energy_Management', 0.07446424663066864)","('NON-ESG', 0.2812079191207886)","('NON-ESG', 0.26612693071365356)","('NON-ESG', 0.07446424663066864)"
Line 289,"Additionally, we continue to support charitable surgeries in  the U.S. by donating implants through Americares.
","('Access_And_Affordability', 0.40922731161117554)","('Management_Of_Legal_And_Regulatory_Framework', 0.17232917249202728)","('Business_Ethics', 0.05352518707513809)","('NON-ESG', 0.40922731161117554)","('NON-ESG', 0.17232917249202728)","('NON-ESG', 0.05352518707513809)"
Line 290,"In 2020,  Americares was able to support approximately 40 charitable  surgeries in the U.S. with Zimmer Biomet implants.15americares Saves lives and improves health for people affected by  poverty or disaster so they can reach their full potential.
","('Access_And_Affordability', 0.36488187313079834)","('Employee_Health_And_Safety', 0.24084553122520447)","('Human_Rights_And_Community_Relations', 0.12405038625001907)","('NON-ESG', 0.36488187313079834)","('NON-ESG', 0.24084553122520447)","('NON-ESG', 0.12405038625001907)"
Line 291,"www.americares.org Faith in Practice Committed to serving the poor of Guatemala through short- term medical mission tripsthat take an integrated approach  to care that strives to reach those in the greatest need.
","('Access_And_Affordability', 0.8220339417457581)","('Human_Rights_And_Community_Relations', 0.05809379369020462)","('Critical_Incident_Risk_Management', 0.02285570092499256)","(['Health Outcome Contribution'], 0.8220339417457581)","('NON-ESG', 0.05809379369020462)","('NON-ESG', 0.02285570092499256)"
Line 292,"www.faithinpractice.org In 2020, Zimmer Biomet provided grants, donations and  funding for numerous educational and philanthropic  projects.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8661908507347107)","('Access_And_Affordability', 0.03172772750258446)","('Human_Rights_And_Community_Relations', 0.012413841672241688)","(['Corporate Governance'], 0.8661908507347107)","('NON-ESG', 0.03172772750258446)","('NON-ESG', 0.012413841672241688)"
Line 293,"These included grants to support orthopedic post- graduate medical education, including funding to OMeGA  Medical Grants Association.
","('Access_And_Affordability', 0.7876567244529724)","('Employee_Engagement_Inclusion_And_Diversity', 0.02647116594016552)","('Management_Of_Legal_And_Regulatory_Framework', 0.019803743809461594)","(['Health Outcome Contribution'], 0.7876567244529724)","('NON-ESG', 0.02647116594016552)","('NON-ESG', 0.019803743809461594)"
Line 294,"OMeGA is an independent  legal entity with a singular mission:  to award and administer  grants for graduate orthopedic medical education through  an open, accessible process designed to safeguard against  potential conflicts of interest and to ensure transparency in  the allocation of resources.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4589015245437622)","('Access_And_Affordability', 0.27846524119377136)","('Business_Ethics', 0.044199202209711075)","('NON-ESG', 0.4589015245437622)","('NON-ESG', 0.27846524119377136)","('NON-ESG', 0.044199202209711075)"
Line 295,"Zimmer Biomet also provided  educational grants to support independent medical  education conferences that promote scientific knowledge,  medical advancement and the delivery of effective  healthcare.
","('Access_And_Affordability', 0.5876713395118713)","('Management_Of_Legal_And_Regulatory_Framework', 0.05816184729337692)","('Ecological_Impacts', 0.05046195164322853)","(['Health Outcome Contribution'], 0.5876713395118713)","('NON-ESG', 0.05816184729337692)","('NON-ESG', 0.05046195164322853)"
Line 296,"In addition, Zimmer Biomet provided grants  to third-party organizations for independent research  to advance patient treatment designed for improved  outcomes.
","('Access_And_Affordability', 0.5726476907730103)","('Customer_Welfare', 0.0762607678771019)","('Product_Quality_And_Safety', 0.05365760996937752)","(['Health Outcome Contribution'], 0.5726476907730103)","('NON-ESG', 0.0762607678771019)","('NON-ESG', 0.05365760996937752)"
Line 297,"Funding was also provided to support programs that  promote diversity and multiculturalism in medical schools  and in surgeon professional development, as well as  industry minority initiatives to raise orthopedic treatment  awareness and support higher education.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9748510718345642)","('Human_Rights_And_Community_Relations', 0.0017207225318998098)","('Employee_Health_And_Safety', 0.0017180840950459242)","(['Human Capital Development'], 0.9748510718345642)","('NON-ESG', 0.0017207225318998098)","('NON-ESG', 0.0017180840950459242)"
Line 298,"One example  of diversity-related funding is the support we provide to  The Perry Initiative, which is committed to inspiring young  women to be leaders in the fields of orthopedic surgery and  engineering.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9688832759857178)","('Employee_Health_And_Safety', 0.00329587422311306)","('Access_And_Affordability', 0.0021157360170036554)","(['Human Capital Development'], 0.9688832759857178)","('NON-ESG', 0.00329587422311306)","('NON-ESG', 0.0021157360170036554)"
Line 299,"Zimmer Biomet is the Founding Sponsor of Nth Dimensions,  an educational non-profit organization created to help  increase diversity of women and underrepresented  minorities in the field of orthopedics, including pre- medical students, medical students and residents.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9750297665596008)","('Employee_Health_And_Safety', 0.0019611383322626352)","('Human_Rights_And_Community_Relations', 0.0017930171452462673)","(['Human Capital Development'], 0.9750297665596008)","('NON-ESG', 0.0019611383322626352)","('NON-ESG', 0.0017930171452462673)"
Line 300,"We are  a corporate partner of the J.
","('Management_Of_Legal_And_Regulatory_Framework', 0.24709102511405945)","('Business_Ethics', 0.12593093514442444)","('Business_Model_Resilience', 0.0861358791589737)","('NON-ESG', 0.24709102511405945)","('NON-ESG', 0.12593093514442444)","('NON-ESG', 0.0861358791589737)"
Line 301,"Robert Gladden Orthopaedic  Society, a multi-cultural organization with a mission to  increase diversity within the orthopedic profession.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9617466330528259)","('Employee_Health_And_Safety', 0.004744085017591715)","('Access_And_Affordability', 0.003352658124640584)","(['Human Capital Development'], 0.9617466330528259)","('NON-ESG', 0.004744085017591715)","('NON-ESG', 0.003352658124640584)"
Line 302,"We  also provide support to the Ruth Jackson Orthopedic  Society, which is dedicated to advancing the science and  practice of orthopedic surgery among women, as well as the American Association of Latino Orthopaedic Surgeons,  which represents not only members of Latino descent,  but all orthopedists who treat members of the Latino and  Hispanic communities.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9428716897964478)","('Employee_Health_And_Safety', 0.006805785931646824)","('Access_And_Affordability', 0.006360221188515425)","(['Human Capital Development'], 0.9428716897964478)","('NON-ESG', 0.006805785931646824)","('NON-ESG', 0.006360221188515425)"
Line 303,"Access to Healthcare Movement is Life Since 2004, Zimmer Biomet has funded initiatives that  focus on defining and reducing musculoskeletal disparities.
","('Employee_Health_And_Safety', 0.34717634320259094)","('Access_And_Affordability', 0.25516441464424133)","('Employee_Engagement_Inclusion_And_Diversity', 0.10662420839071274)","('NON-ESG', 0.34717634320259094)","('NON-ESG', 0.25516441464424133)","('NON-ESG', 0.10662420839071274)"
Line 304,"Movement is Life , a multi-disciplinary coalition, partners  with thought leaders and national member organizations  aligned to create sustainable change in marginalized  populations.
","('Human_Rights_And_Community_Relations', 0.7300485372543335)","('Access_And_Affordability', 0.06415635347366333)","('Labor_Practices', 0.05180629342794418)","(['Community Relations'], 0.7300485372543335)","('NON-ESG', 0.06415635347366333)","('NON-ESG', 0.05180629342794418)"
Line 305,"The coalition is dedicated to the elimination of  racial, ethnic, geographic and gender disparities in muscle  and joint health by promoting physical mobility to improve  quality of life among African American, Hispanic and rural  women.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9767307639122009)","('Employee_Health_And_Safety', 0.002051310148090124)","('Human_Rights_And_Community_Relations', 0.001599563518539071)","(['Human Capital Development'], 0.9767307639122009)","('NON-ESG', 0.002051310148090124)","('NON-ESG', 0.001599563518539071)"
Line 306,"Movement is Life programs include: • Operation Change, a community based public health  intervention focused on positive behavior modification  in individuals who suffer from joint pain and chronic  comorbid conditions such as diabetes and obesity.
","('Access_And_Affordability', 0.436946302652359)","('Employee_Health_And_Safety', 0.11996696144342422)","('Customer_Welfare', 0.05710534378886223)","('NON-ESG', 0.436946302652359)","('NON-ESG', 0.11996696144342422)","('NON-ESG', 0.05710534378886223)"
Line 307,"• The “Start Moving Start Living” website that serves  as a repository for culturally competent patient  communication tools to raise awareness about the  health risks associated with immobility in the United  States.
","('Employee_Health_And_Safety', 0.8613216280937195)","('Access_And_Affordability', 0.01764962449669838)","('Critical_Incident_Risk_Management', 0.017460893839597702)","(['Operational Eco-Efficiency'], 0.8613216280937195)","('NON-ESG', 0.01764962449669838)","('NON-ESG', 0.017460893839597702)"
Line 308,"• During the 2020 legislative session, Movement is Life  worked with the late Congressman John Lewis to create  the Equality in Medicare Medicaid Treatment (EMMT)  Act.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3645714819431305)","('Access_And_Affordability', 0.19082136452198029)","('Labor_Practices', 0.08875452727079391)","('NON-ESG', 0.3645714819431305)","('NON-ESG', 0.19082136452198029)","('NON-ESG', 0.08875452727079391)"
Line 309,"The EMMT bill would require the collection of data  prior to the distribution of funds.
","('Customer_Privacy', 0.6348761916160583)","('Data_Security', 0.10822201520204544)","('Management_Of_Legal_And_Regulatory_Framework', 0.05509575083851814)","(['Privacy Protection'], 0.6348761916160583)","('NON-ESG', 0.10822201520204544)","('NON-ESG', 0.05509575083851814)"
Line 310,"By doing so, it would  improve the distribution of resources based on need  to the disparate communities, thus providing more  equitable healthcare.
","('Access_And_Affordability', 0.8440927267074585)","('Human_Rights_And_Community_Relations', 0.03956069424748421)","('Employee_Engagement_Inclusion_And_Diversity', 0.014196916483342648)","(['Health Outcome Contribution'], 0.8440927267074585)","('NON-ESG', 0.03956069424748421)","('NON-ESG', 0.014196916483342648)"
Line 311,"16Patient Privacy and Data Security At Zimmer Biomet, the patient is always the patient, and  never the product.
","('Data_Security', 0.8768943548202515)","('Customer_Privacy', 0.04877185449004173)","('Business_Ethics', 0.008988791145384312)","(['Information Security/Cybersecurity & System Availability'], 0.8768943548202515)","('NON-ESG', 0.04877185449004173)","('NON-ESG', 0.008988791145384312)"
Line 312,"Patient data is used to improve outcomes  and create value for patients and their care teams through  our algorithms, systems and products in order to support  our commitment to the highest standards of patient safety,  quality and integrity.
","('Product_Quality_And_Safety', 0.8566960096359253)","('Employee_Health_And_Safety', 0.035806577652692795)","('Product_Design_And_Lifecycle_Management', 0.016251705586910248)","(['Product Quality & Recall Management'], 0.8566960096359253)","('NON-ESG', 0.035806577652692795)","('NON-ESG', 0.016251705586910248)"
Line 313,"Our commitment to protecting patient and customer data is  embodied in our four Privacy and Data Security Pillars: • Privacy.
","('Data_Security', 0.7621963620185852)","('Customer_Privacy', 0.1581076830625534)","('Waste_And_Hazardous_Materials_Management', 0.006777672562748194)","(['Information Security/Cybersecurity & System Availability'], 0.7621963620185852)","('NON-ESG', 0.1581076830625534)","('NON-ESG', 0.006777672562748194)"
Line 314,"Zimmer Biomet maintains robust practices  to help ensure that that right is protected.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6826974749565125)","('Human_Rights_And_Community_Relations', 0.10118994861841202)","('Access_And_Affordability', 0.03109947219491005)","(['Corporate Governance'], 0.6826974749565125)","('NON-ESG', 0.10118994861841202)","('NON-ESG', 0.03109947219491005)"
Line 315,"Patients and  customers decide what they share with us.
","('Competitive_Behavior', 0.2342536896467209)","('Management_Of_Legal_And_Regulatory_Framework', 0.14988431334495544)","('Customer_Welfare', 0.11718210577964783)","('NON-ESG', 0.2342536896467209)","('NON-ESG', 0.14988431334495544)","('NON-ESG', 0.11718210577964783)"
Line 316,"• Security.
","('Data_Security', 0.893089771270752)","('Energy_Management', 0.00665604043751955)","('Director_Removal', 0.006648247130215168)","(['Information Security/Cybersecurity & System Availability'], 0.893089771270752)","('NON-ESG', 0.00665604043751955)","('NON-ESG', 0.006648247130215168)"
Line 317,"Zimmer Biomet protects the data that  patients and customers entrust us with through  strong safeguards.
","('Data_Security', 0.5841894149780273)","('Business_Ethics', 0.18445493280887604)","('Customer_Privacy', 0.09398578852415085)","(['Information Security/Cybersecurity & System Availability'], 0.5841894149780273)","('NON-ESG', 0.18445493280887604)","('NON-ESG', 0.09398578852415085)"
Line 318,"Among other measures, we apply  encryption in transit and at rest, scheduled security risk  assessments and penetration testing by third parties.
","('Data_Security', 0.955742597579956)","('Business_Ethics', 0.004877625498920679)","('Systemic_Risk_Management', 0.0035441056825220585)","(['Information Security/Cybersecurity & System Availability'], 0.955742597579956)","('NON-ESG', 0.004877625498920679)","('NON-ESG', 0.0035441056825220585)"
Line 319,"• Data usage.
","('Customer_Privacy', 0.8695544004440308)","('Data_Security', 0.05096687003970146)","('Waste_And_Hazardous_Materials_Management', 0.0061536976136267185)","(['Privacy Protection'], 0.8695544004440308)","('NON-ESG', 0.05096687003970146)","('NON-ESG', 0.0061536976136267185)"
Line 320,"Zimmer Biomet will only use customer  and patient data to provide the services we have  agreed upon, and for purposes that are compatible  with providing those services.
","('Customer_Privacy', 0.9015893340110779)","('Data_Security', 0.010022034868597984)","('Selling_Practices_And_Product_Labeling', 0.006678591948002577)","(['Privacy Protection'], 0.9015893340110779)","('NON-ESG', 0.010022034868597984)","('NON-ESG', 0.006678591948002577)"
Line 321,"• Ownership.
","('Management_Of_Legal_And_Regulatory_Framework', 0.2084650695323944)","('Competitive_Behavior', 0.12915441393852234)","('Business_Model_Resilience', 0.05261562764644623)","('NON-ESG', 0.2084650695323944)","('NON-ESG', 0.12915441393852234)","('NON-ESG', 0.05261562764644623)"
Line 322,"We put patients and customers in control  of their data and have established tools and processes  that give patients easy options to exercise their rights  with respect to their personal data.Privacy There have never been more opportunities to use  information collected in the course of treatment  to create innovative solutions to improve patient  outcomes.
","('Customer_Privacy', 0.9590322375297546)","('Data_Security', 0.010063663125038147)","('Waste_And_Hazardous_Materials_Management', 0.0022647010628134012)","(['Privacy Protection'], 0.9590322375297546)","('NON-ESG', 0.010063663125038147)","('NON-ESG', 0.0022647010628134012)"
Line 323,"At the same time, the importance of  protecting patient privacy has never been higher.
","('Customer_Privacy', 0.48417091369628906)","('Data_Security', 0.3536837100982666)","('Competitive_Behavior', 0.013066945597529411)","('NON-ESG', 0.48417091369628906)","('NON-ESG', 0.3536837100982666)","('NON-ESG', 0.013066945597529411)"
Line 324,"At Zimmer Biomet, privacy is built into our products  by design and by default, and we work to ensure that  privacy measures are fully integrated into our products  and services.
","('Data_Security', 0.677415668964386)","('Customer_Privacy', 0.13197946548461914)","('Business_Ethics', 0.038171153515577316)","(['Information Security/Cybersecurity & System Availability'], 0.677415668964386)","('NON-ESG', 0.13197946548461914)","('NON-ESG', 0.038171153515577316)"
Line 325,"By taking this approach, Zimmer Biomet  products and services accommodate privacy in an  effective and user-friendly way.
","('Customer_Privacy', 0.5211467146873474)","('Data_Security', 0.18549421429634094)","('Product_Design_And_Lifecycle_Management', 0.05656953528523445)","(['Privacy Protection'], 0.5211467146873474)","('NON-ESG', 0.18549421429634094)","('NON-ESG', 0.05656953528523445)"
Line 326,"In 2020, Zimmer Biomet engaged with OneTrust, the  industry-leading privacy management solution, to  further embed privacy in our products and services.
","('Data_Security', 0.8489313125610352)","('Customer_Privacy', 0.05048765242099762)","('Business_Ethics', 0.01844196394085884)","(['Information Security/Cybersecurity & System Availability'], 0.8489313125610352)","('NON-ESG', 0.05048765242099762)","('NON-ESG', 0.01844196394085884)"
Line 327,"Our  mymobility platform, for example, is now supported  with a dedicated portal for individuals to exercise  their privacy rights, with user-friendly features such  as explanatory hovertext, local-language accessibility,  and automated identity verification.
","('Customer_Privacy', 0.8568996787071228)","('Data_Security', 0.07982899248600006)","('Business_Ethics', 0.004349201917648315)","(['Privacy Protection'], 0.8568996787071228)","('NON-ESG', 0.07982899248600006)","('NON-ESG', 0.004349201917648315)"
Line 328,"We want to make  it as easy as possible for patients to communicate their  privacy preferences.
","('Customer_Privacy', 0.9233664870262146)","('Data_Security', 0.022380579262971878)","('Business_Model_Resilience', 0.004277268890291452)","(['Privacy Protection'], 0.9233664870262146)","('NON-ESG', 0.022380579262971878)","('NON-ESG', 0.004277268890291452)"
Line 329,"17Data Security Zimmer Biomet implements and verifies stringent  security requirements to protect data we hold for  patients and customers.
","('Data_Security', 0.9609259963035583)","('Customer_Privacy', 0.004729439504444599)","('Systemic_Risk_Management', 0.0033591482788324356)","(['Information Security/Cybersecurity & System Availability'], 0.9609259963035583)","('NON-ESG', 0.004729439504444599)","('NON-ESG', 0.0033591482788324356)"
Line 330,"These include a broad array  of security controls, including encryption, third- party penetration testing, malware defenses, access  limitations and auditing.
","('Data_Security', 0.9560220837593079)","('Business_Ethics', 0.004423744976520538)","('Systemic_Risk_Management', 0.004305826034396887)","(['Information Security/Cybersecurity & System Availability'], 0.9560220837593079)","('NON-ESG', 0.004423744976520538)","('NON-ESG', 0.004305826034396887)"
Line 331,"We also have our compliance  with security requirements arising under Health  Insurance Portability and Accountability Act (HIPAA),  General Data Protection Regulation (GDPR), California  Consumer Privacy Act (CCPA), LGPD (Brazil) and other  key data protection regulations reviewed and verified  by third-party experts.
","('Data_Security', 0.9229016304016113)","('Customer_Privacy', 0.0129313375800848)","('Management_Of_Legal_And_Regulatory_Framework', 0.010858483612537384)","(['Information Security/Cybersecurity & System Availability'], 0.9229016304016113)","('NON-ESG', 0.0129313375800848)","('NON-ESG', 0.010858483612537384)"
Line 332,"We are transparent regarding  our security controls so that customers can understand  and document the ways in which their information is  protected.
","('Data_Security', 0.8358773589134216)","('Customer_Privacy', 0.09959106147289276)","('Business_Ethics', 0.007937760092318058)","(['Information Security/Cybersecurity & System Availability'], 0.8358773589134216)","('NON-ESG', 0.09959106147289276)","('NON-ESG', 0.007937760092318058)"
Line 333,"Data Usage Zimmer Biomet ensures that information is only  collected, used and disclosed for permissible purposes.
","('Customer_Privacy', 0.9505586624145508)","('Data_Security', 0.011575552634894848)","('Waste_And_Hazardous_Materials_Management', 0.0028929419349879026)","(['Privacy Protection'], 0.9505586624145508)","('NON-ESG', 0.011575552634894848)","('NON-ESG', 0.0028929419349879026)"
Line 334,"Through our contracts with customers, notice and  consent forms, and other means, we are transparent  about the ways we use information to create value for  patients and providers.
","('Customer_Privacy', 0.6884089112281799)","('Business_Ethics', 0.034861788153648376)","('Management_Of_Legal_And_Regulatory_Framework', 0.03374107927083969)","(['Privacy Protection'], 0.6884089112281799)","('NON-ESG', 0.034861788153648376)","('NON-ESG', 0.03374107927083969)"
Line 335,"We have implemented robust  policies, procedures and trainings designed to ensure  that patients’ and customers’ information is being  handled consistent with those statements.
","('Customer_Privacy', 0.8952218294143677)","('Data_Security', 0.010945957154035568)","('Business_Ethics', 0.010703458450734615)","(['Privacy Protection'], 0.8952218294143677)","('NON-ESG', 0.010945957154035568)","('NON-ESG', 0.010703458450734615)"
Line 336,"Ownership The patient, provider and Zimmer Biomet each have  rights and responsibilities regarding data collected in  the course of treatment.
","('Access_And_Affordability', 0.35224097967147827)","('Management_Of_Legal_And_Regulatory_Framework', 0.16817286610603333)","('Customer_Privacy', 0.05248146131634712)","('NON-ESG', 0.35224097967147827)","('NON-ESG', 0.16817286610603333)","('NON-ESG', 0.05248146131634712)"
Line 337,"Zimmer Biomet’s customer engagements, patient  consents and notices and other privacy and information  security practices are designed to ensure that these  rights and responsibilities are respected.Cybersecurity Zimmer Biomet understands a strong cybersecurity  program is essential in today’s business landscape and  has continued to invest in people, processes and next  generation cybersecurity technology solutions to combat  this evolving risk.
","('Data_Security', 0.9647848010063171)","('Customer_Privacy', 0.004920272622257471)","('Business_Ethics', 0.0029748438391834497)","(['Information Security/Cybersecurity & System Availability'], 0.9647848010063171)","('NON-ESG', 0.004920272622257471)","('NON-ESG', 0.0029748438391834497)"
Line 338,"Cyber threats will continue to emerge  and evolve, so we manage cyber-risks in alignment with  industry best practices.
","('Data_Security', 0.9238599538803101)","('Systemic_Risk_Management', 0.018250597640872)","('Physical_Impacts_Of_Climate_Change', 0.008444126695394516)","(['Information Security/Cybersecurity & System Availability'], 0.9238599538803101)","('NON-ESG', 0.018250597640872)","('NON-ESG', 0.008444126695394516)"
Line 339,"Our commitment to cybersecurity includes a programmatic  approach aiming to protect the confidentiality, integrity  and availability of our systems, data and products.
","('Data_Security', 0.9220349788665771)","('Customer_Privacy', 0.022896958515048027)","('Business_Ethics', 0.01214465219527483)","(['Information Security/Cybersecurity & System Availability'], 0.9220349788665771)","('NON-ESG', 0.022896958515048027)","('NON-ESG', 0.01214465219527483)"
Line 340,"This  continuous process ensures that measures are in place to  improve and update our cybersecurity program using key  methods such as independent assessments, penetration  testing, vulnerabilities scanning and obtaining key industry  certifications.
","('Data_Security', 0.9034045338630676)","('Systemic_Risk_Management', 0.02737531252205372)","('Business_Ethics', 0.011038735508918762)","(['Information Security/Cybersecurity & System Availability'], 0.9034045338630676)","('NON-ESG', 0.02737531252205372)","('NON-ESG', 0.011038735508918762)"
Line 341,"Zimmer Biomet has a dedicated global security operations  team that executes the cybersecurity incident response plan  and conducts regular exercises to gauge our preparedness  and effectiveness.
","('Critical_Incident_Risk_Management', 0.9566754698753357)","('Physical_Impacts_Of_Climate_Change', 0.005043535027652979)","('Employee_Health_And_Safety', 0.0037665190175175667)","(['Risk & Crisis Management'], 0.9566754698753357)","('NON-ESG', 0.005043535027652979)","('NON-ESG', 0.0037665190175175667)"
Line 342,"Utilizing our cybersecurity awareness  program, we have increased awareness of cyber threats to  users globally and continue to share best practices with all  our team members.
","('Data_Security', 0.954163134098053)","('Systemic_Risk_Management', 0.0052323052659630775)","('Physical_Impacts_Of_Climate_Change', 0.004203826189041138)","(['Information Security/Cybersecurity & System Availability'], 0.954163134098053)","('NON-ESG', 0.0052323052659630775)","('NON-ESG', 0.004203826189041138)"
Line 343,"The cybersecurity program is led by Zimmer Biomet’s Chief  Information Security Officer and the Chief Information  Officer, and regular progress updates are presented to the  Audit Committee of the Board of Directors.
","('Data_Security', 0.9400296211242676)","('Systemic_Risk_Management', 0.0073315356858074665)","('Director_Removal', 0.004758727271109819)","(['Information Security/Cybersecurity & System Availability'], 0.9400296211242676)","('NON-ESG', 0.0073315356858074665)","('NON-ESG', 0.004758727271109819)"
Line 344,"18Corporate Governance At Zimmer Biomet, the way we conduct our business is  critically important.
","('Business_Model_Resilience', 0.6100755333900452)","('Systemic_Risk_Management', 0.08236078172922134)","('Management_Of_Legal_And_Regulatory_Framework', 0.05668500438332558)","(['Codes of Business Conduct'], 0.6100755333900452)","('NON-ESG', 0.08236078172922134)","('NON-ESG', 0.05668500438332558)"
Line 345,"We are committed to effective corporate  governance, adhering to the highest ethical standards and  acting as a responsible member of our communities.
","('Business_Ethics', 0.8418020009994507)","('Management_Of_Legal_And_Regulatory_Framework', 0.03471403568983078)","('Human_Rights_And_Community_Relations', 0.02312890999019146)","(['Business Ethics'], 0.8418020009994507)","('NON-ESG', 0.03471403568983078)","('NON-ESG', 0.02312890999019146)"
Line 346,"Our business is managed under the direction of our Board  of Directors.
","('Director_Removal', 0.701603353023529)","('Management_Of_Legal_And_Regulatory_Framework', 0.037501491606235504)","('Business_Model_Resilience', 0.026772266253829002)","(['Anti-Crime Policy & Measures'], 0.701603353023529)","('NON-ESG', 0.037501491606235504)","('NON-ESG', 0.026772266253829002)"
Line 347,"The Board has responsibility for establishing  broad corporate policies and for our overall performance.
","('Management_Of_Legal_And_Regulatory_Framework', 0.398286372423172)","('Director_Removal', 0.2226479947566986)","('Business_Model_Resilience', 0.06118100509047508)","('NON-ESG', 0.398286372423172)","('NON-ESG', 0.2226479947566986)","('NON-ESG', 0.06118100509047508)"
Line 348,"As of May 15, 2021, our Board is made up of ten Directors.
","('Director_Removal', 0.7590612173080444)","('Management_Of_Legal_And_Regulatory_Framework', 0.025518517941236496)","('Employee_Engagement_Inclusion_And_Diversity', 0.02108665741980076)","(['Anti-Crime Policy & Measures'], 0.7590612173080444)","('NON-ESG', 0.025518517941236496)","('NON-ESG', 0.02108665741980076)"
Line 349,"Directors are nominated based on their skills, experiences,  backgrounds and the needs of the Board and our Company.
","('Employee_Engagement_Inclusion_And_Diversity', 0.7821608781814575)","('Director_Removal', 0.05778435617685318)","('Business_Model_Resilience', 0.01684986799955368)","(['Human Capital Development'], 0.7821608781814575)","('NON-ESG', 0.05778435617685318)","('NON-ESG', 0.01684986799955368)"
Line 350,"Every Director must stand for election annually.
","('Director_Removal', 0.7801920175552368)","('Management_Of_Legal_And_Regulatory_Framework', 0.03126776963472366)","('Data_Security', 0.015798041597008705)","(['Anti-Crime Policy & Measures'], 0.7801920175552368)","('NON-ESG', 0.03126776963472366)","('NON-ESG', 0.015798041597008705)"
Line 351,"At all times,  a majority of the Board of Directors must meet the criteria  for independence established by applicable laws and  regulations and the New York Stock Exchange.
","('Director_Removal', 0.7151802182197571)","('Management_Of_Legal_And_Regulatory_Framework', 0.10491600632667542)","('Business_Ethics', 0.01913800835609436)","(['Anti-Crime Policy & Measures'], 0.7151802182197571)","('NON-ESG', 0.10491600632667542)","('NON-ESG', 0.01913800835609436)"
Line 352,"All of our  Directors, except our Chairman, are independent.
","('Director_Removal', 0.7449613809585571)","('Business_Ethics', 0.026236461475491524)","('Management_Of_Legal_And_Regulatory_Framework', 0.022394293919205666)","(['Anti-Crime Policy & Measures'], 0.7449613809585571)","('NON-ESG', 0.026236461475491524)","('NON-ESG', 0.022394293919205666)"
Line 353,"Directors are recruited to strengthen the Board’s diversity  and ensure that the Board reflects and understands the  diverse perspectives of Zimmer Biomet’s stakeholders  around the globe.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9229373335838318)","('Director_Removal', 0.012295958586037159)","('Business_Model_Resilience', 0.006311529781669378)","(['Human Capital Development'], 0.9229373335838318)","('NON-ESG', 0.012295958586037159)","('NON-ESG', 0.006311529781669378)"
Line 354,"Three of our ten Directors (30%) are  women, three (30%) are ethnically diverse, one (10%)  identifies as LGBTQ+, and four (40%) were born outside the  United States.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9696404933929443)","('Human_Rights_And_Community_Relations', 0.0026358463801443577)","('Customer_Privacy', 0.00260187778621912)","(['Human Capital Development'], 0.9696404933929443)","('NON-ESG', 0.0026358463801443577)","('NON-ESG', 0.00260187778621912)"
Line 355,"Further, of our four Board committees, one  (25%) is chaired by a woman.
","('Director_Removal', 0.7284014821052551)","('Management_Of_Legal_And_Regulatory_Framework', 0.03822455182671547)","('Employee_Engagement_Inclusion_And_Diversity', 0.026473360136151314)","(['Anti-Crime Policy & Measures'], 0.7284014821052551)","('NON-ESG', 0.03822455182671547)","('NON-ESG', 0.026473360136151314)"
Line 356,"The Board recognizes the importance of having a  strong independent Board leadership structure to  ensure accountability.
","('Director_Removal', 0.678568959236145)","('Management_Of_Legal_And_Regulatory_Framework', 0.05541551858186722)","('Employee_Engagement_Inclusion_And_Diversity', 0.036069728434085846)","(['Anti-Crime Policy & Measures'], 0.678568959236145)","('NON-ESG', 0.05541551858186722)","('NON-ESG', 0.036069728434085846)"
Line 357,"Accordingly, our Corporate  Governance Guidelines provide for the appointment of  a Lead Independent Director when the Chairman is not  independent.
","('Director_Removal', 0.7563479542732239)","('Management_Of_Legal_And_Regulatory_Framework', 0.059638239443302155)","('Business_Ethics', 0.023018550127744675)","(['Anti-Crime Policy & Measures'], 0.7563479542732239)","('NON-ESG', 0.059638239443302155)","('NON-ESG', 0.023018550127744675)"
Line 358,"The Board believes that a Lead Independent  Director is an integral part of our Board structure and  facilitates the effective performance of the Board in its  role of providing governance and oversight.
","('Director_Removal', 0.7442052960395813)","('Management_Of_Legal_And_Regulatory_Framework', 0.053541552275419235)","('Business_Ethics', 0.022066792473196983)","(['Anti-Crime Policy & Measures'], 0.7442052960395813)","('NON-ESG', 0.053541552275419235)","('NON-ESG', 0.022066792473196983)"
Line 359,"Among other  duties and responsibilities, the Lead Independent Director  convenes and presides at meetings of the independent  Directors, including executive sessions of the independent Directors held in conjunction with each regularly scheduled  Board meeting, reviews and provides input on meeting  agendas for the Board and its committees, and provides  feedback on the flow of information from management to  the Board.
","('Director_Removal', 0.7663798332214355)","('Management_Of_Legal_And_Regulatory_Framework', 0.04384386166930199)","('Employee_Engagement_Inclusion_And_Diversity', 0.017106035724282265)","(['Anti-Crime Policy & Measures'], 0.7663798332214355)","('NON-ESG', 0.04384386166930199)","('NON-ESG', 0.017106035724282265)"
Line 360,"The Lead Independent Director is also available,  as appropriate, for direct communication with shareholders.
","('Director_Removal', 0.7693650126457214)","('Management_Of_Legal_And_Regulatory_Framework', 0.02959505096077919)","('Business_Ethics', 0.021000778302550316)","(['Anti-Crime Policy & Measures'], 0.7693650126457214)","('NON-ESG', 0.02959505096077919)","('NON-ESG', 0.021000778302550316)"
Line 361,"Zimmer Biomet has developed risk management processes  designed to promote long-term shareholder value with  oversight by the Board of Directors.
","('Director_Removal', 0.33319148421287537)","('Business_Model_Resilience', 0.20624631643295288)","('Systemic_Risk_Management', 0.08106018602848053)","('NON-ESG', 0.33319148421287537)","('NON-ESG', 0.20624631643295288)","('NON-ESG', 0.08106018602848053)"
Line 362,"Sustainability topics are  incorporated into our risk management processes.
","('Systemic_Risk_Management', 0.6177071928977966)","('Business_Model_Resilience', 0.1688656359910965)","('Physical_Impacts_Of_Climate_Change', 0.04687610641121864)","(['Risk & Crisis Management'], 0.6177071928977966)","('NON-ESG', 0.1688656359910965)","('NON-ESG', 0.04687610641121864)"
Line 363,"Various  executive leadership team members have responsibility  for implementing processes designed to identify, evaluate,  mitigate and monitor risks.
","('Systemic_Risk_Management', 0.8523192405700684)","('Physical_Impacts_Of_Climate_Change', 0.0400557778775692)","('Business_Model_Resilience', 0.019334973767399788)","(['Risk & Crisis Management'], 0.8523192405700684)","('NON-ESG', 0.0400557778775692)","('NON-ESG', 0.019334973767399788)"
Line 364,"Reviews of key risks occur at  regularly scheduled meetings of the Board of Directors  and its committees.
","('Director_Removal', 0.6885661482810974)","('Management_Of_Legal_And_Regulatory_Framework', 0.06268083304166794)","('Business_Ethics', 0.0324234813451767)","(['Anti-Crime Policy & Measures'], 0.6885661482810974)","('NON-ESG', 0.06268083304166794)","('NON-ESG', 0.0324234813451767)"
Line 365,"The Board executes its oversight  responsibility for risk management directly and through its  committees: Audit Committee Oversight Areas: • The integrity of our financial statements • The performance of our Internal Audit function • Our compliance with legal and regulatory  requirements • Our Corporate Compliance Program • Privacy, data security, business continuity and  cybersecurity-related risk exposures Compensation and Management   Development Committee Oversight Areas: • The compensation of our senior executives • Our incentive and equity-based compensation plans  and programs • Senior management talent and development plans (in  conjunction with the full Board) • Our policies and strategies relating to human capital  management (in conjunction with the full Board) GOVERNANCE19Corporate Governance Committee Oversight Areas: • Our public policy, government relations and advocacy  activities • Our sustainability activities, including initiatives  related to the environment • Our community relations activities and charitable  contributions • Our initiatives related to promoting access to  healthcare and other social responsibility issues Quality, Regulatory and Technology Committee Oversight Areas: • Product quality and safety • Risks relating to our compliance with laws and  regulations enforced by the U.S. Food and Drug  Administration and comparable foreign government  regulators • Research, innovation and technology initiatives Executive Compensation Our executives receive fixed compensation (base salary),  as well as short-term and long-term performance-based  compensation.
","('Business_Ethics', 0.9083042740821838)","('Management_Of_Legal_And_Regulatory_Framework', 0.01917598955333233)","('Data_Security', 0.018181119114160538)","(['Business Ethics'], 0.9083042740821838)","('NON-ESG', 0.01917598955333233)","('NON-ESG', 0.018181119114160538)"
Line 366,"The Board executes its oversight  responsibility for risk management directly and through its  committees: Audit Committee Oversight Areas: • The integrity of our financial statements • The performance of our Internal Audit function • Our compliance with legal and regulatory  requirements • Our Corporate Compliance Program • Privacy, data security, business continuity and  cybersecurity-related risk exposures Compensation and Management   Development Committee Oversight Areas: • The compensation of our senior executives • Our incentive and equity-based compensation plans  and programs • Senior management talent and development plans (in  conjunction with the full Board) • Our policies and strategies relating to human capital  management (in conjunction with the full Board) GOVERNANCE19Corporate Governance Committee Oversight Areas: • Our public policy, government relations and advocacy  activities • Our sustainability activities, including initiatives  related to the environment • Our community relations activities and charitable  contributions • Our initiatives related to promoting access to  healthcare and other social responsibility issues Quality, Regulatory and Technology Committee Oversight Areas: • Product quality and safety • Risks relating to our compliance with laws and  regulations enforced by the U.S. Food and Drug  Administration and comparable foreign government  regulators • Research, innovation and technology initiatives Executive Compensation Our executives receive fixed compensation (base salary),  as well as short-term and long-term performance-based  compensation.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3810577094554901)","('Director_Removal', 0.23652859032154083)","('Employee_Engagement_Inclusion_And_Diversity', 0.0686078667640686)","('NON-ESG', 0.3810577094554901)","('NON-ESG', 0.23652859032154083)","('NON-ESG', 0.0686078667640686)"
Line 367,"The Board executes its oversight  responsibility for risk management directly and through its  committees: Audit Committee Oversight Areas: • The integrity of our financial statements • The performance of our Internal Audit function • Our compliance with legal and regulatory  requirements • Our Corporate Compliance Program • Privacy, data security, business continuity and  cybersecurity-related risk exposures Compensation and Management   Development Committee Oversight Areas: • The compensation of our senior executives • Our incentive and equity-based compensation plans  and programs • Senior management talent and development plans (in  conjunction with the full Board) • Our policies and strategies relating to human capital  management (in conjunction with the full Board) GOVERNANCE19Corporate Governance Committee Oversight Areas: • Our public policy, government relations and advocacy  activities • Our sustainability activities, including initiatives  related to the environment • Our community relations activities and charitable  contributions • Our initiatives related to promoting access to  healthcare and other social responsibility issues Quality, Regulatory and Technology Committee Oversight Areas: • Product quality and safety • Risks relating to our compliance with laws and  regulations enforced by the U.S. Food and Drug  Administration and comparable foreign government  regulators • Research, innovation and technology initiatives Executive Compensation Our executives receive fixed compensation (base salary),  as well as short-term and long-term performance-based  compensation.
","('Product_Quality_And_Safety', 0.9071233868598938)","('Product_Design_And_Lifecycle_Management', 0.012978609651327133)","('Selling_Practices_And_Product_Labeling', 0.012618319131433964)","(['Product Quality & Recall Management'], 0.9071233868598938)","('NON-ESG', 0.012978609651327133)","('NON-ESG', 0.012618319131433964)"
Line 368,"The Board executes its oversight  responsibility for risk management directly and through its  committees: Audit Committee Oversight Areas: • The integrity of our financial statements • The performance of our Internal Audit function • Our compliance with legal and regulatory  requirements • Our Corporate Compliance Program • Privacy, data security, business continuity and  cybersecurity-related risk exposures Compensation and Management   Development Committee Oversight Areas: • The compensation of our senior executives • Our incentive and equity-based compensation plans  and programs • Senior management talent and development plans (in  conjunction with the full Board) • Our policies and strategies relating to human capital  management (in conjunction with the full Board) GOVERNANCE19Corporate Governance Committee Oversight Areas: • Our public policy, government relations and advocacy  activities • Our sustainability activities, including initiatives  related to the environment • Our community relations activities and charitable  contributions • Our initiatives related to promoting access to  healthcare and other social responsibility issues Quality, Regulatory and Technology Committee Oversight Areas: • Product quality and safety • Risks relating to our compliance with laws and  regulations enforced by the U.S. Food and Drug  Administration and comparable foreign government  regulators • Research, innovation and technology initiatives Executive Compensation Our executives receive fixed compensation (base salary),  as well as short-term and long-term performance-based  compensation.
","('Labor_Practices', 0.7170709371566772)","('Employee_Engagement_Inclusion_And_Diversity', 0.042179979383945465)","('Human_Rights_And_Community_Relations', 0.03757394477725029)","(['Labor Practice Indicators'], 0.7170709371566772)","('NON-ESG', 0.042179979383945465)","('NON-ESG', 0.03757394477725029)"
Line 369,"Applicable performance metrics and targets  align executives’ interests with those of Zimmer Biomet  shareholders and are approved by the Compensation and  Management Development Committee of our Board of  Directors.
","('Director_Removal', 0.615310788154602)","('Management_Of_Legal_And_Regulatory_Framework', 0.05455389618873596)","('Business_Model_Resilience', 0.046544209122657776)","(['Anti-Crime Policy & Measures'], 0.615310788154602)","('NON-ESG', 0.05455389618873596)","('NON-ESG', 0.046544209122657776)"
Line 370,"We are committed to the highest standards of patient safety  and quality in our products and services and to world-class  integrity and ethical business practices.
","('Product_Quality_And_Safety', 0.9009372591972351)","('Product_Design_And_Lifecycle_Management', 0.01297296304255724)","('Selling_Practices_And_Product_Labeling', 0.011710074730217457)","(['Product Quality & Recall Management'], 0.9009372591972351)","('NON-ESG', 0.01297296304255724)","('NON-ESG', 0.011710074730217457)"
Line 371,"In support of this  commitment, and to drive accountability for compliance  with, and sustained improvements in, our global quality  system, the Compensation and Management Development  Committee included a global quality bonus modifier  component to executives’ annual cash incentive plan in  2020.
","('Business_Ethics', 0.46340668201446533)","('Management_Of_Legal_And_Regulatory_Framework', 0.3696056306362152)","('Labor_Practices', 0.026894787326455116)","('NON-ESG', 0.46340668201446533)","('NON-ESG', 0.3696056306362152)","('NON-ESG', 0.026894787326455116)"
Line 372,"The modifier was designed such that, based on the  achievement of specified global quality metrics related to our FDA inspection results, it could result in a decrease (but  not an increase) to executives’ 2020 bonus payouts by up  to five percent (5%).
","('Labor_Practices', 0.7663612365722656)","('Business_Ethics', 0.06481028348207474)","('Management_Of_Legal_And_Regulatory_Framework', 0.026679374277591705)","(['Labor Practice Indicators'], 0.7663612365722656)","('NON-ESG', 0.06481028348207474)","('NON-ESG', 0.026679374277591705)"
Line 373,"In 2020, across our global network,  we resolved one FDA Warning Letter, we received no new  FDA Warning Letters and our average number of Form 483  observations per inspection was less than 3.0. As a result,  the global quality bonus modifier had no impact on our  executives’ 2020 bonus payouts.
","('Management_Of_Legal_And_Regulatory_Framework', 0.43146201968193054)","('Labor_Practices', 0.2636929452419281)","('Business_Ethics', 0.10518244653940201)","('NON-ESG', 0.43146201968193054)","('NON-ESG', 0.2636929452419281)","('NON-ESG', 0.10518244653940201)"
Line 374,"For more information on our executive compensation  philosophy and programs, please see our 2021 proxy  statement   Ethical Business Conduct  At Zimmer Biomet, we are committed to being a leader in  the area of ethics and compliance.
","('Business_Ethics', 0.9715776443481445)","('Management_Of_Legal_And_Regulatory_Framework', 0.0025523738004267216)","('Product_Quality_And_Safety', 0.0025313447695225477)","(['Business Ethics'], 0.9715776443481445)","('NON-ESG', 0.0025523738004267216)","('NON-ESG', 0.0025313447695225477)"
Line 375,"Every day we strive for  the highest standards of patient safety, quality and integrity  in all that we do.
","('Product_Quality_And_Safety', 0.5497316122055054)","('Employee_Health_And_Safety', 0.2729124128818512)","('Access_And_Affordability', 0.018650241196155548)","(['Product Quality & Recall Management'], 0.5497316122055054)","('NON-ESG', 0.2729124128818512)","('NON-ESG', 0.018650241196155548)"
Line 376,"Whether working with surgeons, regulators, distributors,  partners or fellow team members, we know that what we do  to contribute to the company’s Mission is just as important  as how we do it.
","('Management_Of_Legal_And_Regulatory_Framework', 0.2611815929412842)","('Business_Model_Resilience', 0.19377732276916504)","('Human_Rights_And_Community_Relations', 0.09059713035821915)","('NON-ESG', 0.2611815929412842)","('NON-ESG', 0.19377732276916504)","('NON-ESG', 0.09059713035821915)"
Line 377,"This was especially true during the last year as Zimmer  Biomet navigated the challenges associated with the  COVID-19 pandemic.
","('Physical_Impacts_Of_Climate_Change', 0.40927350521087646)","('Systemic_Risk_Management', 0.13040772080421448)","('Critical_Incident_Risk_Management', 0.08038794994354248)","('NON-ESG', 0.40927350521087646)","('NON-ESG', 0.13040772080421448)","('NON-ESG', 0.08038794994354248)"
Line 378,"Leadership and team members  alike remained focused on doing business the right way to  uphold our high ethical standards as we transitioned many  of our in-person healthcare professional interactions and  training to virtual settings.
","('Business_Ethics', 0.7300460338592529)","('Human_Rights_And_Community_Relations', 0.05110098049044609)","('Employee_Engagement_Inclusion_And_Diversity', 0.02816101722419262)","(['Business Ethics'], 0.7300460338592529)","('NON-ESG', 0.05110098049044609)","('NON-ESG', 0.02816101722419262)"
Line 379,"Our commitment to doing business with integrity is guided  by our comprehensive compliance policies and procedures  which help team members navigate the applicable laws,  regulations and industry codes, as well as Zimmer Biomet’s  own ethical standards.
","('Business_Ethics', 0.9552422761917114)","('Management_Of_Legal_And_Regulatory_Framework', 0.012964325025677681)","('Product_Quality_And_Safety', 0.0037301485426723957)","(['Business Ethics'], 0.9552422761917114)","('NON-ESG', 0.012964325025677681)","('NON-ESG', 0.0037301485426723957)"
Line 380,"These standards are outlined in  Zimmer Biomet’s Code of Business Conduct and Ethics.
","('Business_Ethics', 0.9710025787353516)","('Management_Of_Legal_And_Regulatory_Framework', 0.002705718157812953)","('Director_Removal', 0.0023086932487785816)","(['Business Ethics'], 0.9710025787353516)","('NON-ESG', 0.002705718157812953)","('NON-ESG', 0.0023086932487785816)"
Line 381,"20The Code defines ZB’s approach to delivering high  performance with high integrity and articulates the ethical  standards by which team members are held accountable.
","('Business_Ethics', 0.9484220147132874)","('Human_Rights_And_Community_Relations', 0.00458233617246151)","('Product_Quality_And_Safety', 0.003866999177262187)","(['Business Ethics'], 0.9484220147132874)","('NON-ESG', 0.00458233617246151)","('NON-ESG', 0.003866999177262187)"
Line 382,"It also guides and inspires positive interactions with  customers and with people in the communities in which we  live and work.
","('Human_Rights_And_Community_Relations', 0.9326108694076538)","('Access_And_Affordability', 0.011638911440968513)","('Employee_Engagement_Inclusion_And_Diversity', 0.007027554791420698)","(['Community Relations'], 0.9326108694076538)","('NON-ESG', 0.011638911440968513)","('NON-ESG', 0.007027554791420698)"
Line 383,"To ensure that every team member understands and is  accountable for our Code, Zimmer Biomet: • Provides the Code in 31 languages so team members  can read it in their first language • Requires training on the Code for all new hires within  60 days of their start date and retrains all existing team  members on the Code annually 100% COMPLETED ETHICS TRAININGIn 2020:  • 100 percent of team  members successfully  completed the Code   of Business Conduct   & Ethics training Since 2016, Zimmer Biomet has conducted an annual  Compliance Week to further strengthen our compliance  culture by engaging team members across the globe with  activities and communications that promote ethics and  integrity.
","('Business_Ethics', 0.956046462059021)","('Product_Quality_And_Safety', 0.004671212751418352)","('Data_Security', 0.0035821187775582075)","(['Business Ethics'], 0.956046462059021)","('NON-ESG', 0.004671212751418352)","('NON-ESG', 0.0035821187775582075)"
Line 384,"To ensure that every team member understands and is  accountable for our Code, Zimmer Biomet: • Provides the Code in 31 languages so team members  can read it in their first language • Requires training on the Code for all new hires within  60 days of their start date and retrains all existing team  members on the Code annually 100% COMPLETED ETHICS TRAININGIn 2020:  • 100 percent of team  members successfully  completed the Code   of Business Conduct   & Ethics training Since 2016, Zimmer Biomet has conducted an annual  Compliance Week to further strengthen our compliance  culture by engaging team members across the globe with  activities and communications that promote ethics and  integrity.
","('Business_Ethics', 0.9688796997070312)","('Management_Of_Legal_And_Regulatory_Framework', 0.003480224870145321)","('Product_Quality_And_Safety', 0.0025465560611337423)","(['Business Ethics'], 0.9688796997070312)","('NON-ESG', 0.003480224870145321)","('NON-ESG', 0.0025465560611337423)"
Line 385,"In 2020: • Team members embraced the virtual format of the  Compliance Week celebration by: ◊ Tuning in to watch the Integrity in Action  Compliance Conversations video series between  our Compliance leadership and some of Zimmer  Biomet’s most important stakeholders ◊ Participating in local and global activities  highlighting how to put integrity into action In addition, Zimmer Biomet is committed to compliance  with a variety of industry codes designed to ensure that  relationships with healthcare professionals and other  customers are conducted in accordance with the highest  ethical standards and transparency.
","('Business_Ethics', 0.9455967545509338)","('Management_Of_Legal_And_Regulatory_Framework', 0.01372571848332882)","('Product_Quality_And_Safety', 0.004835474770516157)","(['Business Ethics'], 0.9455967545509338)","('NON-ESG', 0.01372571848332882)","('NON-ESG', 0.004835474770516157)"
Line 386,"In 2020: • Team members embraced the virtual format of the  Compliance Week celebration by: ◊ Tuning in to watch the Integrity in Action  Compliance Conversations video series between  our Compliance leadership and some of Zimmer  Biomet’s most important stakeholders ◊ Participating in local and global activities  highlighting how to put integrity into action In addition, Zimmer Biomet is committed to compliance  with a variety of industry codes designed to ensure that  relationships with healthcare professionals and other  customers are conducted in accordance with the highest  ethical standards and transparency.
","('Business_Ethics', 0.9680033922195435)","('Data_Security', 0.002524233888834715)","('Labor_Practices', 0.002364006359130144)","(['Business Ethics'], 0.9680033922195435)","('NON-ESG', 0.002524233888834715)","('NON-ESG', 0.002364006359130144)"
Line 387,"We endorse and  are committed to complying with the relevant codes for  industry associations of which Zimmer Biomet is a member,  including: • ABHI (UK)  • ABIMED Code of Conduct (Brazil) • ABIMO (Brazil) • ABRAIDI (Brazil) • AdvaMed China (China) • AdvaMed Code of Ethics (United States) • American Medical Devices and Diagnostics  Manufacturers’ Association (Japan)  • AMID (Mexico) • APOMED (Portugal)  • ARTED (Turkey) • Austromed: Verhaltenskodex (Austria) • beMedTech (Belgium) • BVMed: Kodex Medizinprodukte (Germany) • CANIFARMA (Mexico) • Confindustria dispositivi medici (Italy) • CZECHMED (Czech Republic)  • Fenin Code of Ethics (Spain) • IMEDA (CIS)  • Instituto Ética Saúde (Brazil) • Korea Medical Devices Industry Association (Korea)  • Mecomed Code of Ethical Business Practice   (Middle East) • Medical Technology Association of India (India)  • Medical Technology Industry Group (Singapore)  • Medicoindustrien (Denmark) • MedTech Europe: Code of Ethical Business Practice • MedTech Sweden (Sweden) • MTAA Code of Practice (Australia)  • MTANZ Code of Practice (New Zealand)  • Nefemed (Netherlands) • ORDER (Turkey)  • Salib-MedTech (Finland)  • SAMED: Medical Device Code of Ethical Marketing  and Business Practice (South Africa) • SNITEM (France) • Swiss Medtech (Switzerland) • Taiwan Advanced Medical Technology Association  (TAMTA) Code (Taiwan) • Thai Medical Device Technology Industry  Association (Thailand)21Countering Corruption The cornerstone of our best-in-class compliance program  is Zimmer Biomet’s commitment to ensuring that team  members and business partners conduct themselves  ethically and in compliance with all applicable laws,  regulations, industry codes, and company policies,  including refraining from any bribery, kickback or  corruption-related activities.
","('Product_Quality_And_Safety', 0.33170413970947266)","('Business_Ethics', 0.1695200502872467)","('Competitive_Behavior', 0.13714061677455902)","('NON-ESG', 0.33170413970947266)","('NON-ESG', 0.1695200502872467)","('NON-ESG', 0.13714061677455902)"
Line 388,"We endorse and  are committed to complying with the relevant codes for  industry associations of which Zimmer Biomet is a member,  including: • ABHI (UK)  • ABIMED Code of Conduct (Brazil) • ABIMO (Brazil) • ABRAIDI (Brazil) • AdvaMed China (China) • AdvaMed Code of Ethics (United States) • American Medical Devices and Diagnostics  Manufacturers’ Association (Japan)  • AMID (Mexico) • APOMED (Portugal)  • ARTED (Turkey) • Austromed: Verhaltenskodex (Austria) • beMedTech (Belgium) • BVMed: Kodex Medizinprodukte (Germany) • CANIFARMA (Mexico) • Confindustria dispositivi medici (Italy) • CZECHMED (Czech Republic)  • Fenin Code of Ethics (Spain) • IMEDA (CIS)  • Instituto Ética Saúde (Brazil) • Korea Medical Devices Industry Association (Korea)  • Mecomed Code of Ethical Business Practice   (Middle East) • Medical Technology Association of India (India)  • Medical Technology Industry Group (Singapore)  • Medicoindustrien (Denmark) • MedTech Europe: Code of Ethical Business Practice • MedTech Sweden (Sweden) • MTAA Code of Practice (Australia)  • MTANZ Code of Practice (New Zealand)  • Nefemed (Netherlands) • ORDER (Turkey)  • Salib-MedTech (Finland)  • SAMED: Medical Device Code of Ethical Marketing  and Business Practice (South Africa) • SNITEM (France) • Swiss Medtech (Switzerland) • Taiwan Advanced Medical Technology Association  (TAMTA) Code (Taiwan) • Thai Medical Device Technology Industry  Association (Thailand)21Countering Corruption The cornerstone of our best-in-class compliance program  is Zimmer Biomet’s commitment to ensuring that team  members and business partners conduct themselves  ethically and in compliance with all applicable laws,  regulations, industry codes, and company policies,  including refraining from any bribery, kickback or  corruption-related activities.
","('Business_Ethics', 0.8913508653640747)","('Competitive_Behavior', 0.014774029143154621)","('Product_Quality_And_Safety', 0.011400534771382809)","(['Business Ethics'], 0.8913508653640747)","('NON-ESG', 0.014774029143154621)","('NON-ESG', 0.011400534771382809)"
Line 389,"We endorse and  are committed to complying with the relevant codes for  industry associations of which Zimmer Biomet is a member,  including: • ABHI (UK)  • ABIMED Code of Conduct (Brazil) • ABIMO (Brazil) • ABRAIDI (Brazil) • AdvaMed China (China) • AdvaMed Code of Ethics (United States) • American Medical Devices and Diagnostics  Manufacturers’ Association (Japan)  • AMID (Mexico) • APOMED (Portugal)  • ARTED (Turkey) • Austromed: Verhaltenskodex (Austria) • beMedTech (Belgium) • BVMed: Kodex Medizinprodukte (Germany) • CANIFARMA (Mexico) • Confindustria dispositivi medici (Italy) • CZECHMED (Czech Republic)  • Fenin Code of Ethics (Spain) • IMEDA (CIS)  • Instituto Ética Saúde (Brazil) • Korea Medical Devices Industry Association (Korea)  • Mecomed Code of Ethical Business Practice   (Middle East) • Medical Technology Association of India (India)  • Medical Technology Industry Group (Singapore)  • Medicoindustrien (Denmark) • MedTech Europe: Code of Ethical Business Practice • MedTech Sweden (Sweden) • MTAA Code of Practice (Australia)  • MTANZ Code of Practice (New Zealand)  • Nefemed (Netherlands) • ORDER (Turkey)  • Salib-MedTech (Finland)  • SAMED: Medical Device Code of Ethical Marketing  and Business Practice (South Africa) • SNITEM (France) • Swiss Medtech (Switzerland) • Taiwan Advanced Medical Technology Association  (TAMTA) Code (Taiwan) • Thai Medical Device Technology Industry  Association (Thailand)21Countering Corruption The cornerstone of our best-in-class compliance program  is Zimmer Biomet’s commitment to ensuring that team  members and business partners conduct themselves  ethically and in compliance with all applicable laws,  regulations, industry codes, and company policies,  including refraining from any bribery, kickback or  corruption-related activities.
","('Business_Ethics', 0.9066738486289978)","('Product_Quality_And_Safety', 0.01797403022646904)","('Competitive_Behavior', 0.010315469466149807)","(['Business Ethics'], 0.9066738486289978)","('NON-ESG', 0.01797403022646904)","('NON-ESG', 0.010315469466149807)"
Line 390,"We endorse and  are committed to complying with the relevant codes for  industry associations of which Zimmer Biomet is a member,  including: • ABHI (UK)  • ABIMED Code of Conduct (Brazil) • ABIMO (Brazil) • ABRAIDI (Brazil) • AdvaMed China (China) • AdvaMed Code of Ethics (United States) • American Medical Devices and Diagnostics  Manufacturers’ Association (Japan)  • AMID (Mexico) • APOMED (Portugal)  • ARTED (Turkey) • Austromed: Verhaltenskodex (Austria) • beMedTech (Belgium) • BVMed: Kodex Medizinprodukte (Germany) • CANIFARMA (Mexico) • Confindustria dispositivi medici (Italy) • CZECHMED (Czech Republic)  • Fenin Code of Ethics (Spain) • IMEDA (CIS)  • Instituto Ética Saúde (Brazil) • Korea Medical Devices Industry Association (Korea)  • Mecomed Code of Ethical Business Practice   (Middle East) • Medical Technology Association of India (India)  • Medical Technology Industry Group (Singapore)  • Medicoindustrien (Denmark) • MedTech Europe: Code of Ethical Business Practice • MedTech Sweden (Sweden) • MTAA Code of Practice (Australia)  • MTANZ Code of Practice (New Zealand)  • Nefemed (Netherlands) • ORDER (Turkey)  • Salib-MedTech (Finland)  • SAMED: Medical Device Code of Ethical Marketing  and Business Practice (South Africa) • SNITEM (France) • Swiss Medtech (Switzerland) • Taiwan Advanced Medical Technology Association  (TAMTA) Code (Taiwan) • Thai Medical Device Technology Industry  Association (Thailand)21Countering Corruption The cornerstone of our best-in-class compliance program  is Zimmer Biomet’s commitment to ensuring that team  members and business partners conduct themselves  ethically and in compliance with all applicable laws,  regulations, industry codes, and company policies,  including refraining from any bribery, kickback or  corruption-related activities.
","('Business_Ethics', 0.976049542427063)","('Management_Of_Legal_And_Regulatory_Framework', 0.0023762015625834465)","('Competitive_Behavior', 0.0019138162024319172)","(['Business Ethics'], 0.976049542427063)","('NON-ESG', 0.0023762015625834465)","('NON-ESG', 0.0019138162024319172)"
Line 391,"The Company has established anti-bribery and anti- corruption policies and procedures that cover, among  other things, interactions with healthcare providers and  government officials.
","('Business_Ethics', 0.9751756191253662)","('Management_Of_Legal_And_Regulatory_Framework', 0.002743443939834833)","('Competitive_Behavior', 0.0019408288644626737)","(['Business Ethics'], 0.9751756191253662)","('NON-ESG', 0.002743443939834833)","('NON-ESG', 0.0019408288644626737)"
Line 392,"These policies and procedures are  reinforced by a robust training program as well as periodic  auditing and monitoring.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9203569293022156)","('Human_Rights_And_Community_Relations', 0.01307594496756792)","('Business_Ethics', 0.010948056355118752)","(['Corporate Governance'], 0.9203569293022156)","('NON-ESG', 0.01307594496756792)","('NON-ESG', 0.010948056355118752)"
Line 393,"Zimmer Biomet has a zero  -tolerance policy when it comes to bribery and corruption.
","('Business_Ethics', 0.9743273854255676)","('Competitive_Behavior', 0.0022987471893429756)","('Management_Of_Legal_And_Regulatory_Framework', 0.0020360175985842943)","(['Business Ethics'], 0.9743273854255676)","('NON-ESG', 0.0022987471893429756)","('NON-ESG', 0.0020360175985842943)"
Line 394,"Zimmer Biomet’s Global Third-Party Compliance team  supports and monitors business partners, such as  distributors, to help ensure they adhere to the same ethical  standards as our team members.
","('Business_Ethics', 0.9358208179473877)","('Product_Quality_And_Safety', 0.011074191890656948)","('Management_Of_Legal_And_Regulatory_Framework', 0.00923059694468975)","(['Business Ethics'], 0.9358208179473877)","('NON-ESG', 0.011074191890656948)","('NON-ESG', 0.00923059694468975)"
Line 395,"To ensure compliance,  Zimmer Biomet performs anti-corruption due diligence  prior to engaging a third party, and periodically thereafter  during the course of the Company’s relationship with a  third-party, in addition to third-party compliance audits.
","('Business_Ethics', 0.9615827202796936)","('Management_Of_Legal_And_Regulatory_Framework', 0.007149140350520611)","('Systemic_Risk_Management', 0.003490621689707041)","(['Business Ethics'], 0.9615827202796936)","('NON-ESG', 0.007149140350520611)","('NON-ESG', 0.003490621689707041)"
Line 396,"Zimmer Biomet also has a dedicated global compliance  investigations team staffed by experienced anti-corruption  investigators that manages and conducts all compliance  investigations.
","('Business_Ethics', 0.9663779735565186)","('Management_Of_Legal_And_Regulatory_Framework', 0.007614686153829098)","('Data_Security', 0.002313290722668171)","(['Business Ethics'], 0.9663779735565186)","('NON-ESG', 0.007614686153829098)","('NON-ESG', 0.002313290722668171)"
Line 397,"Whistleblower Program Zimmer Biomet’s ability to deliver on our Mission of  improving lives depends on us being a Trusted Partner .
","('Business_Ethics', 0.7886842489242554)","('Data_Security', 0.06275943666696548)","('Management_Of_Legal_And_Regulatory_Framework', 0.03415348753333092)","(['Business Ethics'], 0.7886842489242554)","('NON-ESG', 0.06275943666696548)","('NON-ESG', 0.03415348753333092)"
Line 398,"Team  members and business partners are empowered to speak  up whenever there’s a concern about a potential or actual  violation of organizational policies, procedures or internal  controls, or applicable laws, regulations and industry codes.
","('Management_Of_Legal_And_Regulatory_Framework', 0.71689373254776)","('Business_Ethics', 0.1790342777967453)","('Director_Removal', 0.011019916273653507)","(['Corporate Governance'], 0.71689373254776)","('NON-ESG', 0.1790342777967453)","('NON-ESG', 0.011019916273653507)"
Line 399,"Concerns can be raised directly to managers, Compliance,  HR or through the Company’s Compliance Hotline.
","('Business_Ethics', 0.5965112447738647)","('Management_Of_Legal_And_Regulatory_Framework', 0.2210569679737091)","('Systemic_Risk_Management', 0.03113301284611225)","(['Business Ethics'], 0.5965112447738647)","('NON-ESG', 0.2210569679737091)","('NON-ESG', 0.03113301284611225)"
Line 400,"The  Code strictly prohibits retaliation related to Compliance  reporting.
","('Business_Ethics', 0.87510085105896)","('Management_Of_Legal_And_Regulatory_Framework', 0.0669386014342308)","('Product_Quality_And_Safety', 0.006251800339668989)","(['Business Ethics'], 0.87510085105896)","('NON-ESG', 0.0669386014342308)","('NON-ESG', 0.006251800339668989)"
Line 401,"Zimmer Biomet’s Compliance function tracks and oversees  all reported concerns from investigation to resolution.
","('Business_Ethics', 0.8901721835136414)","('Management_Of_Legal_And_Regulatory_Framework', 0.04454731568694115)","('Product_Quality_And_Safety', 0.008103381842374802)","(['Business Ethics'], 0.8901721835136414)","('NON-ESG', 0.04454731568694115)","('NON-ESG', 0.008103381842374802)"
Line 402,"The  Company has developed a robust and rigorous remediation  process to ensure appropriate corrective actions are  implemented following all substantiated investigations,  such as team member separations, documented warnings  and retraining.
","('Employee_Health_And_Safety', 0.21535927057266235)","('Critical_Incident_Risk_Management', 0.2138756364583969)","('Business_Ethics', 0.14895927906036377)","('NON-ESG', 0.21535927057266235)","('NON-ESG', 0.2138756364583969)","('NON-ESG', 0.14895927906036377)"
Line 403,"100% COMPLETION REMEDIATION ACTIVITIES In 2020: • We had 100 percent completion of remediation  activities arising from compliance investigations,  audits and monitoring.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5054508447647095)","('Business_Ethics', 0.2888842523097992)","('Product_Quality_And_Safety', 0.03014400601387024)","(['Corporate Governance'], 0.5054508447647095)","('NON-ESG', 0.2888842523097992)","('NON-ESG', 0.03014400601387024)"
Line 404,"Ethical Marketing Zimmer Biomet engages in marketing to provide valuable  information regarding our products and services to  healthcare professionals (HCPs), patients and others.
","('Selling_Practices_And_Product_Labeling', 0.5649093389511108)","('Customer_Welfare', 0.0900726392865181)","('Product_Quality_And_Safety', 0.07456590235233307)","(['Marketing Practices'], 0.5649093389511108)","('NON-ESG', 0.0900726392865181)","('NON-ESG', 0.07456590235233307)"
Line 405,"All marketing activities conducted by Zimmer Biomet must  have a commercially reasonable and legitimate business  purpose, and not involve cash, fees or other forms of  compensation provided directly or indirectly to HCPs or  public officials.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6386464238166809)","('Business_Ethics', 0.15129011869430542)","('Competitive_Behavior', 0.055258382111787796)","(['Corporate Governance'], 0.6386464238166809)","('NON-ESG', 0.15129011869430542)","('NON-ESG', 0.055258382111787796)"
Line 406,"Marketing activities are also expected to  be separate from any company-sponsored training or  education program.
","('Access_And_Affordability', 0.17545095086097717)","('Customer_Welfare', 0.13603447377681732)","('Product_Quality_And_Safety', 0.09022361785173416)","('NON-ESG', 0.17545095086097717)","('NON-ESG', 0.13603447377681732)","('NON-ESG', 0.09022361785173416)"
Line 407,"We do not use marketing to improperly  influence purchasing, leasing, recommendation, use,  prescription or coverage decisions associated with our  products and services.22Zimmer Biomet’s Statement of  Engagement on Public Policy Issues  Zimmer Biomet operates in a heavily regulated global  marketplace and, therefore, believes it is important to  be able to express its views on a variety of proposals to  policymakers and other stakeholders in a transparent  manner.
","('Selling_Practices_And_Product_Labeling', 0.27872738242149353)","('Management_Of_Legal_And_Regulatory_Framework', 0.12145740538835526)","('Competitive_Behavior', 0.11028435826301575)","('NON-ESG', 0.27872738242149353)","('NON-ESG', 0.12145740538835526)","('NON-ESG', 0.11028435826301575)"
Line 408,"These efforts include monitoring public policy  proposals, analyzing these proposals and advocating for  those policies that enhance patient and healthcare provider  access to innovative technologies to treat debilitating joint  pain and musculoskeletal conditions.
","('Employee_Health_And_Safety', 0.8456416726112366)","('Access_And_Affordability', 0.022913143038749695)","('Employee_Engagement_Inclusion_And_Diversity', 0.014657552354037762)","(['Operational Eco-Efficiency'], 0.8456416726112366)","('NON-ESG', 0.022913143038749695)","('NON-ESG', 0.014657552354037762)"
Line 409,"Zimmer Biomet is committed to participating constructively  and responsibly in the public policy process.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9145978093147278)","('Human_Rights_And_Community_Relations', 0.013873191550374031)","('Physical_Impacts_Of_Climate_Change', 0.007863697595894337)","(['Corporate Governance'], 0.9145978093147278)","('NON-ESG', 0.013873191550374031)","('NON-ESG', 0.007863697595894337)"
Line 410,"Government  policy proposals to regulate the healthcare system may  directly affect the Company’s business and the incentives  for innovation.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9677351713180542)","('Access_And_Affordability', 0.0036050451453775167)","('Human_Rights_And_Community_Relations', 0.0030353483743965626)","(['Corporate Governance'], 0.9677351713180542)","('NON-ESG', 0.0036050451453775167)","('NON-ESG', 0.0030353483743965626)"
Line 411,"There are also important policy proposals  that can further the Company’s business interests, including  those of the Company’s shareholders.
","('Management_Of_Legal_And_Regulatory_Framework', 0.763671338558197)","('Business_Model_Resilience', 0.036723412573337555)","('Director_Removal', 0.033656466752290726)","(['Corporate Governance'], 0.763671338558197)","('NON-ESG', 0.036723412573337555)","('NON-ESG', 0.033656466752290726)"
Line 412,"Zimmer Biomet  actively seeks to inform the debate on these proposals in  the United States and in other countries.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9210110306739807)","('GHG_Emissions', 0.008789094164967537)","('Physical_Impacts_Of_Climate_Change', 0.008547734469175339)","(['Corporate Governance'], 0.9210110306739807)","('NON-ESG', 0.008789094164967537)","('NON-ESG', 0.008547734469175339)"
Line 413,"The Company also  supports policies that advance the interests of patients,  improve public health and promote access to healthcare  and innovation.
","('Access_And_Affordability', 0.8693647980690002)","('Human_Rights_And_Community_Relations', 0.021739061921834946)","('Critical_Incident_Risk_Management', 0.01023698877543211)","(['Health Outcome Contribution'], 0.8693647980690002)","('NON-ESG', 0.021739061921834946)","('NON-ESG', 0.01023698877543211)"
Line 414,"Zimmer Biomet’s engagement in the political process is  focused on the following areas: • Access to musculoskeletal care • Transparent, timely, and scientifically-based regulatory  decision-making • Market-based payment or reimbursement • Strong protection of patents and other intellectual  property rights • Open and competitive access to international markets • Tax policies that support innovation and global  competitiveness  • Sensible medical malpractice reformSpecific policies of interest to Zimmer Biomet include the  following: • Corporate Tax Policy  – Zimmer Biomet supported  the changes to the U.S. corporate tax code in 2017 ,  which created a more globally competitive system for  U.S. businesses by lowering the corporate tax rate and  shifting to a territorial system.
","('Competitive_Behavior', 0.9068153500556946)","('Management_Of_Legal_And_Regulatory_Framework', 0.0238992627710104)","('Business_Ethics', 0.01196599006652832)","(['Business Ethics'], 0.9068153500556946)","('NON-ESG', 0.0238992627710104)","('NON-ESG', 0.01196599006652832)"
Line 415,"Zimmer Biomet’s engagement in the political process is  focused on the following areas: • Access to musculoskeletal care • Transparent, timely, and scientifically-based regulatory  decision-making • Market-based payment or reimbursement • Strong protection of patents and other intellectual  property rights • Open and competitive access to international markets • Tax policies that support innovation and global  competitiveness  • Sensible medical malpractice reformSpecific policies of interest to Zimmer Biomet include the  following: • Corporate Tax Policy  – Zimmer Biomet supported  the changes to the U.S. corporate tax code in 2017 ,  which created a more globally competitive system for  U.S. businesses by lowering the corporate tax rate and  shifting to a territorial system.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9604640007019043)","('Competitive_Behavior', 0.006912821438163519)","('Business_Ethics', 0.0033319718204438686)","(['Corporate Governance'], 0.9604640007019043)","('NON-ESG', 0.006912821438163519)","('NON-ESG', 0.0033319718204438686)"
Line 416,"• Stability in Payment Policies  – As innovation in  medical technology changes the way that care is  delivered, Zimmer Biomet supports payment and  reimbursement policies that ensure stability and  access for patients, providers, innovators and the  entire healthcare ecosystem.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5227261185646057)","('Business_Ethics', 0.1525350660085678)","('Systemic_Risk_Management', 0.1279590129852295)","(['Corporate Governance'], 0.5227261185646057)","('NON-ESG', 0.1525350660085678)","('NON-ESG', 0.1279590129852295)"
Line 417,"• Diversity, Equity and Inclusion – Zimmer Biomet  supports policies that strengthen a diverse and  inclusive medical technology workforce and ensure  equitable patient access to innovative devices and  therapies.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9746125340461731)","('Employee_Health_And_Safety', 0.0021498682908713818)","('Human_Rights_And_Community_Relations', 0.0016170217422768474)","(['Human Capital Development'], 0.9746125340461731)","('NON-ESG', 0.0021498682908713818)","('NON-ESG', 0.0016170217422768474)"
Line 418,"• Medical Device User Fee Amendments (MDUFA)  – Zimmer Biomet supports a well-resourced and well- functioning U.S. Food and Drug Administration (FDA).
","('Management_Of_Legal_And_Regulatory_Framework', 0.6149132251739502)","('Competitive_Behavior', 0.07667873799800873)","('Customer_Welfare', 0.04330259561538696)","(['Corporate Governance'], 0.6149132251739502)","('NON-ESG', 0.07667873799800873)","('NON-ESG', 0.04330259561538696)"
Line 419,"The long-standing user fee program has helped FDA  make significant improvements to the regulatory  approval process for new medical devices.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8865981698036194)","('Competitive_Behavior', 0.03997935727238655)","('Product_Quality_And_Safety', 0.007172728423029184)","(['Corporate Governance'], 0.8865981698036194)","('NON-ESG', 0.03997935727238655)","('NON-ESG', 0.007172728423029184)"
Line 420,"In 2021,  Zimmer Biomet and its industry trade group will  begin negotiations with FDA and Congress regarding  changes to MDUFA in anticipation of legislation in  2022.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9450916647911072)","('Competitive_Behavior', 0.006305236369371414)","('GHG_Emissions', 0.004950516391545534)","(['Corporate Governance'], 0.9450916647911072)","('NON-ESG', 0.006305236369371414)","('NON-ESG', 0.004950516391545534)"
Line 421,"• Support for International Trade Agreements  –  Zimmer Biomet supports trade policy initiatives that  seek to improve access to medical devices in overseas  export markets.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6968419551849365)","('Competitive_Behavior', 0.14125947654247284)","('Labor_Practices', 0.02273576706647873)","(['Corporate Governance'], 0.6968419551849365)","('NON-ESG', 0.14125947654247284)","('NON-ESG', 0.02273576706647873)"
Line 422,"23How Zimmer Biomet Engages The primary means by which Zimmer Biomet engages  in public policy debate is through communication of   information to government officials, policy makers and  their staffs.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9344869256019592)","('Human_Rights_And_Community_Relations', 0.009603221900761127)","('Physical_Impacts_Of_Climate_Change', 0.00528755784034729)","(['Corporate Governance'], 0.9344869256019592)","('NON-ESG', 0.009603221900761127)","('NON-ESG', 0.00528755784034729)"
Line 423,"Zimmer Biomet’s Government Affairs office  in Washington, D.C. is responsible for advocacy activities  with the U.S. Congress and the Executive Branch, as well as  advocacy at the state level.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9385911822319031)","('Human_Rights_And_Community_Relations', 0.007084826938807964)","('Director_Removal', 0.006309676915407181)","(['Corporate Governance'], 0.9385911822319031)","('NON-ESG', 0.007084826938807964)","('NON-ESG', 0.006309676915407181)"
Line 424,"The Government Affairs office,  which also has staff outside the United States, reports to the  Senior Vice President and General Counsel.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8712693452835083)","('Director_Removal', 0.0190114788711071)","('Business_Ethics', 0.008834361098706722)","(['Corporate Governance'], 0.8712693452835083)","('NON-ESG', 0.0190114788711071)","('NON-ESG', 0.008834361098706722)"
Line 425,"Globally, the  Company currently has eight full-time employees wholly  dedicated to Government Affairs matters.
","('Management_Of_Legal_And_Regulatory_Framework', 0.47247594594955444)","('Labor_Practices', 0.11805206537246704)","('Director_Removal', 0.10969901084899902)","('NON-ESG', 0.47247594594955444)","('NON-ESG', 0.11805206537246704)","('NON-ESG', 0.10969901084899902)"
Line 426,"To assist with its advocacy and policy analysis work,  Zimmer Biomet occasionally contracts with private firms  specializing in government affairs advocacy.
","('Management_Of_Legal_And_Regulatory_Framework', 0.934499979019165)","('Human_Rights_And_Community_Relations', 0.009098520502448082)","('Director_Removal', 0.004745831713080406)","(['Corporate Governance'], 0.934499979019165)","('NON-ESG', 0.009098520502448082)","('NON-ESG', 0.004745831713080406)"
Line 427,"These firms  provide the organization with expertise on issues that are  important to the Company and its shareholders.
","('Management_Of_Legal_And_Regulatory_Framework', 0.37881919741630554)","('Business_Model_Resilience', 0.11202067136764526)","('Systemic_Risk_Management', 0.08254816383123398)","('NON-ESG', 0.37881919741630554)","('NON-ESG', 0.11202067136764526)","('NON-ESG', 0.08254816383123398)"
Line 428,"In compliance with the U.S. Lobbying Disclosure Act ,  Zimmer Biomet files quarterly reports with the U.S.  Congress describing the Company’s advocacy activities  in Washington, D.C. and the amount of money spent each  quarter to support these activities.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9153329133987427)","('Director_Removal', 0.009861513040959835)","('Business_Ethics', 0.008422202430665493)","(['Corporate Governance'], 0.9153329133987427)","('NON-ESG', 0.009861513040959835)","('NON-ESG', 0.008422202430665493)"
Line 429,"These reports also  include the cost of maintaining the Government Affairs  office in Washington, D.C. and the portion of Zimmer  Biomet’s trade association dues associated with advocacy  activities.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9499933123588562)","('Director_Removal', 0.0055716861970722675)","('Business_Ethics', 0.005133521743118763)","(['Corporate Governance'], 0.9499933123588562)","('NON-ESG', 0.0055716861970722675)","('NON-ESG', 0.005133521743118763)"
Line 430,"To view Zimmer Biomet’s quarterly lobbying  expenditures, click on the above link and search for Zimmer  Biomet under registrant.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7830579876899719)","('Competitive_Behavior', 0.06448131799697876)","('Business_Ethics', 0.022270215675234795)","(['Corporate Governance'], 0.7830579876899719)","('NON-ESG', 0.06448131799697876)","('NON-ESG', 0.022270215675234795)"
Line 431,"All Zimmer Biomet employees and agents must abide by the  Company’s Code of Business Conduct and Ethics.
","('Business_Ethics', 0.9619169235229492)","('Customer_Privacy', 0.003618063172325492)","('Product_Quality_And_Safety', 0.0029517074581235647)","(['Business Ethics'], 0.9619169235229492)","('NON-ESG', 0.003618063172325492)","('NON-ESG', 0.0029517074581235647)"
Line 432,"This Code  covers a wide range of business practices and procedures,  and is designed to deter wrongdoing and promote the highest ethical standards.
","('Business_Ethics', 0.971839189529419)","('Management_Of_Legal_And_Regulatory_Framework', 0.002628694288432598)","('Product_Quality_And_Safety', 0.0022902791388332844)","(['Business Ethics'], 0.971839189529419)","('NON-ESG', 0.002628694288432598)","('NON-ESG', 0.0022902791388332844)"
Line 433,"Among other things, the Code  makes clear that no illegal payments of any kind (monetary  or otherwise) are to be offered or made to an individual or  entity—including officials or employees of national, state,  local or foreign governments or national or foreign political  candidates—at any time or under any circumstances.
","('Business_Ethics', 0.9135029315948486)","('Management_Of_Legal_And_Regulatory_Framework', 0.02024383284151554)","('Labor_Practices', 0.009865078143775463)","(['Business Ethics'], 0.9135029315948486)","('NON-ESG', 0.02024383284151554)","('NON-ESG', 0.009865078143775463)"
Line 434,"Industry Groups and Trade Associations Zimmer Biomet is a member of several industry and trade  groups.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5828256011009216)","('Competitive_Behavior', 0.15230700373649597)","('Labor_Practices', 0.03408832848072052)","(['Corporate Governance'], 0.5828256011009216)","('NON-ESG', 0.15230700373649597)","('NON-ESG', 0.03408832848072052)"
Line 435,"The Company works with these groups on a variety  of issues of importance to Zimmer Biomet and the medical  device industry.
","('Supply_Chain_Management', 0.2839304804801941)","('Product_Design_And_Lifecycle_Management', 0.20676198601722717)","('Customer_Welfare', 0.07091302424669266)","('NON-ESG', 0.2839304804801941)","('NON-ESG', 0.20676198601722717)","('NON-ESG', 0.07091302424669266)"
Line 436,"These groups can help the industry reach  consensus on policy issues and be more effective with  issue advocacy.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7888920903205872)","('Human_Rights_And_Community_Relations', 0.06453129649162292)","('Physical_Impacts_Of_Climate_Change', 0.02858939953148365)","(['Corporate Governance'], 0.7888920903205872)","('NON-ESG', 0.06453129649162292)","('NON-ESG', 0.02858939953148365)"
Line 437,"With Zimmer Biomet representatives  on the boards and committees of industry groups and  associations, the Company can voice questions or concerns  it may have about policy or related activities.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9147189855575562)","('Director_Removal', 0.017429817467927933)","('Human_Rights_And_Community_Relations', 0.009138225577771664)","(['Corporate Governance'], 0.9147189855575562)","('NON-ESG', 0.017429817467927933)","('NON-ESG', 0.009138225577771664)"
Line 438,"At times,  the Company may not agree fully with the views of these  associations or their individual member companies; in such  instances, Zimmer Biomet reserves the right to remove  itself from related association or industry group activities  when the Company determines it is appropriate to do so.
","('Management_Of_Legal_And_Regulatory_Framework', 0.36726492643356323)","('Competitive_Behavior', 0.13869480788707733)","('Director_Removal', 0.13343247771263123)","('NON-ESG', 0.36726492643356323)","('NON-ESG', 0.13869480788707733)","('NON-ESG', 0.13343247771263123)"
Line 439,"Following is a list of U.S. industry and trade groups of which  Zimmer Biomet is a member and for which the Company  pays at least $25,000/year in membership fees, with the  percentage of fees attributable to non-tax deductible,  federal lobbying expenditures noted in italics:  • Advanced Medical Technology Association   (AdvaMed) – 10% • Medical Device Competitiveness Coalition   (MDCC) – 100%  • U.S. Chamber of Commerce – 20-25%  24Political Contributions Zimmer Biomet’s policies prohibit contributions of  corporate funds to candidates, political party committees  and political action committees.
","('Competitive_Behavior', 0.6361619234085083)","('Management_Of_Legal_And_Regulatory_Framework', 0.20804941654205322)","('Business_Ethics', 0.03856193646788597)","(['Business Ethics'], 0.6361619234085083)","('NON-ESG', 0.20804941654205322)","('NON-ESG', 0.03856193646788597)"
Line 440,"Following is a list of U.S. industry and trade groups of which  Zimmer Biomet is a member and for which the Company  pays at least $25,000/year in membership fees, with the  percentage of fees attributable to non-tax deductible,  federal lobbying expenditures noted in italics:  • Advanced Medical Technology Association   (AdvaMed) – 10% • Medical Device Competitiveness Coalition   (MDCC) – 100%  • U.S. Chamber of Commerce – 20-25%  24Political Contributions Zimmer Biomet’s policies prohibit contributions of  corporate funds to candidates, political party committees  and political action committees.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9283292889595032)","('Business_Ethics', 0.008503677323460579)","('Director_Removal', 0.008181093260645866)","(['Corporate Governance'], 0.9283292889595032)","('NON-ESG', 0.008503677323460579)","('NON-ESG', 0.008181093260645866)"
Line 441,"Contributions by Zimmer  Biomet’s Political Action Committee (Z-PAC) – which is  supported entirely by voluntary contributions made by  employees and non-employee directors of the Company  – support candidates, parties or committees whose views  on specific issues are consistent with the Company’s  priorities.
","('Management_Of_Legal_And_Regulatory_Framework', 0.37054529786109924)","('Director_Removal', 0.2049500197172165)","('Human_Rights_And_Community_Relations', 0.08249514549970627)","('NON-ESG', 0.37054529786109924)","('NON-ESG', 0.2049500197172165)","('NON-ESG', 0.08249514549970627)"
Line 442,"The Z-PAC is governed by an Advisory Committee  consisting of representatives from across the Company’s  U.S. business units and business functions.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4218556582927704)","('Director_Removal', 0.17000305652618408)","('Competitive_Behavior', 0.04922833666205406)","('NON-ESG', 0.4218556582927704)","('NON-ESG', 0.17000305652618408)","('NON-ESG', 0.04922833666205406)"
Line 443,"The Advisory  Committee reviews Z-PAC activities and establishes policies  and priorities.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8130030632019043)","('Human_Rights_And_Community_Relations', 0.050463974475860596)","('Ecological_Impacts', 0.01749030500650406)","(['Corporate Governance'], 0.8130030632019043)","('NON-ESG', 0.050463974475860596)","('NON-ESG', 0.01749030500650406)"
Line 444,"The Z-PAC contributes to candidates and political  committees on a bi-partisan basis, and does not make  contributions in connection with U.S. Presidential elections.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5810424089431763)","('Competitive_Behavior', 0.08794979751110077)","('Director_Removal', 0.07138636708259583)","(['Corporate Governance'], 0.5810424089431763)","('NON-ESG', 0.08794979751110077)","('NON-ESG', 0.07138636708259583)"
Line 445,"Contribution decisions are not made to reflect the personal  political views or interests of senior management.
","('Director_Removal', 0.1568872332572937)","('Management_Of_Legal_And_Regulatory_Framework', 0.12966251373291016)","('Customer_Privacy', 0.12494395673274994)","('NON-ESG', 0.1568872332572937)","('NON-ESG', 0.12966251373291016)","('NON-ESG', 0.12494395673274994)"
Line 446,"In deciding  whom to support, consideration is given to candidates who  represent the communities Zimmer Biomet serves, those  who serve on relevant committees or in leadership and  those who have shown support for policies and initiatives of  importance to the Company.
","('Management_Of_Legal_And_Regulatory_Framework', 0.46061086654663086)","('Director_Removal', 0.16018256545066833)","('Human_Rights_And_Community_Relations', 0.08903030306100845)","('NON-ESG', 0.46061086654663086)","('NON-ESG', 0.16018256545066833)","('NON-ESG', 0.08903030306100845)"
Line 447,"Z-PAC contribution guidelines  also emphasize the character and integrity of candidates,  including the candidate’s position on issues that may impair  Zimmer Biomet’s corporate reputation or are contrary to its  values, such as the candidate’s positions and record in the  area of diversity, equity and inclusion.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9693208336830139)","('Employee_Health_And_Safety', 0.00238137342967093)","('Human_Rights_And_Community_Relations', 0.0022869491949677467)","(['Human Capital Development'], 0.9693208336830139)","('NON-ESG', 0.00238137342967093)","('NON-ESG', 0.0022869491949677467)"
Line 448,"Contributions made  by the Z-PAC are, as required by law, reported in filings with  the Federal Election Commission (FEC).
","('Management_Of_Legal_And_Regulatory_Framework', 0.8663074374198914)","('Director_Removal', 0.01570836454629898)","('Ecological_Impacts', 0.01234497968107462)","(['Corporate Governance'], 0.8663074374198914)","('NON-ESG', 0.01570836454629898)","('NON-ESG', 0.01234497968107462)"
Line 449,"The most recent  FEC report is available here .Following the events of January 6, 2021 at the U.S. Capitol  in Washington, DC, we halted our Z-PAC contributions, but  these contributions have since been partially reinstated.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6803083419799805)","('Director_Removal', 0.06428924947977066)","('Business_Ethics', 0.025891734287142754)","(['Corporate Governance'], 0.6803083419799805)","('NON-ESG', 0.06428924947977066)","('NON-ESG', 0.025891734287142754)"
Line 450,"We continue to review the ongoing pause in contributions  to those who voted against the Presidential election  certification in Arizona and/or Pennsylvania.252020 Sustainability Accounting Standards Board Index We are proud to publish Zimmer Biomet’s first Sustainability Accounting Standards Board (SASB) Index.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6576830148696899)","('Director_Removal', 0.05107584595680237)","('Product_Quality_And_Safety', 0.04746147617697716)","(['Corporate Governance'], 0.6576830148696899)","('NON-ESG', 0.05107584595680237)","('NON-ESG', 0.04746147617697716)"
Line 451,"This reflects our  continued commitment to our sustainability efforts and increased transparency in our sustainability disclosures.
","('Business_Ethics', 0.6387910842895508)","('Systemic_Risk_Management', 0.07192594558000565)","('Management_Of_Legal_And_Regulatory_Framework', 0.05458856374025345)","(['Business Ethics'], 0.6387910842895508)","('NON-ESG', 0.07192594558000565)","('NON-ESG', 0.05458856374025345)"
Line 452,"Topic Code SASB Metric 2020 Reporting Affordability & Pricing HC-MS-240a.2 Description of how price information for each  product is disclosed to customers or to their  agentsIn the United States, customers will typically  engage with a local sales representative  and local office to  provide pricing for  products.
","('Selling_Practices_And_Product_Labeling', 0.39367085695266724)","('Product_Design_And_Lifecycle_Management', 0.3532814383506775)","('Customer_Welfare', 0.06938166171312332)","('NON-ESG', 0.39367085695266724)","('NON-ESG', 0.3532814383506775)","('NON-ESG', 0.06938166171312332)"
Line 453,"Larger healthcare systems will issue  Requests for Proposals (RFPs).
","('Management_Of_Legal_And_Regulatory_Framework', 0.8838855028152466)","('Competitive_Behavior', 0.013008156791329384)","('Energy_Management', 0.011369962245225906)","(['Corporate Governance'], 0.8838855028152466)","('NON-ESG', 0.013008156791329384)","('NON-ESG', 0.011369962245225906)"
Line 454,"The pricing is  communicated through the contract process  either via hard copy (local, state or federal  government accounts), email or through  electronic interchanges.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9026861190795898)","('Business_Ethics', 0.018621185794472694)","('Competitive_Behavior', 0.01749817468225956)","(['Corporate Governance'], 0.9026861190795898)","('NON-ESG', 0.018621185794472694)","('NON-ESG', 0.01749817468225956)"
Line 455,"Product Safety HC-MS-250a.1 Number of recalls issued, total units recalled 21 recalls in 2020.
","('Product_Quality_And_Safety', 0.8812742233276367)","('Selling_Practices_And_Product_Labeling', 0.020085889846086502)","('Employee_Health_And_Safety', 0.009302315302193165)","(['Product Quality & Recall Management'], 0.8812742233276367)","('NON-ESG', 0.020085889846086502)","('NON-ESG', 0.009302315302193165)"
Line 456,"Product Safety HC-MS-250a.3 Number of fatalities related to products as  reported in the FDA Manufacturer and User  Facility Device ExperienceNone Product Safety HC-MS-250a.4 Number of FDA enforcement actions taken  in response to violations of current Good  Manufacturing Practices (cGMP), by typeIn 2020, Zimmer Biomet did not receive any   warning letters, seizures, or consent decrees.
","('Product_Quality_And_Safety', 0.9179729223251343)","('Selling_Practices_And_Product_Labeling', 0.014213266782462597)","('Employee_Health_And_Safety', 0.007898367941379547)","(['Product Quality & Recall Management'], 0.9179729223251343)","('NON-ESG', 0.014213266782462597)","('NON-ESG', 0.007898367941379547)"
Line 457,"Ethical Marketing HC-MS-270a.1 Total amount of monetary losses as a result  of legal proceedings associated with false  marketing claimsNone Ethical Marketing HC-MS-270a.2 Description of code of ethics governing  promotion of off-label use of productsPlease see page Product Design &  Lifecycle ManagementHC-MS-410a.2 Total amount of products accepted for takeback  and reused, recycled, or donated, broken down  by: 1) devices and equipment and 2) suppliesNone Supply Chain  ManagementHC-MS-430a.1 Percentage of 1) entity's facilities and 2) tier I  suppliers' facilities participating in third-party  audit programs for manufacturing and product  quality100% of Zimmer Biomet manufacturing   sites are audited by a third party and are   ISO certified.
","('Product_Design_And_Lifecycle_Management', 0.7832183241844177)","('Selling_Practices_And_Product_Labeling', 0.06064051017165184)","('Product_Quality_And_Safety', 0.05196386203169823)","(['Product Stewardship'], 0.7832183241844177)","('NON-ESG', 0.06064051017165184)","('NON-ESG', 0.05196386203169823)"
Line 458,"Ethical Marketing HC-MS-270a.1 Total amount of monetary losses as a result  of legal proceedings associated with false  marketing claimsNone Ethical Marketing HC-MS-270a.2 Description of code of ethics governing  promotion of off-label use of productsPlease see page Product Design &  Lifecycle ManagementHC-MS-410a.2 Total amount of products accepted for takeback  and reused, recycled, or donated, broken down  by: 1) devices and equipment and 2) suppliesNone Supply Chain  ManagementHC-MS-430a.1 Percentage of 1) entity's facilities and 2) tier I  suppliers' facilities participating in third-party  audit programs for manufacturing and product  quality100% of Zimmer Biomet manufacturing   sites are audited by a third party and are   ISO certified.
","('Product_Design_And_Lifecycle_Management', 0.7543968558311462)","('Product_Quality_And_Safety', 0.12187307327985764)","('Supply_Chain_Management', 0.018844692036509514)","(['Product Stewardship'], 0.7543968558311462)","('NON-ESG', 0.12187307327985764)","('NON-ESG', 0.018844692036509514)"
Line 459,"50% of Tier 1 suppliers are audited by a third  party.
","('Supply_Chain_Management', 0.8744347095489502)","('Systemic_Risk_Management', 0.01494059432297945)","('Labor_Practices', 0.011219507083296776)","(['Supply Chain Management'], 0.8744347095489502)","('NON-ESG', 0.01494059432297945)","('NON-ESG', 0.011219507083296776)"
Line 460,"The highest risk suppliers are audited by a third  party as part of their ISO certification or are  audited by a Zimmer Biomet facility.
","('Supply_Chain_Management', 0.9126579761505127)","('Systemic_Risk_Management', 0.01611712947487831)","('Waste_And_Hazardous_Materials_Management', 0.005468291696161032)","(['Supply Chain Management'], 0.9126579761505127)","('NON-ESG', 0.01611712947487831)","('NON-ESG', 0.005468291696161032)"
Line 461,"Those suppliers not participating in third-party  audit programs have been vetted as the lowest  risk,  given the minimal likelihood of severity  to the Zimmer Biomet quality system based  on a failure of the product or service to meet  specifications.26Topic Code SASB Metric 2020 Reporting Supply Chain  ManagementHC-MS-430a.2 Description of efforts to maintain traceability  within the distribution chainZimmer Biomet and all distributors, including all  sales and office staff, are required to implement   identification and traceability controls.
","('Supply_Chain_Management', 0.5825924873352051)","('Product_Design_And_Lifecycle_Management', 0.2539033591747284)","('Product_Quality_And_Safety', 0.02576822228729725)","(['Supply Chain Management'], 0.5825924873352051)","('NON-ESG', 0.2539033591747284)","('NON-ESG', 0.02576822228729725)"
Line 462,"Those suppliers not participating in third-party  audit programs have been vetted as the lowest  risk,  given the minimal likelihood of severity  to the Zimmer Biomet quality system based  on a failure of the product or service to meet  specifications.26Topic Code SASB Metric 2020 Reporting Supply Chain  ManagementHC-MS-430a.2 Description of efforts to maintain traceability  within the distribution chainZimmer Biomet and all distributors, including all  sales and office staff, are required to implement   identification and traceability controls.
","('Data_Security', 0.45409879088401794)","('Customer_Privacy', 0.1503114402294159)","('Systemic_Risk_Management', 0.11229091882705688)","('NON-ESG', 0.45409879088401794)","('NON-ESG', 0.1503114402294159)","('NON-ESG', 0.11229091882705688)"
Line 463,"Distribution records must include the  customer's name, address, part number, control  number, date and quantity shipped.
","('Customer_Privacy', 0.7350096106529236)","('Waste_And_Hazardous_Materials_Management', 0.041715286672115326)","('Selling_Practices_And_Product_Labeling', 0.03795922175049782)","(['Privacy Protection'], 0.7350096106529236)","('NON-ESG', 0.041715286672115326)","('NON-ESG', 0.03795922175049782)"
Line 464,"The distribution record is maintained by  Zimmer Biomet from the time of receipt  through storage, handling and distribution  until the product is implanted into a patient,  permanently retired from use or permanently  disposed of.
","('Product_Design_And_Lifecycle_Management', 0.7876772284507751)","('Selling_Practices_And_Product_Labeling', 0.07635316997766495)","('Waste_And_Hazardous_Materials_Management', 0.026545071974396706)","(['Product Stewardship'], 0.7876772284507751)","('NON-ESG', 0.07635316997766495)","('NON-ESG', 0.026545071974396706)"
Line 465,Supply Chain  ManagementHC-MS-430a.3 Description of the management of risks  associated with the use of critical materialsPlease see page Business Ethics HC-MS-510a.1 Total amount of monetary losses as a result of  legal proceedings associated with bribery or  corruptionNone Business Ethics HC-MS-510a.2 Description of code of ethics governing  interactions with health care professionalsPlease see page For ESG surveys please contact surveys@zimmerbiomet.com For ESG inquiries please contact Keri Mattox at keri.mattox@zimmerbiomet.com    or Ezgi Yagci at ezgi.yagci@zimmerbiomet.com  ©2020 Zimmer Biomet  | www.zimmerbiomet.com  | 3427.1-GLBL-en-Issue Date 2021-MM-DD,"('Business_Ethics', 0.9726650714874268)","('Data_Security', 0.002094999887049198)","('Systemic_Risk_Management', 0.0020188309717923403)","(['Business Ethics'], 0.9726650714874268)","('NON-ESG', 0.002094999887049198)","('NON-ESG', 0.0020188309717923403)"
Line 466,Supply Chain  ManagementHC-MS-430a.3 Description of the management of risks  associated with the use of critical materialsPlease see page Business Ethics HC-MS-510a.1 Total amount of monetary losses as a result of  legal proceedings associated with bribery or  corruptionNone Business Ethics HC-MS-510a.2 Description of code of ethics governing  interactions with health care professionalsPlease see page For ESG surveys please contact surveys@zimmerbiomet.com For ESG inquiries please contact Keri Mattox at keri.mattox@zimmerbiomet.com    or Ezgi Yagci at ezgi.yagci@zimmerbiomet.com  ©2020 Zimmer Biomet  | www.zimmerbiomet.com  | 3427.1-GLBL-en-Issue Date 2021-MM-DD,"('Customer_Welfare', 0.31302961707115173)","('Competitive_Behavior', 0.08227553218603134)","('Product_Design_And_Lifecycle_Management', 0.08109986037015915)","('NON-ESG', 0.31302961707115173)","('NON-ESG', 0.08227553218603134)","('NON-ESG', 0.08109986037015915)"
